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ALTERNATIVE SCENARIOS FOR HEALTH, 
LIFE EXPECTANCY AND SOCIAL EXPENDITURE 




This study deals with the impact of ageing populations and changes in their health status on 
health care and the utilisation of long-term care services. Two kinds of projection methods 
have been used to estimate increases up to 2050 in the number of hospital cases and days, 
contacts with doctors, long-term care recipients and severely hampered persons for Belgium, 
Denmark, Finland, France, Germany, the Netherlands, Spain and the UK. In the first 
projection method, health care utilisation data from national sources (which cover the whole 
population) are combined with two demographic scenarios. This kind of projection shows the 
impact of demographic change and increasing life expectancy on the utilisation of health care 
services. In the second projection method, data from the European Community Household 
Panel are used (which only includes persons aged 16+ but allows differentiation of utilisation 
data by health status) and combined with four demographic and health scenarios. 
The two projection methods generally point to the same findings: 
•  changes in the number of hospital days and in the demand for long-term care-giving (i.e. 
the number of severely hampered persons) are likely to be stronger than changes in the 
number of hospital admissions and contacts with doctors; 
•  an additional increase in life expectancy leads to higher population figures by 2050, but 
increases in the utilisation of health care services are more dynamic; and  
•  for the most part, countries with decreasing populations by 2050 do not show lower 
increases in the utilisation of health care services than countries with increasing 
populations. 
Improvements in health status lead to a more moderate increase in the utilisation of health 
care services compared with the scenarios that show no improvements in health. But in 
general, given the underlying assumptions improvements in health cannot completely 
compensate for the effect of increasing life expectancy.  
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GIR’s fourth work package (WP4) focuses on the implications of ageing 
populations for health care utilisation, health care expenditure, pension 
expenditure and the sustainability of public finance and pension regimes. It 
pays particular attention to the role of new insights concerning the relation between 
‘living-longer and in better health’ and health care consumption, health care expenditure 
and pension expenditure. So it may shed new light on the impact of the ageing process 
upon the future development of health care and long-term care utilisation and important 
macroeconomic variables. 
Generally it is expected that the ageing process will have an important effect on the 
sustainability of public finances, especially the pension systems and the health care 
systems. In the background is the fact that in all EU countries health care expenditure 
increases with age (EU-EPC, 2001) and that the share of the elderly will increase in the 
future too. But the population development is not directly related to health care 
expenditures. Besides demography, other important factors influence health care 
expenditures, especially medical and technological progress, political decisions and 
economic framework conditions. A study for Germany showed that health care 
expenditures were mostly influenced by technological progress and not by the ageing 
process (Breyer, 1999). The same results were observed for health care expenditures in 
the US (Okunade & Murthy, 2002). 
The level of health care expenditures is usually the result of demand and supply factors, 
political decisions (including those by health-care insurance schemes as well) and 
overall economic conditions. Ageing could be an important factor on the demand side. 
A relevant intermediate step is the current health status. Health status deteriorates with 
age, and health status is the main factor in the demand for health care services. In the 
case of long-term care, functional disability and mental illness (especially among the 
oldest old) play an important role. The relation between age, disability and the need for 
long-term care is stronger than in the case of acute health care. Therefore, alongside the 
ageing process the development of health status and disability influences the further 
demand for health care and long-term care services. Consequently, AGIR deals with 
both the ageing process and health status. 
WP4 focuses on the impact of increasing life expectancy on health care utilisation as 
well as on health care expenditures, pension benefits and public finances. Thus the tasks 
of WP4 are separated into two parts: Part A shows the impact of the demographic 
development and changes in the health status of the population on hospital cases, total 
hospital days and outpatient utilisation as well as on the number of long-term care 
recipients. This part of the research has been carried out by DIW (Berlin). Part B shows 
the impact of ageing populations on public finances, especially on health care 
expenditures and pension expenditures, and has been carried out by CPB (The Hague). 
WP4 builds a bridge between WPs 1, 2 and 3 on one hand and work WPs 5 and 6 on the 
other hand. The first three work packages have collected data on several important 
aspects for the participating countries (Belgium, Denmark, Finland, France, Germany, 
the Netherlands, Spain and the UK) on a similar basis. Whereas WPs1, 2 and 3 have 
focused on developments in the past, WP4 looks at future developments and uses the 
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collected data and information to make projections to 2050. The sensitivity of 
demographic projections for health care utilisation, expenditures and retirement benefits 
are demonstrated using a scenario approach with alternative assumptions about 
improvements in life expectancy and health. WPs 5 and 6 draw upon these scenarios to 
enable a discussion of policies that may cope with the population ageing problem. 
Part A of WP4 presents projections of hospital cases, hospital days, contacts with 
doctors and long-term care recipients for eight EU countries (depending on the available 
data) with reference to the results of WP1 and WP2. The countries are: Belgium, 
Denmark, Finland, France, Germany, the Netherlands, Spain and the UK. Part A gives 
an idea of the further utilisation of inpatient and outpatient care as well as long-term 
care. This information can be useful for government officials, hospital administrators, 
practising physicians and providers of long-term care – mostly communities – to 
address the changes brought about by population ageing. In detail, the research has 
required the following tasks: 
•  provide population scenarios with alternative assumptions about further 
improvements in life expectancy; 
•  build scenarios about the further development of health status; 
•  formulate projections about acute and long-term care utilisation; and 
•  assess the impact of population development and female labour-force participation 
on the potential supply of informal care-givers. 
To present the results of these tasks this report is divided into four chapters. In chapter 
1, demographic and health scenarios are shown. The Eurostat baseline scenario is used 
as a base case and an additional demographic scenario is created with higher 
improvements in life expectancy to show the impact of living longer (living-longer 
scenario). A combination of these two demographic scenarios with an improving health 
scenario lead to the baseline better-health and living longer in better health scenarios.  
In WP2 data were collected on two levels: first, country-specific data from national 
sources was collected that covered the total population and also gave information about 
long-term care-giving in institutions and as well as by professional care-givers at home, 
but did not allow differentiation by the health status of the population. Second, data was 
collected from the European Community Household Panel (ECHP), which covers only 
persons in private households aged 16+, but allows differentiation by health status. 
Therefore, the following projections are also made on two levels. In chapter 2 the 
impact of demographic developments on acute health and long-term care using country-
specific data is projected. In this section the impact of the two demographic scenarios, 
mainly the impact of improving life expectancy, is shown on a national level for most of 
the eight participating countries. In chapter 3 the four demographic and health scenarios 
are used to show the effect of demographic developments and further improvements in 
the health status of the population on acute health care and on the need for long-term 
care based on data from the ECHP. These projections can be carried out for the EU (15) 
and the participating countries. Chapter 2 and chapter 3 are based on different data sets 
and are therefore not fully compatible, but each of these approaches has its advantage 
and it is worthwhile to show the results. Chapter 4 deals with the impact of an ageing 
population on informal care-giving at home.  
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Chapter 1. 
Demographic and Health Scenarios 
1.1 Demographic  scenarios 
1.1.1 Assumptions 
The ageing process is determined by an increasing life expectancy and by fertility rates 
that are too low to ensure a natural replacement of the population. In the EU (15), the 
total fertility rate was on average 1.5 in 2002 (Table 1.1). In all participating countries 
the fertility rate has decreased in the past 40 years. In 2002 the highest fertility rate was 
realised in France with 1.9 and was the lowest in Spain with 1.25. 
Table 1.1 Fertility rate in selected EU countries 
 
The decreasing fertility rates were accompanied by increasing life expectancies. The life 
expectancy at birth within the EU (15) member states has increased in the last 40 years 
(between 1960 and 2002) by 8.4 years for men and 8.7 years for women; for the elderly 
(aged 60 years) the increase was 4.2 years (men) and 5.2 years (women) (Table 1.2). In 
the EU (15) the life expectancy at birth for men was 75.8 and 81.6 years for women in 
2002. The greatest gains in life expectancy at birth between 1960 and 2002 were seen in 
France, with 9.3 years for women and 8.7 years for men; the lowest appeared in 
Denmark with 5.1 years for women and 4.4 years for men (but Denmark had a high life 
expectancy in 1960). In 2002 the life expectancy for men aged 60 was 20.1 years (19.7 
years in 2000) and for women aged 60 it was 24.2 years (24.1 years in 2000) in the EU 
(15). Among the participating countries Spain and France had the highest life 
expectancy for both genders in 2000. Belgium, Denmark, Germany, the Netherlands, 
Finland and the UK could not achieve the EU (15) average in 2000.  
Whereas in the first decades of the 19
th century improvements in life expectancy could 
be mostly linked to the reduction of mortality rates at birth and in the first years of life, 
in recent decades the greatest reduction in mortality rates can be observed in the middle 
and higher ages. As a result more and more people are alive at older ages: the number of 
Countries 1960 1970 1980 1990 2000 2002
Belgium 2,56     2,25     1,68     1,62     1,66     1,62    
Denmark 2,57     1,95     1,55     1,67     1,77     1,72    
Finland 2,72     1,82     1,63     1,78     1,73     1,72    
France 2,73     2,47     1,95     1,78     1,88     1,89    
Germany 2,37     2,03     1,56     1,45     1,38     1,31    
Netherlands 3,12     2,57     1,60     1,62     1,72     1,73    
Spain 2,86     2,90     2,20     1,36     1,24     1,25    
United Kingdom 2,72     2,43     1,90     1,83     1,64     1,64    
EU (15) 2,59     2,38     1,82     1,57     1,50     1,50    
Source: Eurostat, Population Statistics 2004.4 | ERIKA SCHULZ 
 
centenarians shows a high increase. This development could heighten the pressure on 
the health care system if improvements in health do not counter this effect. 
Table 1.2 Life expectancy in selected EU countries 
 
Thus, the main focus of the AGIR work package (WP) 4 lies on the development of life 
expectancy at older ages and the question of to what extent further improvements in life 
expectancy can be anticipated. Studies show that in the past the further development of 
life expectancy was mostly underestimated. If life expectancy is computed by cohorts 
and not by periods, a higher life expectancy of five years can be assumed (Bomsdorf, 
1993). Furthermore, Oeppen & Vaupel (2002) showed in an analysis with worldwide 
data that since 1840 the life expectancy in the record-holding country has risen at a 
steady pace of almost three months per year for women. The record life expectancy has 
also risen linearly for men, albeit more slowly (2.2 months). Therefore, it may be that 
we can also expect a linear increase in life expectancy for the future. This idea is 
controversial as discussed by demographic experts. The majority of the experts assume 
that using an approach of the observed life expectancy to the maximum life span – 
which is assumed to be 120 years – the further increase will be not linear, but declining 
(see for example Birg, 2000 and Eurostat, 1998).  
Kannisto (1994) analysed the development of the oldest-old mortality rate between 
1950 and 1990 for 28 developed countries. The study shows that the mortality rate in 
older ages has undergone a substantial transformation in the developed countries during 
the post-war period, reaching much lower levels than have been recorded before. The 
so-called ‘new stage’ in mortality transition can be traced back to advances in medicine 
and in living conditions and to the fact that older persons have received increasing 
male female male female male female male female male female male female
Belgium 67,7     73,5     67,8     74,2     70,0     76,8     72,7     79,4     74,6     80,8     75,1     81,1    
Denmark 70,4     74,4     70,7     75,9     71,2     77,3     72,0     77,7     74,5     79,3     74,8     79,5    
Finland 65,5     72,5     66,5     75,0     69,2     77,6     70,9     78,9     74,2     81,0     74,9     81,5    
France 66,9     73,6     68,4     75,9     70,2     78,4     72,8     80,9     75,3     82,7     75,6     82,9    
Germany
1)2) 66,8     72,2     67,3     73,6     69,6     76,1     72,0     78,4     75,0     81,0     75,4     81,2    
Netherlands 71,5     75,3     70,7     76,5     72,7     79,3     773,8     80,9     75,5     80,5     76,0     80,7    
Spain 67,4     72,2     74,8     7,0     72,5     78,6     73,3     80,3     75,7     82,5     75,7     83,1    
United Kingdom 67,9     73,7     68,7     75,0     70,2     76,2     72,9     78,5     75,5     80,2     - -
EU (15) 67,4     72,9     68,4     74,7     70,5     77,2     72,8     79,4     75,5     81,4     75,8     81,6    
Belgium 15,5     18,7     15,2     19,2     16,3     20,9     17,9     22,7     19,3     23,8     19,6     23,9    
Denmark 17,1     19,3     17,1     20,6     17,0     21,4     17,4     21,6     18,9     22,3     19,1     22,4    
Finland - - - - 15,6     20,5     17,1     21,9     19,2     23,6     19,5     24,0    
France 15,6     19,5     16,2     20,8     17,3     22,4     19,0     24,1     20,4     25,5     - -
Germany
1)3) 15,5     18,4     15,1     18,9     16,4     20,7     17,4     21,7     19,4     23,6     19,7     23,8    
Netherlands 17,7     19,7     16,8     20,5     17,5     22,6     18,1     23,1     19,1     23,4     19,5     23,5    
Spain 16,5     19,2     16,8     20,0     18,4     22,1     19,1     23,3     20,3     24,9     - -
United Kingdom 15,0     18,9     15,2     19,8     15,9     20,4     17,5     21,8     19,4     23,0     - -
EU (15) 15,9     19,0     15,9     19,8     16,8     21,2     18,2     22,5     19,7     24,1     20,1     24,2    
1) 1960 West-Germany without Berlin.-  2) 1970 West-Germany.- 3) 1970 and 1980 West-Germany.
Source: Eurostat, Population Statistics 2004; Federal Statistical Office Germany.
at 60
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medical attention. The main beneficiaries of these advances are the elderly persons aged 
from their 60s to their 80s and 90s and, to a hardly lesser extent, even beyond. 
The population development under alternative assumptions regarding further life 
expectancy is basic information for the forecast of health care and long-term care 
utilisation. In view of the previous studies, particular attention was given to further 
developments in the mortality of the elderly. The AGIR participants
1 discussed in 
several meetings whether it would be valuable to make own-population projections 
based on the assumptions of the experts of a single country or if it is acceptable to use 
the widespread and well-known Eurostat population forecast. Finally it was decided to 
use the baseline scenario from Eurostat, which was specially prepared for the EU-EPC 
Working Group for Ageing in 2000 (EU-EPC, 2000), but to make additional scenarios 
with higher life expectancies taking into account an additional reduction in mortality 
rates. The CPB (Pellikaan & Westerhout, 2004) created three living-longer scenarios: 
•  the living-longer low scenario, which reduces the mortality rates of people aged 55 
to 85 stepwise to 20% until 2050; 
•  the living-longer middle scenario, which reduces the mortality rates of people aged 
20 to 90 by 35.7% until 2050; and 
•  the living-longer high scenario, which reduces the mortality rates of persons aged 20 
to 90 by 50% in gradual equal steps until 2050 (performed for all scenarios in 
addition to the reduction of mortality rates in the Eurostat baseline scenario). 
In all alternative scenarios the assumptions about the development of the total fertility 
rates and the migration flows are the same as in the baseline scenario from Eurostat.  
Table 1.3 shows the assumptions from Eurostat for the baseline scenario and for the 
three alternative mortality scenarios. Generally, an overall increase in fertility rates is 
expected from Eurostat. On average the EU (15) fertility rate is expected to rise from 
1.5 in 1999 to 1.8 in 2050. In Belgium, Denmark, France, the Netherlands and the UK 
the total fertility rate does indeed rise up to 1.8 by 2050 (Eurostat baseline scenario). 
For Finland (1.7), Germany and Spain (both 1.5), the fertility rate is expected to be 
lower than in the other participating countries. Eurostat gives no clear explanation as to 
why they expect an overall increase in fertility rates. In a discussion about the 
assumptions from Eurostat, the experts of the single participating countries mostly 
assume no increase in fertility rates.  
Where the net migration is held nearly constant in the Eurostat baseline scenario,
2 the 
average EU (15) life expectancy at birth for men is projected to rise by five years from 
75 years in 2000 to 80 years in 2050; for women an increase of four years is expected 
(from 81 years to 85 years in 2050 – Eurostat baseline scenario). It is anticipated that 
the life expectancy in all participating countries will increase, but the rates of change 
                                                 
1 FPB (Belgium), Terkel Christiansen (Denmark), ETLA (Finland), Legos (France), DIW (Germany), 
CPB (the Netherlands), FEDEA (Spain), NIESR (the UK) and CEPS (Belgium). 
2 Eurostat take into consideration the effect of EU enlargement on migration in another scenario with 
higher migration, but in the baseline scenario the migration trends in the past were used for the forecast. 6 | ERIKA SCHULZ 
 
vary between 1999 and 2050. The highest gain in life expectancy is expected for 
Finland with a rate of 6.5% and the lowest is expected for the Netherlands with 3.8%  
Table 1.3 Assumptions of population forecasts 
 
The living-longer scenarios expect a higher increase in life expectancies. In the living-
longer low scenario the life expectancy is around 1.1 to 1.3 years higher as in the 
baseline scenario in 2050. In the living-longer middle scenario, an additional gain is 
assumed in life expectancy of around 3.1 to 3.5 years and in the living-longer high an 
additional increase of around 4.7 to 5.3 years is assumed (2050). 
1.1.2 Population  development 
In 1999 around 375 million people lived in the EU (15) (Table 1.4). The population will 
increase in the next 20 years in the baseline and living-longer low scenarios. If the 
increase in life expectancy is higher, a growth of the population is expected for the next 
30 years (living-longer middle and high scenarios), but after 2020-30 a decline is 
expected in all scenarios. In the baseline scenario, 363 million people are projected to 
live in the EU (15) in 2050; in the living-longer low (middle/high) scenario the 
population forecast is around 5 (14/22) million higher (2050). Whereas the total EU 
(15) population decreases until 2050 in the baseline and living-longer low scenarios, the 
population in the living-longer middle and living-longer high scenarios is higher in 
2050 than in the base year. 
1999 2050 1999 2050 1999 2050
low middle high
Belgium 1,5       1,8       78,2       83,0       84,1       86,1       87,7       10 978 15 000
Denmark 1,8       1,8       77,0       81,4       82,8       84,9       86,7       10 876 10 000
Finland 1,7       1,7       77,9       82,9       84,1       86,1       87,8       5 499 5 000
France 1,7       1,8       79,2       83,8       84,9       87,0       88,5       50 230 50 000
Germany 1,4       1,5       78,3       82,9       84,1       86,2       87,8       192 000 200 000
Netherlands 1,7       1,8       78,6       81,5       82,8       84,9       86,7       32 594 35 000
Spain 1,2       1,5       79,0       82,4       83,6       85,7       87,4       30 257 60 000
United Kingdom 1,7       1,8       78,2       82,9       84,2       86,2       87,9       175 000 70 000
EU (15) 1,5       1,8       78,0       82,6       83,8       85,8       87,4       637 254 622 000
Living-longer-scenario: Fertility rates and migration same assumptions as baseline-scenario, life expectancy higher as a
result of 20% (low), 35,7% (middle) and 50% (high) reduction of mortality rates between 55 and 85 years (low) and between
20 to 90 years (middle and high).
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Table 1.4 Population development (million persons) 
 
Countries 1999 2001 2010 2020 2030 2040 2050
Belgium 10,2   10,2   10,4   10,5   10,5   10,4   10,1  
Denmark 5,3   5,4   5,5   5,6   5,6   5,6   5,5  
Finland 5,2   5,2   5,3   5,3   5,3   5,1   4,9  
France 59,2   59,6   61,5   62,9   63,7   63,3   61,9  
Germany 82,1   82,5   83,5   83,2   81,8   79,3   75,6  
Netherlands 16,0   16,2   16,8   17,3   17,6   17,7   17,6  
Spain 39,4   39,5   39,9   39,5   38,5   37,2   34,9  
United Kingdom 59,5   59,8   61,0   62,3   63,2   62,8   61,6  
Total 277,0   278,5   283,8   286,6   286,3   281,4   272,2  
EU (15) 376,3   378,0   383,8   386,0   384,0   376,3   362,7  
Belgium 10,2   10,2   10,4   10,5   10,6   10,5   10,2  
Denmark 5,3   5,4   5,5   5,6   5,7   5,7   5,6  
Finland 5,2   5,2   5,3   5,3   5,3   5,2   5,0  
France 59,2   59,6   61,6   63,1   64,1   63,9   62,7  
Germany 82,1   82,5   83,6   83,6   82,4   80,3   76,9  
Netherlands 16,0   16,2   16,8   17,4   17,8   17,9   17,8  
Spain 39,4   39,5   39,9   39,6   38,8   37,6   35,5  
United Kingdom 59,5   59,8   61,1   62,5   63,7   63,5   62,6  
Total 277,0   278,5   284,2   287,7   288,3   284,6   276,4  
EU (15) 376,3   378,0   384,4   387,5   386,8   380,6   368,4  
Belgium 10,2   10,2   10,4   10,6   10,7   10,7   10,5  
Denmark 5,3   5,4   5,5   5,6   5,8   5,8   5,8  
Finland 5,2   5,2   5,3   5,4   5,4   5,3   5,1  
France 59,2   59,6   61,7   63,5   64,6   64,9   64,0  
Germany 82,1   82,5   83,7   84,1   83,4   81,7   78,9  
Netherlands 16,0   16,2   16,8   17,5   18,0   18,2   18,2  
Spain 39,4   39,5   40,0   39,8   39,2   38,3   36,5  
United Kingdom 59,5   59,8   61,2   62,9   64,3   64,5   64,0  
Total 277,0   278,5   284,7   289,3   291,2   289,2   282,9  
EU (15) 376,3   378,0   385,1   389,6   390,6   386,8   377,2  
Belgium 10,2   10,2   10,4   10,6   10,8   10,8   10,6  
Denmark 5,3   5,4   5,5   5,6   5,8   5,9   5,9  
Finland 5,2   5,2   5,3   5,4   5,4   5,3   5,2  
France 59,2   59,6   61,8   63,7   65,1   65,6   65,0  
Germany 82,1   82,5   83,9   84,5   84,1   82,8   80,5  
Netherlands 16,0   16,2   16,9   17,5   18,1   18,4   18,6  
Spain 39,4   39,5   40,1   40,0   39,5   38,8   37,2  
United Kingdom 59,5   59,8   61,3   63,1   64,7   65,3   65,1  
Total 277,0   278,6   285,1   290,4   293,5   292,9   288,2  
EU (15) 376,3   378,0   385,6   391,2   393,7   391,7   384,3  
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In the baseline scenario, four countries among those participating experience an increase 
in population (Denmark, France, the Netherlands and the UK) and four countries a 
decrease (Belgium, Finland, Germany and Spain) until 2050 (Figure 1.1 and Table A1). 
In the living-longer high scenario, only Germany and Spain experience a decrease. The 
population development in the living-longer low and middle scenarios are between the 
results of the baseline scenario and the living-longer high scenario. The differences 
between the single scenarios are not too large; therefore, the following sections focus 
only on the baseline scenario and the living-longer high scenario as the two scenarios 
with the highest difference in the results of population development. 
In all EU countries the population is growing older. In the participating countries 
altogether around 18 million people were aged 75 to 89 in 1999, contributing to the EU 
(15) total of 25 million (Table 1.5). By 2050 the figure is forecast to double in the 
baseline scenario. In 1999, 1.6 million people aged 90+ lived in the participating 
countries altogether and in the EU (15) the figure was 2.1 million. The number of these 
‘oldest old’ will triple by 2050 in the baseline scenario. As a result of the reduced 
mortality rates in the middle and higher ages, the number of the oldest old is markedly 
higher in the living-longer high scenario in 2050. The number of people aged 90+ 
accounts for around 8.5 million in the participating countries altogether and for around 
11.5 million in the EU (15). 
Table 1.5 Population development by age group (per 1000 persons) 
Countries
0 - 14 15 - 59 60 - 74 75 - 89 90+ total 0 - 14 15 - 59 60 - 74 75 - 89 90+ total
Belgium  1 795  6 190  1 506   677   54  10 222  1 795  6 190  1 506   677   54  10 222
Denmark   983  3 299   674   347   29  5 332   983  3 299   674   347   29  5 332
Finland   943  3 204   694   310   21  5 172   943  3 204   694   310   21  5 172
France  11 145  35 909  7 927  3 809   405  59 194  11 145  35 909  7 927  3 809   405  59 194
Germany  12 915  50 380  13 098  5 274   477  82 144  12 915  50 380  13 098  5 274   477  82 144
Netherlands  2 978  10 092  1 945   902   68  15 985  2 978  10 092  1 945   902   68  15 985
Spain  5 940  24 970  5 726  2 612   185  39 432  5 940  24 970  5 726  2 612   185  39 432
United Kingdom  11 390  35 994  7 785  3 965   370  59 503  11 390  35 994  7 785  3 965   370  59 503
Total  48 089  170 038  39 355  17 895  1 609  276 985  48 089  170 038  39 355  17 895  1 609  276 985
EU (15)  63 565  231 328  54 519  24 721  2 148  376 282  63 565  231 328  54 519  24 721  2 148  376 282
Belgium  1 620  5 913  1 970   900   92  10 495  1 620  5 926  2 001   972   112  10 631
Denmark   879  3 232   963   455   34  5 562   879  3 240   986   495   42  5 642
Finland   830  2 935  1 057   452   42  5 315   830  2 942  1 077   489   51  5 389
France  10 470  35 396  11 292  5 096   688  62 942  10 470  35 485  11 476  5 448   806  63 686
Germany  11 243  47 714  15 183  8 363   733  83 236  11 243  47 828  15 449  9 064   890  84 474
Netherlands  2 834  10 017  3 055  1 289   106  17 302  2 834  10 040  3 118  1 404   130  17 526
Spain  5 283  23 428  6 842  3 499   400  39 452  5 283  23 491  6 958  3 778   480  39 990
United Kingdom  10 146  36 307  10 562  4 786   502  62 303  10 146  36 375  10 769  5 205   607  63 102
Total  43 305  164 942  50 924  24 840  2 597  286 607  43 305  165 326  51 833  26 856  3 119  290 439
EU (15)  56 850  222 283  68 896  34 386  3 591  386 006  56 850  222 791  70 109  37 158  4 314  391 221
Belgium  1 549  5 252  1 777  1 326   172  10 076  1 549  5 281  1 856  1 654   304  10 643
Denmark   874  3 079   870   654   69  5 546   874  3 099   924   844   127  5 869
Finland   728  2 607   910   599   86  4 930   728  2 624   954   751   151  5 207
France  9 571  32 107  10 768  8 207  1 267  61 920  9 571  32 319  11 251  9 858  2 016  65 013
Germany  9 764  39 016  14 316  11 026  1 471  75 593  9 764  39 236  15 002  13 949  2 581  80 533
Netherlands  2 900  9 816  2 774  1 885   211  17 585  2 900  9 873  2 931  2 465   406  18 575
Spain  4 289  17 032  7 109  5 803   649  34 882  4 289  17 155  7 480  7 172  1 130  37 226
United Kingdom  9 550  32 775  10 630  7 661  1 016  61 631  9 550  32 923  11 141  9 726  1 788  65 127
Total  39 224  141 684  49 153  37 161  4 940  272 163  39 224  142 509  51 539  46 418  8 503  288 192
EU (15)  51 091  187 261  66 184  51 484  6 723  362 743  51 091  188 325  69 333  63 987  11 514  384 250
Sources: EU-EPC 2000 (Baseline scenario); Pellikaan/Westerhout 2004 (Living-longer scenarios). 
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Finland will experience the highest increase in their oldest-old population. The number 
of people aged 90+ will be four times higher in 2050 than in 1999 (baseline scenario) 
and seven times higher in the living-longer high scenario (Table 1.6). Denmark will 
experience the lowest increase in their oldest-old population: in the baseline scenario the 
number of people aged 90+ will double and in the living-longer high scenario it will 
quadruple. Generally, in the participating countries the combined number of persons 
aged under 60 years in 2050 will be around 80% of the basic figure in 1999, the number 
of persons aged 60-74 (the younger old) will increase up to 125% (131%), the older 
population (aged 75-89) will double (260%) and the oldest old (90+) will triple (528%) 
in the baseline scenario (living-longer high scenario). Thus the development is nearly 
the same in the participating countries altogether as in the EU (15). 
Table 1.6 Population development by age group (1999 = 100) 
 
For all the participating countries, massive displacements in the age structure were 
expected with the greatest displacements anticipated for Spain (Figure 1.2 and Tables 
A2 and A3): the share of active Spanish people aged 15 to 59 will decrease by 15 
percentage points (from 63% in 1999 to 49% in the baseline scenario and to 46% in the 
living-longer high scenario in 2050), whereas the share of people aged 75-89 will 
increase by 10 percentage points (from 7% to 17% in the baseline scenario and to 19% 
in the living-longer high scenario). The changing age structure will lead to an increase 
in the old age dependency ratio in all EU countries.  
Countries
0 - 14 15 - 59 60 - 74 75 - 89 90+ Total 0 - 14 15 - 59 60 - 74 75 - 89 90+ Total
Belgium   90       96       131       133       171       103       90       96       133       144       208       104    
Denmark   89       98       143       131       116       104       89       98       146       143       142       106    
Finland   88       92       152       146       199       103       88       92       155       158       243       104    
France   94       99       142       134       170       106       94       99       145       143       199       108    
Germany   87       95       116       159       154       101       87       95       118       172       187       103    
Netherlands   95       99       157       143       155       108       95       99       160       156       190       110    
Spain   89       94       120       134       216       100       89       94       122       145       260       101    
United Kingdom   89       101       136       121       136       105       89       101       138       131       164       106    
Total   90       97       129       139       161       103       90       97       132       150       194       105    
EU (15)   89       96       126       139       167       103       89       96       129       150       201       104    
Belgium   86       85       118       196       321       99       86       85       123       244       566       104    
Denmark   89       93       129       189       232       104       89       94       137       243       432       110    
Finland   77       81       131       194       410       95       77       82       137       242       718       101    
France   86       89       136       216       313       105       86       90       142       259       498       110    
Germany   76       77       109       209       309       92       76       78       115       265       542       98    
Netherlands   97       97       143       209       308       110       97       98       151       273       594       116    
Spain   72       68       124       222       351       88       72       69       131       275       611       94    
United Kingdom   84       91       137       193       275       104       84       91       143       245       483       109    
Total   82       83       125       208       307       98       82       84       131       259       528       104    
EU (15)   80       81       121       208       313       96       80       81       127       259       536       102    
Sources: EU-EPC 2000 (Baseline scenario); Pellikaan/Westerhout 2004 (Living-longer scenarios). 
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Figure 1.2 Age structure of the population in the EU and participating countries  
 altogether (PC) 
1.2 Health  scenarios 
Alongside the ageing process, health status has an important influence on health care 
utilisation and health care expenditure. Therefore, one task of WP4 has been to generate 
alternative health scenarios. If the hypothesis of increasing life expectancy being 
connected with ‘living longer in better health’ is true, then it could be expected that the 
changes in the health of the elderly have important consequences for the further demand 
of health care services, the need for long-term care and also for the development of 
health care expenditures. Better health suggests that the demand for health and long-
term care by the elderly could decrease. Hence the development of health care 
expenditures could be more moderate than in the case of a static projection with 
constant, age-specific morbidity rates. 
1.2.1  Life expectancy and changes in health status 
The AGIR WP1 study on bio-demographic aspects of ageing carried out by FEDEA 
focused on the following question: Is increasing life expectancy connected with living 
longer in better health (Ahn et al., 2003)? Whereas data on life expectancy are available 
for all countries as long-time series, data about the health status of a population are rare. 
Information about self-assessed health are available from national health surveys (NHS) 
and the European Community Household Panel (ECHP). But an overall clear trend in 
self-assessed health could not be observed in the past, neither from the NHS data nor 
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calculated life expectancies in good health (LEGH) and disability-free life expectancies 
(DFLE). But these indicators do not show a clear trend in the past either: Spain, Ireland, 
Greece and Italy seem to improve in the health of their populations, while Portugal and 
France appear to have a deteriorating trend. In view of these results FEDEA concludes 
“We think it is difficult to establish any coherent set of hypotheses for projections of 
health status based on past trends” (Ahn et al., 2003, p. 66). The same conclusion is 
drawn from the analyses based on NHS: “In summary, our examination of the data from 
the National Health Surveys leads us to conclude that it is impossible to establish any 
trend of health status and health expectancy using these data” (Ahn et al., 2003, p. 67).  
In view of these results additional analyses were done with data from the ECHP. It 
could be shown that a higher level of education is connected with a better health status. 
Therefore, FEDEA concludes that a more educated population will lead to 
improvements in the health status of the EU population. For the future, an increase of 
the average level of education of the population is assumed and thus improvements in 
the health status can be expected. 
FEDEA used the concept of health-adjusted life expectancies to create two health 
scenarios. The first scenario assumes that the proportion of good health expectancies 
and life expectancies stays constant at the average level of the period 1994-98 (based on 
data from the ECHP). The second scenario assumes that good health expectancies 
increase by the same number of years as life expectancies, thus implying that any gain 
in life years is free of health and disability problems. They calculated life expectancy in 
good health (LEGH), disability-free life expectancy (DFLE) and severe disability-free 
life expectancy (SDFLE) at age 15 and 65 for men and women for 2010 and 2025.  
The calculation of life expectancies in good health is used for the projection of health 
care utilisation in chapter 3. Based on data from the ECHP it is possible to forecast the 
population aged 15+ differentiated by health status. In the ECHP, people were asked 
“How is your health in general – very good, good, fair, bad or very bad?”. These five 
answer categories were grouped in this study to very good/good, fair, bad/very bad and 
the proportion of people in these three health categories were calculated. FEDEA 
implies in their first health scenario that the health status of the population remains 
constant (constant health status), while the second health scenario leads to a higher 
share of people in good health, because additional years are assumed to be years in good 
health (better health scenario). To calculate the changes in the share of people in good 
health, the differences in the growth rates of LEGH between the first (constant health 
status) and the second scenarios (improvements in health) are used for the projection to 
2025. From 2025 to 2050 the growth rate of life expectancy is much lower than between 
2010 and 2025 (the assumption of the Eurostat baseline scenario) and thus it is also 
assumed that the growth rates of the share of people in good health are more moderate 
(two-thirds of the growth rate between 2010 and 2025). FEDEA calculated that 
improvements in life expectancy in good health are higher for people aged 65 than for 
people aged 15. Thus, the projection made in this part also takes the latter into account.  
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Table 1.7 Share of people aged 15+ in good/very good, fair, bad/very bad health 









15-29 0,91     0,08     0,01     0,93     0,07     0,00     0,94     0,06     0,00    
30-44 0,84     0,12     0,03     0,86     0,13     0,01     0,87     0,13     0,00    
45-59 0,73     0,22     0,05     0,74     0,22     0,03     0,75     0,23     0,02    
60-69 0,58     0,35     0,07     0,61     0,36     0,03     0,63     0,36     0,00    
70-79 0,48     0,40     0,13     0,50     0,41     0,09     0,52     0,41     0,06    
80+ 0,39     0,45     0,16     0,41     0,46     0,13     0,42     0,47     0,11    
15-29 0,91     0,08     0,01     0,91     0,08     0,00     0,92     0,08     0,00    
30-44 0,84     0,13     0,03     0,85     0,13     0,02     0,86     0,13     0,01    
45-59 0,75     0,20     0,05     0,76     0,20     0,04     0,76     0,20     0,03    
60-69 0,62     0,28     0,10     0,64     0,28     0,08     0,66     0,29     0,05    
70-79 0,52     0,32     0,16     0,54     0,32     0,14     0,55     0,33     0,12    
80+ 0,40     0,36     0,24     0,41     0,37     0,22     0,42     0,37     0,20    
15-29 0,89     0,10     0,01     0,91     0,09     0,00     0,92     0,08     0,01    
30-44 0,84     0,15     0,01     0,85     0,15     0,00     0,86     0,14     0,00    
45-59 0,56     0,38     0,06     0,57     0,39     0,04     0,58     0,39     0,03    
60-69 0,40     0,51     0,09     0,42     0,52     0,06     0,44     0,53     0,03    
70-79 0,24     0,62     0,15     0,25     0,63     0,11     0,26     0,64     0,09    
80+ 0,15     0,52     0,34     0,16     0,53     0,31     0,16     0,54     0,30    
15-29 0,79     0,19     0,02     0,81     0,18     0,01     0,83     0,17     0,00    
30-44 0,69     0,27     0,04     0,71     0,27     0,02     0,73     0,28     0,00    
45-59 0,55     0,37     0,08     0,57     0,38     0,06     0,58     0,38     0,04    
60-69 0,42     0,45     0,13     0,46     0,48     0,07     0,48     0,49     0,03    
70-79 0,28     0,54     0,19     0,30     0,56     0,13     0,32     0,58     0,10    
80+ 0,20     0,59     0,21     0,22     0,61     0,16     0,24     0,63     0,13    
15-29 0,76     0,19     0,06     0,79     0,19     0,02     0,82     0,18     0,00    
30-44 0,62     0,29     0,09     0,65     0,30     0,06     0,67     0,30     0,03    
45-59 0,38     0,40     0,22     0,40     0,41     0,19     0,42     0,41     0,17    
60-69 0,25     0,48     0,28     0,28     0,51     0,21     0,31     0,53     0,16    
70-79 0,17     0,48     0,36     0,19     0,51     0,30     0,21     0,53     0,26    
80+ 0,10     0,40     0,50     0,11     0,43     0,45     0,12     0,45     0,42    
15-29 0,88     0,10     0,02     0,89     0,10     0,00     0,90     0,10     0,00    
30-44 0,83     0,15     0,03     0,84     0,15     0,02     0,85     0,15     0,00    
45-59 0,71     0,24     0,05     0,72     0,24     0,04     0,72     0,24     0,03    
60-69 0,58     0,35     0,07     0,60     0,36     0,04     0,62     0,36     0,01    
70-79 0,47     0,43     0,10     0,49     0,44     0,07     0,51     0,44     0,05    
80+ 0,37     0,52     0,11     0,39     0,53     0,09     0,40     0,54     0,06    
15-29 0,92     0,07     0,02     0,93     0,07     0,00     0,95     0,05     0,00    
30-44 0,83     0,14     0,03     0,84     0,14     0,02     0,85     0,14     0,01    
45-59 0,65     0,26     0,09     0,66     0,26     0,07     0,67     0,26     0,06    
60-69 0,42     0,37     0,21     0,46     0,38     0,16     0,48     0,39     0,13    
70-79 0,31     0,41     0,28     0,33     0,43     0,24     0,35     0,44     0,21    
80+ 0,24     0,41     0,35     0,26     0,43     0,31     0,27     0,44     0,29    
15-29 0,78     0,17     0,05     0,80     0,17     0,03     0,81     0,17     0,02    
30-44 0,73     0,19     0,08     0,75     0,19     0,06     0,76     0,19     0,05    
45-59 0,70     0,20     0,10     0,71     0,20     0,08     0,73     0,20     0,07    
60-69 0,61     0,28     0,11     0,65     0,28     0,06     0,68     0,29     0,03    
70-79 0,54     0,31     0,15     0,58     0,32     0,10     0,60     0,33     0,07    
80+ 0,49     0,32     0,19     0,52     0,33     0,15     0,54     0,34     0,12    
15-29 0,85     0,13     0,03     0,86     0,13     0,01     0,87     0,12     0,01    
30-44 0,77     0,19     0,05     0,78     0,19     0,03     0,79     0,19     0,02    
45-59 0,61     0,29     0,09     0,63     0,29     0,08     0,64     0,30     0,07    
60-69 0,43     0,39     0,18     0,46     0,40     0,14     0,48     0,41     0,11    
70-79 0,32     0,43     0,26     0,33     0,44     0,23     0,35     0,45     0,20    
80+ 0,24     0,42     0,34     0,25     0,43     0,32     0,26     0,44     0,30    
1) People in good and very good health.-  2) People in bad and very bad health.
Sources: ECHP; calculations by DIW.
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Table 1.7 shows the results of the health status projection. In the first health scenario the 
observed share of people in good/very good health, fair health and bad/very bad health 
by age group in the single country and in the EU (15 without Luxembourg or Sweden) 
in 2001 is held constant over the forecast period. In the second health scenario the share 
of people in good health increases. Based on the assumptions of WP1, France and 
Germany will experience the highest improvements in health and the Netherlands the 
lowest, but in all countries the share of people in bad/very bad health decreases to an 
appreciable degree until 2050. The differences in the proportion of people in good, fair 
and bad health between the single countries in 2001 cannot only be explained by real 
differences in health status. The self-assessed health status is also influenced by other 
factors, such as culture or traditional behaviour. Thus, the health scenarios are used to 
show the effect of improvements in health within the countries, but not to explain 
different developments between the countries. 
1.2.2  Population development by health status 
These health scenarios combined with the two demographic scenarios – the baseline 
scenario and the living-longer high scenario – yield four further scenarios as illustrated 
in Table 1.8: 
−  a baseline scenario with constant health status (1); 
−  a living-longer scenario with constant health status (2); 
−  a baseline scenario with improvements in health (3); and 
−  a living longer in better health scenario (4). 
Table 1.8 Population scenarios by health status 
 
For these four scenarios the population aged 15+ as subdivided by health status can be 
projected until 2050. Table 1.9 and Figure 1.3 show the population development 
between 2001 and 2050 in the four scenarios. The difference between the baseline 
scenario and the living-longer scenario shows the effect of improvements in life 
expectancy, the difference with the baseline better-health scenario reveals the effect of 
improvements in health status and the difference with the living longer in better health 
scenario shows the combination of these effects.  
In the participating countries around 140 million people aged 15+ were in good health 
(61%), 64 million were in fair health (28%) and 26 million (11%) were in bad health in 
Demographic constant proportion of people increasing proportion of people 
scenarios  in good/fair/bad health  in good health
Baseline baseline scenario  baseline scenario with 
scenarios with constant health improvements in health
Living-longer-high living-longer scenario  living-longer in 
scenarios with constant health better health scenario
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2001 (Table 1.9). The analogue figures for the EU (15 without Luxembourg or Sweden) 
were 197 million in good health (64%), 78 million in fair health (26%) and 32 million in 
bad health (10%). In the baseline scenario (with constant age-specific health status) the 
number of people in good health will decrease, while the number of people in fair and 
bad health will increase between 2001 and 2050 in the EU and in the participating 
countries altogether. Whereas the total population aged 15+ is expected to be nearly the 
same in 2050 as in the base year, the number of people in good health will decrease by 
11% (EU) and 8% (participating countries), the number of people in fair health will 
increase by 11% (EU and participating countries) and the number of people in bad 
health will increase by 31% (EU) and 24% (participating countries) (Figure 1.3 and 
Table A4). The ageing process leads to a reduction of the proportion of people in good 
health (to 56% in the participating countries and 58% in the EU in 2050), although the 
health status in the single age group and country is held constant.  
In the living-longer scenario with higher life expectancies, the increase of people in bad 
health will be much higher. The number of people in bad health rises by 51% in the EU 
and by 41% in the participating countries altogether between 2001 and 2050. Thus, the 
proportion of people in good health will decline to 54% in the participating countries 
combined and to 56% in the EU in 2050, while the proportion of people in bad health 
will increase to nearly 15%.  
Improvements in health status lead to a contrary effect. In the baseline scenario with 
improvements in health the share of people in bad health in 2050 at 8% (participating 
countries) and 10% (EU) is lower than in the base year and significantly lower than in 
the baseline scenario in 2050.  
The results of the living longer in better health scenario show that the effects of 
improvements in health compensate for the effect of an additional increase in life 
expectancy. Improvements in health reduce the proportion of people in bad health by 
5.5 percentage points in the participating countries and by 3.9 percentage points in the 
EU in 2050, while a higher life expectancy leads to an increase of the proportion of 
people in bad health by 1 percentage point in the EU and 0.7 percentage points in the 
participating countries (living-longer scenario). 
According to the assumptions, the changes between 2001 and 2050 in the single age 
group for people in good, fair or bad health are the same in the two scenarios with 
constant health status. The highest increase is expected for the oldest persons aged 80+ 
by around 160% in the EU in the baseline scenario and 260% in the living-longer 
scenario. But improvements in health change these figures. The increase of persons 
aged 80+ in bad health will be lower, 120% in the baseline scenario with improvements 
in health and 210% in the living longer in better health scenario (EU), and the increase 
of persons aged 80+ in good health will be higher, 180% and 290% respectively (EU). 16 | ERIKA SCHULZ 
 
Table 1.9 Population aged 15+ by health status in 2001 and 2050 
good health fair health bad health good health fair health bad health
Belgium 6,32     1,75     0,40     74,61     20,63     4,77    
Denmark 3,30     0,79     0,27     75,69     18,20     6,12    
Finland 2,74     1,28     0,25     64,13     29,95     5,92    
France 28,61     16,28     3,71     58,86     33,49     7,64    
Germany 33,14     23,88     12,74     47,50     34,24     18,26    
Netherlands 9,68     2,89     0,61     73,42     21,93     4,65    
Spain  23,26     7,09     3,33     69,07     21,05     9,88    
UK 33,65     10,41     4,45     69,37     21,45     9,18    
All 140,70     64,37     25,77     60,95     27,88     11,16    
EU (15)* 197,36     78,26     31,71     64,22     25,46     10,32    
Belgium 5,97     2,05     0,51     69,99     24,03     5,98    
Denmark 3,37     0,95     0,36     72,16     20,23     7,61    
Finland 2,41     1,44     0,36     57,32     34,16     8,52    
France 27,81     19,52     5,02     53,13     37,29     9,58    
Germany 27,11     23,78     14,95     41,18     36,12     22,70    
Netherlands 10,24     3,66     0,79     69,74     24,91     5,35    
Spain  17,86     8,16     4,57     58,38     26,69     14,94    
UK 34,83     11,93     5,32     66,88     22,90     10,22    
All 129,60     87,16     41,47     55,64     30,68     13,68    
EU (15)* 174,77     87,16     41,47     57,60     28,73     13,67    
Belgium 6,22     2,29     0,59     68,35     25,15     6,50    
Denmark 3,52     1,06     0,42     70,39     21,23     8,38    
Finland 2,47     1,58     0,43     55,10     35,27     9,62    
France 28,63     21,22     5,60     51,63     38,27     10,10    
Germany 27,79     25,85     17,14     39,26     36,52     24,22    
Netherlands 10,67     4,12     0,89     68,04     26,30     5,67    
Spain  18,55     9,10     5,29     56,32     27,62     16,06    
UK 36,64     13,01     5,93     65,93     23,41     10,66    
All 134,47     78,22     36,28     54,01     31,42     14,57    
EU (15)* 180,85     95,78     47,81     55,74     29,52     14,74    
Belgium 6,21     2,09     0,23     72,87     24,45     2,68    
Denmark 3,49     0,94     0,24     74,71     20,19     5,10    
Finland 2,51     1,45     0,24     59,74     34,48     5,78    
France 29,95     20,27     2,13     57,22     38,71     4,07    
Germany 30,08     25,58     10,17     45,69     38,86     15,45    
Netherlands 10,63     3,73     0,33     72,39     25,39     2,23    
Spain  18,84     8,46     3,29     61,59     27,66     10,75    
UK 36,89     12,36     2,83     70,83     23,73     5,44    
All 138,61     74,87     19,46     59,50     32,14     8,35    
EU (15)* 183,59     89,97     29,84     60,51     29,65     9,84    
Belgium 6,48     2,33     0,28     71,28     25,67     3,05    
Denmark 3,65     1,05     0,29     73,08     21,10     5,81    
Finland 2,57     1,60     0,30     57,48     35,72     6,80    
France 30,88     22,10     2,47     55,70     39,85     4,45    
Germany 30,91     27,89     11,97     43,68     39,41     16,91    
Netherlands 11,08     4,21     0,38     70,71     26,85     2,44    
Spain  19,61     9,45     3,87     59,55     28,70     11,76    
UK 38,89     13,50     3,19     69,97     24,29     5,74    
All 144,08     82,14     22,75     57,87     32,99     9,14    
EU (15)* 190,26     99,03     35,16     58,64     30,52     10,84    
*) Without Luxembourg and Sweden.
Source: Calculations by DIW.
2001 (Baseline scenario)
2050 (Living-longer in better health scenario)
2050 (Baseline scenario with improvement in health)
2050 (Living-longer scenario with constant age-specific health status)
2050 (Baseline scenario with constant age-specific health status)
Proportion in % Number of people aged 15+ in million in
Countries
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Figure 1.3 Changes in the population aged 15+ by health status between  
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1.2.3  Health status and health care utilisation 
The main aim of WP2 was to describe the current use of health and long-term care by 
the elderly and its past trends. For these analyses data could be collected on two levels. 
First, the participants of the AGIR project provided data based on national sources, 
mostly covering the whole population and for several years in the past. With these data, 
it was possible to calculate prevalence rates for hospital cases, contacts with a doctor 
and for long-term care-giving in institutions and to show their development over time. 
But with these data it was not possible to differentiate the utilisation by the health of the 
population.  
Therefore, data from the ECHP were used to analyse the link between health care 
utilisation, health status and other determinants. These data are in general available for 
1994 to 2001, but they cover only persons aged 15+ in private households. Persons in 
institutions are not included and the information about health care utilisation shows a 
bias because the elderly – especially persons in bad health – are under represented.  
In view of these different data bases and the different advantages of each of these data 
sets two projections were made. Chapter 2 uses the prevalence rates based on national 
sources to project the hospital and outpatient utilisation as well as the long-term care-
giving in institutions and from professional home care services. The results show the 
general development in utilisation and the effect of improvements in life expectancy. 
Chapter 3 uses the data from the ECHP and in combination with the four demographic 
and health scenarios four projections of health care utilisation were made.  
Information about the number of people receiving long-term care at home is rare. For 
the most part, professional home care is the task of the community and is delivered by 
different providers. But professional home care is only a small proportion of the total 
home care. In chapter 2, a projection of this part of long-term care-giving at home is 
made. In most cases care-giving at home is provided by members of the family or other 
related persons, and no information on the total number of informal care-givers or 
people receiving informal care exists. The ECHP provides no information about the 
people in need of long-term care at home. But the ECHP provides data about persons 
who are hampered in their daily activities due to disability or a long-standing illness. To 
obtain an idea of the proportion of people in households in need of care, the share of the 
severely hampered persons is used. Jacobzone (1998) pointed out that severe disability 
is a good proxy for the need of long-term care. Thus, the share of persons severely 
hampered in daily activities, who had to cut down things they usually do based on the 
ECHP was used as a ‘soft proxy’ for the need of long-term care at home. Chapter 3 
includes a projection of severely hampered persons. 
1.2.4  Trends in health care utilisation 
Regression analyses based on the ECHP showed that the use of inpatient and outpatient 
acute health care services are related to health status, age, gender, education, marital 
status and income. But with the data from the ECHP it is not possible to calculate a 
trend in health care utilisation. The sample size of the ECHP is limited, thus utilisation 
data for a single country have been calculated using a three-year average (1999 to 
2001). The data are only available for 1994 to 2001, but – especially in view of the AGEING, HEALTH AND RETIREMENT IN EUROPE – AGIR WP4, PART A | 19 
 
three-year averages – this period is not long enough to show a significant trend. Thus, 
utilisation scenarios based on the ECHP cannot be created. 
The country-specific data based on national sources showed that the increasing life 
expectancies were connected with higher inpatient utilisation rates in the past, with the 
exception of the Netherlands (Table 1.10). It is feasible that the improvements in life 
expectancy could be mainly realised by new and/or better hospital treatments arising 
from the availability of new technologies and surgical methods, and therefore lead to 
more hospital admissions. In several countries waiting lists for surgeries in hospitals 
already exist. 
Table 1.10 Trends in hospital utilisation 








United Kingdom 1990/1-2000/1 1990/1-2000/1
(England)




Length of hospital stay
 
 
While the prevalence rates of hospital admissions/discharges increased in the past, the 
average length of hospital stay has decreased over time. This trend is caused by new 
medical treatments, such as the increasing use of minimal invasive surgery and the de-
institutionalisation strategy in most countries, and not by a better health status of the 
population. In Germany, for example, it is expected that the implementation of the 
Diagnosis Related Groups in 2003-04 will lead to fewer hospital days for patients, 
because this financial system implies incentives to reduce the number of bed days per 
patient.  
The number of bed days (as a result of hospital admissions and length of hospital stay) 
shows a decreasing trend in the past. Table 1.11 shows the changes in hospital 
admissions per 1000 inhabitants, the length of hospital stay of inpatients and bed days 
per 1000 inhabitants between 1993 and 1998 for the participating countries. In most 
countries the number of bed days decreased, especially in the younger age groups. But 
as previously mentioned this could only be traced back to the reduction of the length of 
hospital stay, which was influenced by factors other than the health status. Thus, it is 
doubtful if this trend will continue in the future or if it can be used for a projection. 20 | ERIKA SCHULZ 
 
Table 1.11 Hospital utilisation – Changes between 1993 and 1998 (%) 
Age-
groups male female total male female total male female total
 0-4 37,6       51,7       43,7       -2,8       -3,3       -3,0       33,8       46,7       39,5      
 5-14 -17,0       -10,5       -14,2       -7,1       -1,5       -4,4       -22,9       -11,8       -18,0      
15-24 -14,0       -13,3       -13,5       -11,1       -8,3       -9,3       -23,6       -20,5       -21,6      
25-34 -4,4       -1,6       -2,2       -13,5       -3,7       -6,2       -17,2       -5,3       -8,3      
35-44 -0,4       -3,9       -2,4       -12,9       -6,9       -9,6       -13,3       -10,6       -11,7      
45-54 5,5       0,5       3,0       -11,0       -8,5       -9,7       -6,1       -8,0       -7,0      
55-64 4,8       9,6       7,1       -13,2       -13,2       -13,2       -9,0       -4,9       -7,1      
65-74 10,7       12,0       11,5       -11,7       -13,7       -12,8       -2,3       -3,3       -2,7      
75+ 1,9       4,9       4,1       -16,9       -16,6       -16,8       -15,3       -12,4       -13,4      
Total 7,0       5,0       5,9       -9,5       -8,8       -9,2       -7,8       -5,6       -6,4      
 0-4 10,0       10,5       10,2       -2,0       -11,0       -5,9       7,9       -1,6       3,7      
 5-14 -10,9       -7,6       -9,5       -7,1       -8,1       -7,5       -17,2       -15,1       -16,2      
15-24 -8,6       -12,6       -11,1       -11,5       -7,0       -8,5       -19,1       -18,6       -18,7      
25-34 -8,4       -8,7       -8,4       -12,7       -10,1       -10,7       -20,0       -17,9       -18,2      
35-44 -1,6       -1,1       -1,3       -12,3       -13,2       -12,9       -13,7       -14,1       -14,0      
45-54 0,6       -7,9       -3,8       -11,5       -7,2       -9,3       -11,0       -14,5       -12,7      
55-64 1,5       2,2       2,0       -11,7       -14,0       -12,8       -10,3       -12,1       -11,1      
65-74 4,0       4,1       4,2       -12,3       -13,7       -13,1       -8,8       -10,2       -9,4      
75+ 7,5       5,5       6,4       -16,0       -20,0       -18,7       -9,7       -15,6       -13,5      
Total 11,1       3,8       6,9       -14,1       -14,4       -14,3       -9,7       -14,0       -12,2      
 0-14 4,9       7,2       5,9       -11,6       -15,0       -14,3       -7,3       -8,9       -9,2      
15-64 7,3       3,5       5,2       -25,7       -25,3       -25,3       -20,3       -22,7       -21,4      
65-74 5,3       9,3       8,0       -38,2       -35,6       -36,9       -34,9       -29,6       -31,8      
75+ 11,4       14,8       13,7       -28,6       -32,4       -31,5       -20,5       -22,5       -22,2      
Total 10,2       9,5       9,8       -26,9       -27,0       -27,0       -23,9       -23,6       -23,9      
 0-4 2,8       4,4       3,5       -15,3       -30,4       -22,5       -13,0       -27,3       -19,8      
 5-14 -4,0       1,1       -1,7       -22,5       -21,6       -22,3       -25,5       -20,7       -23,7      
15-24 2,7       0,5       1,5       -23,8       -18,9       -21,1       -21,8       -18,5       -19,9      
25-34 3,5       3,5       3,7       -26,7       -17,8       -21,2       -24,1       -14,9       -18,3      
35-44 10,4       3,4       6,5       -28,7       -19,4       -23,7       -21,3       -16,6       -18,8      
45-54 10,5       5,4       7,9       -27,6       -22,3       -25,3       -20,0       -18,1       -19,4      
55-64 17,2       19,3       18,2       -23,7       -26,2       -24,8       -10,6       -11,9       -11,1      
65-74 20,7       22,7       23,2       -22,2       -25,1       -24,4       -6,1       -8,1       -6,9      
75+ 22,9       26,0       25,0       -21,1       -25,7       -24,4       -3,0       -6,4       -5,5      
Total 15,7       12,7       14,0       -22,4       -20,6       -21,8       -10,7       -12,2       -11,6      
  0 - 4 5,5       4,7       6,6       -11,4       -13,0       -12,1       -6,5       -8,9       -6,3      
  5 - 14 -16,4       -18,2       -14,0       -0,2       -15,1       -7,0       -16,5       -30,5       -20,0      
15 - 24 -11,4       -14,0       -9,8       -12,4       -13,9       -13,4       -22,4       -26,0       -21,9      
25 - 34 -2,5       -18,1       3,4       -10,3       -15,8       -14,9       -12,5       -31,0       -12,0      
35 - 44 -6,8       -11,4       -3,6       -9,4       -13,4       -11,8       -15,6       -23,3       -14,9      
45 - 54 -8,1       -9,1       -7,0       -8,5       -10,8       -9,7       -15,9       -19,0       -16,0      
55 - 64 -7,1       -8,9       -5,1       -11,6       -12,8       -12,2       -17,8       -20,6       -16,6      
65 - 74 -5,2       -6,6       -4,3       -8,6       -10,0       -9,3       -13,3       -15,9       -13,2      
75 + -1,9       -2,5       -1,7       -8,4       -8,5       -8,5       -10,1       -10,8       -10,1      
Total -3,2       -5,1       -1,7       -8,3       -10,7       -9,6       -12,6       -14,8       -12,4      
0-4 1,0       4,8       2,6       -6,3       -5,1       -5,7       -5,4       -0,6       -3,3      
5-14 -9,7       -4,1       -7,4       -11,7       -6,4       -9,4       -20,2       -10,2       -16,1      
15-24 -6,3       0,7       -2,6       -11,1       -9,4       -10,7       -16,7       -8,8       -13,0      
25-34 -9,9       -2,3       -4,6       -19,7       -11,8       -15,8       -27,7       -13,8       -19,6      
35-44 0,5       6,1       3,7       -12,5       -18,5       -15,9       -12,1       -13,5       -12,8      
45-54 4,3       -0,4       2,0       -25,4       -21,1       -23,4       -22,2       -21,4       -21,9      
55-64 5,4       3,1       4,5       -21,0       -19,1       -20,2       -16,7       -16,6       -16,6      
65-74 6,6       5,6       6,3       -20,1       -22,3       -21,1       -14,9       -17,9       -16,1      
75+ 14,3       15,5       15,2       -19,7       -16,0       -17,6       -8,3       -2,9       -5,1      
Total 5,7       6,7       6,2       -16,6       -13,9       -15,3       -13,4       -10,6       -12,0      
 0-4 -2,0       2,2       -0,1       -14,0       -14,2       -14,0       -15,7       -12,3       -14,1      
 5-14 -4,3       -1,2       -3,0       -30,5       -34,5       -32,3       -33,5       -35,3       -34,3      
15-24 6,0       6,2       6,6       -1,2       -18,0       -11,4       4,8       -12,9       -5,5      
25-34 3,9       3,7       4,3       19,6       -8,7       1,5       24,3       -5,3       5,9      
35-44 9,9       9,9       10,0       2,3       -9,2       -4,1       12,4       -0,3       5,4      
45-54 11,1       10,3       10,7       -9,1       -15,1       -12,2       1,1       -6,4       -2,8      
55-64 13,9       21,8       17,6       -17,1       -23,5       -20,2       -5,5       -6,9       -6,2      
65-74 13,6       18,9       16,4       -20,1       -21,8       -21,0       -9,3       -7,0       -8,0      
75+ 10,8       14,5       13,4       -19,6       -18,1       -18,8       -10,9       -6,3       -7,9      
Total 8,5       9,0       8,8       -10,0       -14,6       -12,6       -7,1       -7,5       -7,0      
1) 1995/1999 in %
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In the case of the number of contacts with a doctor, no overall trend could be observed 
either. In most countries the number of contacts with a doctor increased over time 
(Table 1.12). Whether health care treatment is provided as an outpatient service or in 
hospitals depends on the health care system. In several countries general practitioners 
pose as gatekeepers and specialists are concentrated in hospitals (or health care centres). 
Otherwise the de-institutionalisation strategy leads to a replacement of treatments from 
hospitals to outpatient services. Therefore, the increase in contacts with a doctor can 
partly lead back to latter. It is not possible to forecast further displacements between 
inpatient and outpatient services. In Germany, for example, combining outpatient and 
inpatient services is being discussed as a new way of providing health care. 








Source: Schulz 2004 (AGIR WP2 Report).
Countries
Changes in number
of contacts with doctors
 
 
The use of long-term care services is closely related to age. The prevalence rates for 
long-term care rise sharply from age 70 onwards. While life expectancy has increased, 
the prevalence rates for long-term care-giving in institutions have shown no clear trend 
(Table 1.13). Institutional care is influenced by other pertinent factors, especially 
political decisions and the availability of places in nursing homes, rather than trends in 
life expectancy. In several countries waiting lists for nursing homes exist. An overall 
improvement in health status could lead to better health of the oldest old, but additional 
functional and mental illness play an important role. It is not clear to what extent better 
health in the younger ages could reduce functional and mental illness in old ages or 
could change the prevalence rates for long-term care-giving in institutions. Another 
point is that long-term care-giving in institutions is the last step in providing care. 
People in need of long-term care want to live as long as possible in their familiar 
surroundings. Only if care-giving at home by members of the family or friends is not 
possible, for example if they live alone, do they consider living in nursing homes. Thus, 
the expected changes in family structure and household composition also have an 
important influence on the demand for care-giving in institutions. 
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Table 1.13 Trends in long-term care in institutions and at home 
 
Professional care-giving at home also depends on other factors as well as the acute 
health status. Informal care-givers need help by professionals if they alone are not able 
to provide the required care. This is mostly the case if the required intensity of care-
giving is high (care-giving night and day) and if the care-giver is also an older person. 
In the past no general trend in professional long-term care at home has existed in the 
participating countries, but an increase can generally be observed. Together with the 
ageing of the population and expected changes in the family and household structures, 
the demand for long-term care-giving by professional care-givers could increase. But 
with the existing data it is not possible to estimate to what extent the demand will 
increase by such changes. Therefore, we can assume that the pressure on professional 
care-giving will increase, but we cannot quantify this.  
To summarise: it is not possible with the existing data to create a coherent set of health-
care utilisation scenarios for acute health and long-term care. Thus, the prevalence rates 
for health care and long-term care utilisation are held constant over the forecast period. 
This regards the forecasts in chapter 2 as well as the forecasts in chapter 3. 






Source: Schulz 2004 (AGIR WP2 Report).
Countries
Care giving in institutions Care giving at home
Changes in prevalence rates 
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Chapter 2. 
Impact of Demographic Changes on Acute Health Care and 
Long-Term Care 
n this chapter estimations of health and long-term care utilisation are made using 
national sources of utilisation (which cover the whole population) and the two 
demographic scenarios. The projections show the influence of the demographic 
development and the impact of additional improvements in life expectancy on the 
development of health care utilisation. The projections assume that the health status of 
the population will remain constant. That means that the factors that lead to 
improvements in health (such as new medical or surgical treatments) and the factors that 
may have a contrary effect (such as the increase in overweight children) are balanced.  
2.1  Acute health care 
In WP2, data from our participating partners were collected on the admissions into or 
discharges from a hospital, the length of hospital stay for inpatients and the frequency of 
contacts with a doctor (general practitioners or medical specialists) based on national 
sources. This data allows the calculation of age-specific prevalence rates, the average 
length of hospital stay by age groups and the average number of contacts with a doctor. 
These utilisation rates for the most recent year are held constant and are combined with 
the two demographic scenarios. 
2.1.1  Development of hospital cases 
Data regarding hospital utilisation includes acute health care in hospitals and not 
nursing care for the elderly. Data were collected for hospital admissions (Belgium, 
Denmark, France and the UK) and for hospital discharges (Finland, Germany, the 
Netherlands and Spain).  
Figure 2.1 shows the number of hospitalised persons (within one year) per 1000 
inhabitants by age groups for several participating countries (prevalence rates). The 
share of hospitalised persons increases with age in all the countries. At a given age, 
large differences in prevalence rates can be observed between the countries. The 
prevalence rates are highest in the youngest (0 to 4 years) and oldest (75+) age groups 
for Denmark and the UK. This is also true for persons aged 25-34 and 35-44. The 
lowest prevalence rates in the youngest and oldest age groups can be observed for 
Spain. In general, the prevalence rates for Denmark, Germany and the UK are higher 
than for Belgium, the Netherlands and Spain.  
Keeping the country-specific prevalence rates constant, the development of hospital 
cases caused by the ageing process can be calculated. Table 2.1 shows the results for the 
baseline and the living-longer high scenarios.  
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Figure 2.1 Hospitalised persons per 1000 inhabitants 
 
Table 2.1 Development of hospital admissions/discharges (million persons per year) 
Countries 1999*) 2010 2020 2030 2040 2050
Belgium 1,72   1,82   1,92   2,02   2,05   1,99  
Denmark 1,10   1,14   1,23   1,31   1,32   1,32  
Finland 1,38   1,50   1,64   1,79   1,77   1,70  
France 9,20   9,77   10,31   10,81   11,00   10,81  
Germany 16,20   17,42   18,37   18,87   19,07   18,24  
Netherlands 1,52   1,69   1,87   2,00   2,03   1,99  
Spain 4,50   4,79   4,91   5,11   5,26   5,11  
United Kingdom 11,33   11,73   12,54   13,21   13,56   13,53  
Total 46,95   49,85   52,78   55,12   56,04   54,67  
Belgium 1,72   1,83   1,97   2,11   2,21   2,21  
Denmark 1,10   1,15   1,27   1,39   1,45   1,50  
Finland 1,38   1,51   1,70   1,91   1,97   1,94  
France 9,20   9,84   10,51   11,21   11,66   11,71  
Germany 16,20   17,60   18,93   19,91   20,71   20,61  
Netherlands 1,52   1,71   1,92   2,11   2,21   2,25  
Spain 4,50   4,84   5,05   5,38   5,71   5,79  
United Kingdom 11,33   11,84   12,87   13,88   14,68   15,17  
Total 46,95   50,33   54,22   57,89   60,59   61,17  
*) France and United Kingdom = 2000.
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In the participating countries altogether, approximately 47 million persons were 
hospitalised at least once in 1999. This number will increase to 56 million in 2040 and 
is expected to decrease to 55 million by 2050 (baseline scenario). In the living-longer 
high scenario the number of hospitalised people is around 6.5 million higher in 2050. 
The development of the number of hospitalised persons is different among the 
participating countries (Figure 2.2 and Table A5). The highest increase can be observed 
for the Netherlands (an increase of 32% by 2050 in the baseline scenario) and the lowest 
for Germany and Spain (around 13% by 2050). Additional improvements in life 
expectancy lead to a higher growth rate of hospital cases. In the participating countries 
combined the increase will be 30% by 2050, which is around 14 percentage points more 
than in the baseline scenario.  
Table 2.2. Hospital cases by age group (million persons) 
Countries
0 - 14 15 - 64 65 - 74 75+ Total 0 - 14 15 - 64 65 - 74 75+ Total
Belgium 0,2     0,9     0,3     0,3     1,7     0,2     0,9     0,3     0,3     1,7    
Denmark 0,2     0,6     0,1     0,2     1,1     0,2     0,6     0,1     0,2     1,1    
Finland 0,1     0,7     0,2     0,3     1,4     0,1     0,7     0,2     0,3     1,4    
France 1,2     5,3     1,3     1,4     9,2     1,2     5,3     1,3     1,4     9,2    
Germany 1,4     9,1     2,7     3,0     16,2     1,4     9,1     2,7     3,0     16,2    
Netherlands 0,2     0,8     0,2     0,3     1,5     0,2     0,8     0,2     0,3     1,5    
Spain 0,4     2,5     0,8     0,8     4,5     0,4     2,5     0,8     0,8     4,5    
United Kingdom 1,7     6,1     1,5     2,0     11,3     1,7     6,1     1,5     2,0     11,3    
Total 5,5     26,0     7,2     8,3     46,9     5,5     26,0     7,2     8,3     46,9    
Belgium 0,2     0,9     0,4     0,4     1,9     0,2     0,9     0,4     0,5     2,0    
Denmark 0,2     0,6     0,2     0,3     1,2     0,2     0,6     0,2     0,3     1,3    
Finland 0,1     0,7     0,4     0,5     1,6     0,1     0,7     0,4     0,6     1,7    
France 1,2     5,5     1,8     1,8     10,3     1,2     5,5     1,8     2,0     10,5    
Germany 1,2     9,1     3,3     4,7     18,4     1,2     9,1     3,4     5,2     18,9    
Netherlands 0,2     0,9     0,4     0,4     1,9     0,2     0,9     0,4     0,4     1,9    
Spain 0,4     2,5     0,8     1,2     4,9     0,4     2,5     0,9     1,3     5,1    
United Kingdom 1,5     6,5     2,1     2,4     12,5     1,5     6,5     2,1     2,7     12,9    
Total 5,0     26,6     9,4     11,8     52,8     5,0     26,7     9,6     12,9     54,2    
Belgium 0,2     0,8     0,3     0,6     2,0     0,2     0,8     0,3     0,8     2,2    
Denmark 0,2     0,5     0,2     0,4     1,3     0,2     0,5     0,2     0,6     1,5    
Finland 0,1     0,6     0,3     0,7     1,7     0,1     0,6     0,3     0,9     1,9    
France 1,1     5,0     1,7     3,0     10,8     1,1     5,1     1,8     3,8     11,7    
Germany 1,1     7,4     3,3     6,5     18,2     1,1     7,5     3,5     8,6     20,6    
Netherlands 0,2     0,8     0,4     0,6     2,0     0,2     0,8     0,4     0,8     2,2    
Spain 0,3     1,8     1,0     2,0     5,1     0,3     1,8     1,1     2,6     5,8    
United Kingdom 1,4     5,9     2,1     4,1     13,5     1,4     6,0     2,2     5,5     15,2    
Total 4,6     22,9     9,3     17,9     54,7     4,6     23,1     9,9     23,6     61,2    
*) France and United Kingdom = 2000.
Source: Calculations by DIW.
2050
Age-groups
Baseline scenario Living-longer-high scenario
1999
*)
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Figure 2.3 Changes in the number of hospital cases within the age groups 
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This moderate increase in hospital admissions in the baseline scenario is the result of 
contrary developments in the younger and older age groups. The ageing process leads to 
increasing hospital admissions at older ages, but to decreasing hospital admissions in 
the younger and middle age groups. The number of hospitalised people aged 75+ will 
rise from 8.3 million in 1999 to 17.9 million in the baseline scenario and to 23.6 million 
in the living-longer high scenario in 2050 (Tables 2.2 and A6). That is an increase of 
115% (baseline scenario) and 184% (living-longer high scenario). In the age group 65-
74, the increment is 30% (baseline scenario) and 38% (living-longer high scenario) 
(Figure 2.3 and Table A7). In the age groups 0-14 and 15-64, the hospital admissions 
decline by 4 million, at 17% (0-14) and 12% (15-64) in the baseline scenario. In the 
living-longer high scenario an additional reduction in mortality rates for people aged 
20+ is assumed. Therefore, the decline in the youngest age group will be the same as in 
the baseline scenario and in the age group 15-64 it will be a little bit lower, specifically 
11%. 
The ageing process will lead to changes in the age structure of inpatients. In the 
participating countries altogether approximately 18% of inpatients were aged 75+ in 
1999. By 2050, one in three inpatients will be aged 75+ (Figure 2.4 and Tables A8 and 
A9) and one in two inpatients will be aged 65+ (baseline scenario). In the living-longer 
scenario, the proportion of patients aged 75+ will be nearly 40% in 2050. 
The projected proportion of patients aged 75+ is highest in Finland (41% in the baseline 
and 47% in the living-longer scenario) followed by Spain (38% and 44% respectively) 
in 2050. The change in percentage points is greatest for Spain (20 percentage points and 
26 percentage points respectively). 
2.1.2  Development of bed days 
Hospital utilisation and the expenditure on hospital care depend on the number of 
hospitalised persons as well as on the length of hospital stay. Figure 2.5 shows the 
length of hospital stays by age group in the participating countries (with the exception 
of Finland, which provided alternative age groups). The length of a hospital stay 
increases with age in all countries. On average, the length of a hospital stay is highest 
for Germany and lowest for the UK for nearly every age group. The length of a hospital 
stay has decreased in all age groups in the past. But this is not mainly the result of a 
better health status of the population. This trend is caused by new medical treatments, 
for example the increasing use of minimal invasive surgery and the de-
institutionalisation strategy of health policies. Full inpatient care is being substituted by 
outpatient care or by day care. This means that not only health expenditures but also 
health care utilisation is influenced by other factors besides demography and health 
status. 
Therefore, the average length of a hospital stay for 1999 (for France and the UK in 
2000) is held constant over the forecasting period. The total number of days spent in a 
hospital (bed days or hospital days are used here interchangeably) is the result of 
hospital cases multiplied with the average length of hospital stay in the single age 
group. 
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Table 2.3 Development of hospital days (million days) 
Countries 1999*) 2010 2020 2030 2040 2050
Belgium 13,9     15,3     16,6     18,4     19,4     18,7    
Denmark 5,9     6,3     7,1     7,8     8,0     8,0    
Finland 14,6     16,7     19,4     23,4     23,9     22,6    
France 65,1     69,7     75,5     79,7     81,1     79,6    
Germany 169,8     187,3     201,1     209,9     215,7     206,7    
Netherlands 13,2     15,4     17,5     19,4     20,1     19,7    
Spain 38,6     42,6     45,2     48,4     51,3     51,0    
United Kingdom 59,4     62,5     68,4     75,8     81,9     84,4    
Total 380,5     415,8     450,7     482,7     501,4     490,6    
Belgium 13,9     15,5     17,3     19,7     21,6     21,9    
Denmark 5,9     6,4     7,4     8,4     9,0     9,4    
Finland 14,6     17,1     20,5     25,9     28,0     27,6    
France 65,1     70,2     77,1     82,7     86,3     86,6    
Germany 169,8     189,6     208,4     223,6     237,5     238,3    
Netherlands 13,2     15,6     18,2     20,9     22,7     23,4    
Spain 38,6     43,2     47,0     51,7     56,9     59,6    
United Kingdom 59,4     63,6     71,7     82,7     94,1     102,8    
Total 380,5     421,3     467,7     515,7     556,0     569,5    
*) France and United Kingdom = 2000.
Source: Calculations by DIW.
Living-longer-high scenario
Baseline scenario
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Table 2.3 shows the development of total hospital days for the participating countries. 
In the participating countries altogether, people spent 380 million days in a hospital in 
1999. By 2040 the number of hospital days will increase to 501 million in the baseline 
scenario and to 556 million in the living-longer high scenario. After 2040 a slight 
decline is expected, reducing the figures down to 491 million days in the baseline 
scenario. In the living-longer high scenario a further increase up to 570 million days in 
2050 is expected. The rise in the number of hospital days is highest for Finland (an 
increase of 55% in the baseline and 90% in the living-longer high scenario by 2050) and 
lowest for Germany and France (Figure 2.6). On average, the increase in the living-
longer high scenario is 21 percentage points higher compared with the baseline scenario 
(which is an increase of 71%). 
As in the case of hospital admissions, the length of hospital stays increases with age. 
Therefore, the observed trend in hospital admissions within the age groups will be 
strengthened. In the oldest age group (75+) the number of days spent in a hospital will 
more than double in the baseline scenario and nearly triple in the living-longer high 
scenario (Table 2.4 and Figure 2.7 and Tables A10-A12). The population development 
will lead to massive displacements in the age structure of hospital days in all 
participating countries (Figure 2.8 and Tables A13-A14). In the participating countries 
altogether around a quarter of the hospital days were used by inpatients aged 75+ in 
1999. By 2050, 44% (baseline scenario) and 50% (living-longer high scenario) of the 
total hospital days will be utilised by this age group. Whereas the share of days of the 
old inpatients is expected to rise, the share of days of the younger-old inpatients (65-74 
years) will be nearly constant and the share of the younger and middle-aged patients 
will decline by 2050. 
To summarise: The ageing population in most participating countries will lead to a 
moderate increase in the number of hospital admissions. This is caused by the contrary 
developments in the younger and older age groups. By 2050, approximately half of the 
hospital days will be required for persons aged 75+. The spectrum of diseases of the 
elderly is different from that of the younger inpatients, and thus the elderly require a 
different spectrum of hospital treatments. Except for acute illness, old people mostly 
suffer from functional disability and mental illness. Thus, the significant structural 
change requires substantial reorganisation and restructuring of hospital departments. 
Government officials and hospital administrators should take into account this 
information in the strategic planning of hospital services as well as in the training of 
medical and nursing staff. 
2.1.3  Hospital utilisation and the nearness to mortality – the example of 
Germany 
Another intensively discussed question is whether age is the driver of health utilisation 
and health care expenditure or the nearness to mortality. Studies have shown that the 
intensity of health care utilisation is much higher for decedents than for survivors, with 
the ratio of health care expenditures of decedents to survivors being higher in the 
younger and the middle ages than among the elderly (Busse et al., 2002). Several 
studies have focused on the health care expenditure related to mortality (Lubitz & Riley, 
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Table 2.4 Number of hospital days by age group (1999 = 100) 
 
The studies have pointed out that the costs of acute care rise with age, but that the 
proximity to mortality is a more important factor in determining the costs (McGrail et 
al., 2000; Felder et al., 2000; Scitovsky, 1994; Serup-Hansen et al., 2002). One study 
concluded that health care expenditure depends on the remaining lifespan but not on 
calendar age per se (Zweifel et al., 1999; Salas & Raftery, 2001; Zweifel et al., 2001; 
Getzen, 2001). 
One aim of WP4 is to make forecasts of hospital utilisation with utilisation rates 
subdivided by survivors and decedents. But data could only be collected for Germany. 
For Germany, Busse et al. (2002) presented data on hospital utilisation decomposed by 
age group, survivors and decedents in their last, second and third year of life before 
mortality. Their data source was a 10% random sample of the insured persons of one 
German sickness fund with data on approximately 70,000 survivors and 1,400 
decedents between November 1991 and November 1995. Figure 2.9 shows the results. 
Decedents in their last year of life spent markedly more days in a hospital than survivors 
in a given age group. Based on these data, projections for Germany were made. 
Countries
0 - 14 15 - 64 65 - 74 75+ Total 0 - 14 15 - 64 65 - 74 75+ Total
Belgium 98    108    126    136    120    98    108    128    148    125   
Denmark 89    106    148    131    120    89    106    153    144    125   
Finland 88    95    161    151    133    88    95    165    165    141   
France 94    106    141    134    116    94    107    144    145    119   
Germany 89    101    123    159    118    89    102    126    174    123   
Netherlands 97    114    162    150    132    97    115    166    165    137   
Spain 85    109    110    145    117    85    109    113    159    122   
United Kingdom 93    106    136    122    115    93    106    139    137    121   
Total 91    104    129    145    118    91    104    132    159    123   
Belgium 93    93    117    205    135    93    94    124    268    158   
Denmark 88    100    132    193    135    88    101    143    260    159   
Finland 77    85    137    209    155    77    85    145    275    190   
France 86    96    135    219    122    86    97    142    274    133   
Germany 77    82    122    218    122    77    83    129    288    140   
Netherlands 98    108    148    230    149    98    110    158    320    177   
Spain 71    79    132    238    132    71    80    140    314    154   
United Kingdom 86    97    136    214    142    86    98    145    300    173   
Total 82    88    129    218    129    82    89    136    291    150   
*) France and United Kingdom = 2000.
Source: Calculations by DIW.
2050
Age-groups
Baseline scenario Living-longer-high scenario
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Figure 2.9 Days spent in a hospital within one year by decedents and survivors in  
Germany (1999) 
 
Schulz et al. (2004) made a population forecast decomposed by survivors, decedents in 
the last, the second to last, and the third to last year before mortality and combined the 
results with a) age- and gender-specific average prevalence rates and with b) the 
utilisation data decomposed by decedents and survivors from Busse et al. (2002). The 
two estimations were compared to show the effects of ‘nearness to mortality’. The 
decomposition by survivors and decedents leads to a more moderate increase of hospital 
days (Table 2.5). While the estimation with average utilisation rates leads to an increase 
up of to 231 million hospital days in 2050, the decomposition leads to an increase of up 
to 212 million days. A look at the changes in percentages shows a clear distinction: an 
increase of 34% in the case of average utilisation rates and an increase of 24% in the 
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Table 2.5 Development of hospital days in Germany 
 
2.1.4 Outpatient  care 
National sources for outpatient utilisation are mainly surveys: health surveys as well as 
general household surveys. Some participants – the UK, Belgium and the Netherlands – 
provided data about contact with a general practitioner (GP); Finland and Spain 
provided data about the contact with doctors (GPs and specialists). Germany and France 
provided data on the share of people having had contact with a doctor and no data exists 
for Denmark. The data provided from Germany and France are not compatible with the 
data from the other participants. Thus, the forecast for the development of the number of 
contacts with a doctor includes only five countries (Belgium, Finland, the Netherlands, 
Spain and the UK).  
The analyses in WP2 based on data from the European Community Household Panel 
(ECHP) show that people visit a general practitioner more often than a specialist 
(Schulz, 2004). On average the number of contacts with a specialist was around half of 
the amount for practitioners. This can be traced back to the institutional setting of the 
health care systems. In the UK and in the Netherlands, for example, specialists are 
concentrated in hospitals. In Finland, Belgium and Spain most of the specialist work is 
in hospital outpatient departments and in Spain and Finland patients need a referral from 
a general practitioner to visit a specialist. The latter is also true for Denmark. In 
Belgium there are incentives to go first to a general practitioner before consulting a 
specialist (the practitioner serves as a gatekeeper to save contributions to the health 
insurance schemes). In Germany and France ambulatory care by self-employed 
specialists and a free choice of services exist. Such differences have to be kept in mind 
in the interpretation of the results presented here. The estimation is made in the 
underlying current health care system and no changes in the framework conditions are 
supposed. 
 
1998 2020 2050 2050/1998 1998 2020 2050 2050/1998
in % in %
  0-24 18,7     15,3     11,7     -37,6     18,7     14,9     11,4     -39,0    
25-34 15,9     11,7     8,6     -45,5     15,9     11,9     8,8     -44,7    
35-44 16,8     13,0     9,9     -41,1     16,8     12,6     9,5     -43,3    
45-54 18,2     21,5     15,6     -14,3     18,2     20,9     14,9     -18,4    
55-64 29,3     35,6     27,6     -5,9     29,3     33,2     24,8     -15,3    
65-74 33,1     42,7     44,7     35,0     33,1     39,2     39,0     17,7    
75+    39,9     70,5     112,8     182,8     39,9     65,2     104,0     160,5    
Total 
*) 171,9     210,4     231,0     34,4     171,9     198,0     212,4     23,5    
1) Projection method A: Projection by age-groups, gender and  diagnosis (ICD9).-
2) Projection method B: Projection by age-groups, decomposed by survivors and decedents in their last,
second and third year before death.
Source: Schulz, Leidl, König 2004.
Not taking into account the nearness to death  Taking into account the nearness to death 
in million days in million days
Projection method B
2) Projection method A
1)
Age-
groups38 | ERIKA SCHULZ 
 
Figure 2.10 shows the average number of contacts with doctors by age group for 
Belgium, Finland, the Netherlands, Spain and the UK within one year. The average 
number of contacts is highest in the youngest and oldest age groups and lowest for the 
age group 15-24. Generally, the number of contacts is lower in Finland than in the other 
countries, but the data from Finland are from 1996. 
Figure 2.10 Average number of contacts with a general practitioner (GP) 
 and a specialist (SP) within one year 
 
For Belgium, Finland, the Netherlands, Spain and the UK combined, around 797 
million contacts with a doctor can be observed in 2001. The number of contacts is 
expected to rise to 869 million by 2040 and thereafter decline to 845 million in the 
baseline scenario (Table 2.6). This is a moderate increase of 6%. In the living-longer 
high scenario the development is expected to be more dynamic. The number of contacts 
with a doctor increases up to 922 million in 2040 and after this will be nearly constant at 
920 million until 2050. Thus, the expected increase by 2050 is 15%. The highest rise in 
outpatient utilisation is expected for the Netherlands and for Belgium, whereas in Spain 
the number of contacts will be the same in 2050 as in 2001, and in Finland the number 
of contacts will be less than in 2001 in the baseline scenario (Figure 2.11 and Table 
A15). In the living-longer high scenario the number of contacts with a doctor is 
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Table 2.6 Development of contacts with a doctor within one year (millions) 
Countries 2001 2010 2020 2030 2040 2050
Belgium 
1)  (GP) 53,7     56,6     59,3     62,7     64,0     61,8    
Finland 
2)  (GP+SP) 20,6     21,2     21,7     21,6     20,9     20,2    
Netherlands  (GP) 64,1     68,2     71,9     74,7     75,6     74,9    
Spain 
1)  (GP+SP) 350,1     363,0     368,6     369,7     366,4     351,2    
United Kingdom 
3)  (GP) 308,9     318,3     330,6     340,6     342,6     336,5    
Total 797,4     827,2     852,2     869,3     869,5     844,7    
Belgium 
1)  (GP) 53,8     57,1     61,0     65,7     69,2     69,1    
Finland 
2)  (GP+SP) 20,6     21,3     22,0     22,3     22,0     21,5    
Netherlands  (GP) 64,1     68,7     73,3     77,6     80,4     81,6    
Spain 
1)  (GP+SP) 350,2     365,5     376,1     383,5     389,4     385,7    
United Kingdom 
3)  (GP) 309,1     320,3     336,4     351,9     360,8     362,4    
Total 797,7     832,9     868,8     901,1     921,9     920,2    
Average population based on: 1) 1997, 2) 1996, 3) 2000.
GP = General practitioner; SP = Specialist.




The development of contacts with a doctor appears to be more dynamic when 
examining separate age groups. As in the case of hospital days, contacts with a doctor 
will decline in the younger (0-14) and middle (15-64) age groups, while in the older age 
groups a marked growth is expected. The number of contacts with a doctor for people 
aged 75+ will double and for people aged 65-74 the expected increase is 34% in the 
baseline scenario (Figure 2.12 and Tables A16-A18). In the living-longer high scenario 
the number of contacts with a doctor for people aged 75+ is expected to increase by 
170% (nearly triple) and for people aged 65-74 the expected increase is 42%. Among 
the countries the changes within the age groups are different. In the Netherlands, 
practically no change in the number of contacts for people aged less than 65 is expected, 
whereas in Spain a decrease in the number of contacts by one-quarter is estimated for 
this age group.  
Thus, the age structure of contacts with a doctor will change. In the five countries 
altogether 13% of contacts were used by people aged 75+ in 2001 (Table 2.7). For the 
baseline scenario (and living-longer high scenario) the share of this age group is 
expected to be 25% (30%) in 2050, with the highest share of 34% (40%) in Belgium 
and the lowest share of 16% (19%) in Finland. The change in the age structure of 
contacts with a doctor in percentage points between 2001 and 2050 is highest for Spain 
and Belgium and lowest for Finland and the UK (Table A19). 
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Figure 2.12 Changes in the number of contacts with a doctor within the age groups 
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Table 2.7 Age structure of contacts with a doctor (%) 
 
To summarise: The number of contacts with a doctor could be estimated for general 
practitioners in Belgium, the Netherlands and the UK and for general practitioners and 
specialists in Finland and Spain. Generally, the expected increase in the number of 
contacts between 2001 and 2050 is moderate with 6% in the baseline and 15% in the 
living-longer high scenarios and less as in the case of hospital utilisation. Nevertheless, 
in the single age group clear changes are expected with a high increase in the share of 
the elderly using outpatient services.  
2.2 Long-term  care 
The ageing process often involves functional disabilities and impairments in living 
independently as well as mental illness. In most cases this is a slow process. People with 
functional disabilities will increasingly need personal help and assistance in regularly 
recurring activities of daily living. The physical and functional impairments of people in 
Countries
0 - 14
4) 15 - 64
5) 65 - 74 75+ 0 - 14
4) 15 - 64
5) 65 - 74 75+
Belgium 
1)  (GP) 11,6     52,5     15,8     20,1     11,6     52,5     15,8     20,1    
Finland 
2)  (GP+SP) 15,3     65,5     11,4     7,8     15,3     65,5     11,4     7,8    
Netherlands (GP) 14,7     64,1     10,1     11,1     14,7     64,1     10,1     11,1    
Spain 
1)  (GP+SP) 15,7     58,7     12,2     13,4     15,7     58,7     12,2     13,5    
United Kingdom 
3)  (GP) 14,5     63,4     11,3     10,8     14,5     63,4     11,3     10,8    
Total 14,9     60,7     11,9     12,5     14,9     60,7     11,9     12,6    
Belgium 
1)  (GP) 9,6     48,6     18,2     23,5     9,4     47,5     18,1     25,0    
Finland 
2)  (GP+SP) 12,9     59,1     17,5     10,5     12,7     58,3     17,7     11,3    
Netherlands (GP) 12,8     59,0     14,2     14,0     12,5     58,1     14,3     15,1    
Spain 
1)  (GP+SP) 13,5     57,0     12,8     16,7     13,2     56,1     12,8     17,9    
United Kingdom 
3)  (GP) 12,1     61,4     14,2     12,2     11,9     60,6     14,3     13,2    
Total 12,6     58,4     14,0     15,1     12,4     57,4     14,0     16,2    
Belgium 
1)  (GP) 8,8     40,8     16,3     34,1     7,9     36,8     15,4     39,9    
Finland 
2)  (GP+SP) 12,1     56,3     15,9     15,6     11,4     53,5     15,9     19,3    
Netherlands (GP) 12,5     54,8     12,4     20,2     11,5     50,8     12,2     25,4    
Spain 
1)  (GP+SP) 11,5     43,4     16,0     29,1     10,5     40,0     15,5     34,1    
United Kingdom 
3)  (GP) 11,2     54,9     14,2     19,7     10,4     51,4     14,0     24,2    
Total 11,3     49,1     15,0     24,6     10,4     45,5     14,6     29,5    
Average population based on: 1) 1997, 2) 1996, 3) 2000.-  4) Netherlands = 0-17 years.-  5) Netherlands = 18-64 years.
GP = General practitioner; SP = Specialist.
Source: Calculations by DIW.
2050
Age-groups
Baseline scenario Living-longer-high scenario
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need of long-term care are not reversible. If their condition deteriorates, permanent 
personal help and nursing care are required. The elderly prefer living at home as long as 
it remains feasible and, in case of a need for long-term care, the partner or members of 
the extended family are the primary caregivers. Professional home care is however 
required if informal care-giving by partners or other members of the family is not 
possible. Nursing homes are in most cases the last choice.  
The institutional settings and the extent of the supply of long-term care services within 
the community are strongly correlated with the long-term care policy (Eisen & Mager, 
1999). In most countries, long-term care-giving is deemed to be a task of the extended 
family. Therefore, informal long-term care-giving by members of the family is 
dominant. Often institutional care-giving is provided for disabled persons with the worst 
health and in cases where adequate informal care-giving is not available. The number of 
beds in nursing homes is often not large enough to cover the demand. Waiting lists are 
common as a consequence. In several EU countries, it is difficult to obtain an overview 
of the number of people in need of long-term care. Often informal care-giving is not 
documented, and information regarding institutionalised persons and those who provide 
community care is difficult to collect.  
For our participating countries it was also not easy to collect data about long-term care-
giving in institutions and especially at home. That is because most social care for the 
elderly is the responsibility of the municipalities and different organisations 
(private/public) and/or political institutions provides care services, as previously 
mentioned. In most countries ‘care in the community’ is favoured as an alternative to 
long-term institutional care. Therefore, places in nursing homes have often been 
reduced in recent years and public monies moved from institutional care to home care. 
In Denmark, for example, the number of people in nursing homes has fallen 
dramatically, from 50,000 in 1987 to 36,500 in 1996. This was accompanied by a large 
increase in the number of home nurses and home helps employed by municipalities 
(EOHCS, 2001). In the UK between 1960 and 1980, around 100,000 people in need of 
long-term care were discharged into the community (EOHCS, 1999). Another trend 
could be observed in Belgium: they have planned to increase the places in combined 
rest and nursing homes, which provide a high level of nursing care (EOHCS, 2000a). 
Providers of home care services supply a broad spectrum of services, so an overview 
about people receiving long-term care services is hard to gather. Provision of social care 
for the elderly – namely long-term care – is different among EU countries and also 
among the participating countries. But institutional care and home care services 
generally exist. Data about institutional care by age group are provided for Belgium, 
Denmark, Finland, France, Germany and the Netherlands. The UK could only provide 
data about residential care for people aged 65+ (not subdivided into age groups). 
Information about care-giving at home in most participating countries is related to 
formal care-giving by professionals. In Germany informal care-giving is included, if 
people receive benefits from the long-term care insurance scheme.  
For Spain no data could be collected. A report from the European Observatory on 
Health Care Systems (2000b, p. 84) for Spain pointed out that in Spain “most of the 
responsibilities within the field of social affairs have been transferred to the 
Autonomous Communities, which gradually enacted legislation in the 1980s to govern 44 | ERIKA SCHULZ 
 
social services provision within their area of responsibility. There is a national plan for 
the elderly aimed at improving older people’s standard of living. This plan includes a 
component on health care which focuses on health promotion, the prevention of illness 
and accidents, and healthy lifestyle. Social services are responsible for elderly 
residential care.” The total number of places amounted to 188,913 in 3,689 elderly 
homes in 1998. Additional places are purchased through contracts with private 
institutions. In 1998, there were 2.8 places per 1000 persons over 65. Home care is 
being expanded and within most municipalities an infrastructure exists to deliver basic 
support to those being cared for or caring for others at home. Accessibility to these 
services is severely restricted, however, and coordination with medical care is still 
lacking in many aspects (EOHCS 2000b, p. 85). The report summarised that long-term 
care for the elderly and handicapped is still considerably underdeveloped and managed 
by different organisational structures. In view of the different organisational structures, 
no comprehensive national database for long-term care services exists and no analyses 
can be carried out in this case. But it can be held that the supply of long-term care 
services in nursing homes or by home care are far away from meeting the need for long-
term care in Spain.  
Another difficulty is that no general, internationally comparable definition of the need 
for long-term care exists. In Germany, for example, the social dependency insurance act 
includes a definition of the need for long-term care: people in need of long-term care are 
“persons with physical or mental disability, who need assistance in normally and 
regularly recurring activities of daily living on a long-term basis, prospectively for at 
least 6 months, to a substantial or exceeding degree”. 
In all participating countries indices of activities in daily living (ADL) and instrumental 
activities in daily living (IADL) were used to define the need for long-term care. But the 
composition of indices and the frequency with which assistance is needed can differ 
among the countries. In most countries no special long-term care insurance system or 
long-term care law exists. The need for long-term care is often governed by selected 
paragraphs in several pieces of legislation (social assistance, health security, etc.) and is 
the responsibility of the community or local government. Thus, it is feasible that in 
practice there are different definitions of the need for long-term care among the 
countries. In Germany, the statutory long-term care insurance scheme is using the 
following ADL and IADL indices: ADL – washing, bathing, brushing the teeth, 
combing, shaving, toileting, eating, getting in and out of bed, dressing, walking, 
standing, using stairs and walking outdoors; IADL – shopping, preparing meals, 
cleaning, dishwashing, laundering and heating the apartment/home. The law 
distinguishes between three levels of disability – substantial, severe and very severe – 
based on the frequency with which assistance is needed in personal care and 
housekeeping. At all levels of disability, people must need assistance in two or more 
ADLs and assistance in housekeeping for at least six months to be eligible. Therefore, 
severe disability is the condition required to receive benefits for long-term care in 
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2.2.1  Long-term care in institutions 
The data provided allows the computation of prevalence rates of institutionalisation, i.e. 
the number of people receiving long-term care in institutions per 1000 inhabitants by 
age group. Figure 2.13 shows the prevalence rates for Germany, Finland, Belgium, the 
Netherlands, Denmark and France. In all countries the prevalence rates increase with 
age. The highest prevalence rates can be observed for the Netherlands, the second 
highest for Belgium. The figure shows clearly that long-term care-giving is related to 
the oldest old. Prior to the age of 60 long-term care-giving is seldom required, but for 
people aged 60-79 the prevalence rate is also low. After the age of 80, the possibility of 
long-term care-giving in institutions rises dramatically. In the oldest age group (90+) the 
prevalence rates are between 20% for France and more than 50% in the Netherlands.  
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These prevalence rates were combined with the two population scenarios to estimate the 
development of the number of long-term care recipients in institutions. Table 2.8 shows 
the results for the six countries. In these countries, around 1.2 million people received 
institutional long-term care in 2001. The number of long-term care recipients in 
institutions is expected to increase by 2.7 million in the baseline scenario and by 
approximately 3.9 million in the living-longer high scenario. In the six countries the 
numbers of long-term care recipients will more than double with the exception of 
Denmark (Figure 2.14). 46 | ERIKA SCHULZ 
 
Table 2.8 Number of long-term care recipients in institutions (per 1000 persons) 
 
Around 820,000 long-term care recipients were aged 80+; 300,000 were aged 60 to 79 
and 130,000 were aged under 60 in 2001 (Tables 2.9 and A20). By 2050 the number of 
long-term care recipients in institutions aged under 60 will decline to 108,000 (baseline 
and living-longer high scenarios), but the number of the older and especially the oldest 
old long-term care recipients will rise sharply. In the baseline scenario around 400,000 
long-term care recipients will be aged 60-79 and 2.2 million will be aged 80+ in 2050. 
In the living-longer high scenario the number of these recipients will be 1.2 million 
higher.  
Thus, the number of the oldest old (80+) recipients will nearly triple by 2050 in the 
baseline scenario and quadruple in the living-longer high scenario (Figure 2.15 and 
Table A21). The change in this age group is expected to be highest in France in the 
baseline scenario (an increase by 186%) and in Belgium in the living-longer high 
scenario (an increase by 331%). 
Countries 2001 2010 2020 2030 2040 2050
Belgium  89      111      134      157      195      214    
  Denmark
1)  35      37      42      53      58      62    
Finland  36      43      52      66      76      73    
  France
1)  296      356      432      498      641      682    
Germany  612      688      865     1 000     1 129     1 301    
Netherlands  174      205      242      315      379      407    
Total 1 244     1 441     1 768     2 089     2 477     2 739    
Belgium  90      116      152      190      259      315    
  Denmark
1)  35      38      46      62      74      86    
Finland  37      45      57      77      98      102    
  France
1)  297      369      476      582      813      931    
Germany  612      716      965     1 218     1 467     1 874    
Netherlands  175      215      275      391      523      625    
Total 1 245     1 499     1 972     2 521     3 233     3 933    
1) Only 15+ years.
Source: Calculations by DIW.
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Table 2.9 Long-term care recipients in institutions by age group (per 1000 persons) 
 
Examining the age structure of long-term care recipients shows the same picture. 
Around two-thirds of the recipients in the six countries altogether were aged 80+ in 
2001; the share of the oldest old will increase by up to 81% in the baseline scenario and 
86% in the living-longer high scenario by 2050 (Figure 2.16 and Tables A22-A23). In 
2050 Denmark shows the ‘youngest’ age structure of long-term care recipients. Only 
two out of three long-term care recipients in institutions will be aged 80+ in 2050 in the 
baseline scenario in Denmark, whereas in Belgium around 86% of people receiving 
long-term care in institutions will be aged 80+ in 2050 (baseline scenario). 
Countries
0 - 59
1)2) 60 - 79
2) 80+ Total 0 - 59
1)2) 60 - 79
2) 80+ Total
Belgium  2       22       65       89       2       22       65       90     
  Denmark  7       9       19       35       7       9       19       35     
Finland  6       10       20       36       6       10       20       37     
  France  37       67       193       296       37       67       193       297     
Germany  70       153       389       612       70       153       389       612     
Netherlands  5       38       131       174       5       38       131       175     
Total  128       299       817      1 244       128       299       819      1 245     
Belgium  2       25       107       134       2       26       123       152     
  Denmark  7       14       22       42       7       14       25       46     
Finland  6       15       32       52       6       15       36       57     
  France  36       82       314       432       36       84       357       476     
Germany  71       180       614       865       71       186       708       965     
Netherlands  5       57       180       242       5       60       210       275     
Total  127       373      1 268      1 768       127       386      1 459      1 972     
Belgium  2       28       184       214       2       31       282       315     
  Denmark  6       14       41       62       6       16       63       86     
Finland  5       13       55       73       5       14       83       102     
  France  32       98       551       682       33       106       792       931     
Germany  56       189      1 055      1 301       57       207      1 610      1 874     
Netherlands  5       60       341       407       5       68       552       625     
Total  108       403      2 228      2 739       108       443      3 382      3 933     
1) Denmark and France = 15-59 years.-  2) Netherlands = 0-64 years and 65-79 years.
Source: Calculations by DIW.
2050
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Figure 2.15  Changes in the number of people receiving long-term care within the age 
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2.2.2  Long-term care at home 
Four countries have provided data on care-giving at home by professional care-givers. 
Figure 2.17 shows the number of people receiving long-term care at home per 1000 
inhabitants in 2001 for Germany, Finland, France and Belgium. The prevalence rates 
are highest for Germany, because the data for Germany includes formal care-giving at 
home and informal care-giving insofar as people in need of care receive benefits from 
the long-term care insurance schemes. But also in Finland a high share of the elderly 
receive formal care-giving at home. Care-giving at home is also related to the oldest old, 
but on average the people receiving formal care at home are younger than those 
institutionalised. Around 3% (Finland and Germany) and 1.3% (Belgium) of people 
aged 60-79 receive formal home care, but only 0.15% were institutionalised. 
Figure 2.17 People receiving long-term care at home per 1000 inhabitants (2001) 
 
To estimate the future development of care-giving at home (by professionals) the 
prevalence rates of the most recent year were held constant and combined with the two 
demographic scenarios. The results for the four countries (Belgium, Finland, France and 
Germany) are shown in Table 2.10. Around 2.2 million persons received long-term care 
at home in 2001. The number of recipients will rise up to 4 million in the baseline 
scenario and 5.4 million in the living-longer high scenario by 2050. There are no great 
differences in the development between the four countries, but Belgium and France are 
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Table 2.10 Long-term care recipients at home (1000 persons) 
 
Countries 2001 2010 2020 2030 2040 2050
Belgium  123     148     169     198     232     239   
Finland  78     92     110     137     147     142   
  France
1)  642     749     887    1 021    1 220    1 272   
Germany 1 338    1 512    1 791    1 993    2 228    2 387   
Total 2 182    2 501    2 956    3 348    3 828    4 041   
Belgium  123     153     184     228     287     322   
Finland  78     95     119     156     182     186   
  France
1)  643     769     957    1 153    1 485    1 653   
Germany 1 338    1 557    1 946    2 310    2 730    3 206   
Total 2 183    2 573    3 205    3 848    4 684    5 367   
1) Only 15+ years.




The long-term care recipients at home are on average younger than the long-term care 
recipients in institutions. Nevertheless, the increase in the oldest age group (80+) is 
highest. The number of long-term care recipients at home aged 80+ will rise from 
around 1 million in 2001 to 2.7 million in the baseline scenario and to around 4 million 
in the living-longer high scenario by 2050 (Tables A24 and A25). As in the case of 
institutional care, the number of recipients aged 80+ will nearly triple by 2050, while in 
the age group 60-79 the increase will be around 30% and in the younger age group a 
decrease is expected (Table 2.11). Thus, the age structure of long-term care recipients at 
home will change (Figure 2.19 and Tables A26 and A27). Around 20% of recipients 
were aged under 60, 35% were aged 60-79 and 46% were aged 80+ in 2001. In the 
baseline scenario (and living-longer high scenario) the share of long-term care 
recipients at home under the age of 60 will decline to 9% (7%), the share of recipients 
aged 60-79 will increase to 24% (20%) and the share of the oldest old will rise up to 
67% (74%) by 2050. 
To summarise: information about long-term care-giving in nursing homes or homes for 
the elderly are available for six countries: Belgium, Denmark, Finland, France, 
Germany and the Netherlands. Thus the further development of long-term care 
recipients in homes could be estimated for these countries. But a projection of long-term 
care recipients at home could only be carried out for four participating countries: 
Belgium, Finland, France and Germany. Long-term care at home in Belgium, Finland 
and France only includes care-giving at home by professional care-givers. In Germany 
additional care-giving by members of the family or other informal care-givers is 
included if the person in need of care receives cash benefits for informal care from the 
insurance schemes.  AGEING, HEALTH AND RETIREMENT IN EUROPE – AGIR WP4, PART A | 53 
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Table 2.11 Long-term care recipients at home by age group (2001 = 100) 
 
The number of long-term care recipients is expected to increase markedly. On average 
the number of recipients will more than double. The shift towards the oldest old will 
continue. The number of recipients aged 80+ will triple in the baseline scenario and 
quadruple in the living-longer high scenario, whereas the number and proportion of the 
‘younger’ long-term care recipients will decline. The development will be nearly the 
same for long-term care-giving in institutions and long-term care-giving at home. In 
several EU countries, waiting lists for nursing homes already exist. The pressure from 
the demand side will increase dramatically. Especially for the oldest old, care-giving at 
home is in most cases not possible and places in nursing homes are needed. 
Communities have to ensure that they can meet the challenge. This will not be an easy 
task.  
Furthermore, the increasing need for long-term care-giving at home is not easily met. 
The high increase in the numbers of the oldest individuals means that the potential care-
givers are, on average, also older. But as health status deteriorates with age, the share of 
care-givers in bad health will increase, thus informal care-giving could become a hard 
task. It can be expected that the need for professional home care and the demand for day 




1) 60 - 79 80+ Total 0 - 59
1) 60 - 79 80+ Total
Belgium  94      119      159      137      94      122      180      150    
Finland  91      149      151      140      91      154      171      151    
  France  97      130      160      138      98      133      180      149    
Germany  99      117      163      134      100      121      186      145    
Total  98      122      162      136      99      126      183      147    
Belgium  85      129      264      195      85      140      385      262    
Finland  81      135      255      181      82      146      366      237    
  France  88      144      280      198      89      154      396      257    
Germany  81      121      269      178      81      132      399      240    
Total  83      129      272      185      83      139      396      246    
1) France = 15-59 years.
Source: Calculations by DIW.
2050
Age-groups
Baseline scenario Living-longer-high scenario
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Figure 2.19 Age structure of long-term care recipients at home 
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2.3 Summary 
In this chapter the development of hospital cases, hospital bed days, contacts with a 
doctor and long-term care recipients in institutions and at home are projected using the 
national sources for utilisation data and the two demographic scenarios. In this part no 
health scenarios could be used, because the national sources do not allow utilisation to 
be desegregated by health status. The advantage of the national sources is that the total 
population is mostly covered and thus the development of utilisation caused by the 
ageing process and increasing life expectancy can be shown for a single country. But 
not all the utilisation data are available for all participating countries (Belgium, 
Denmark, Finland, France, Germany, the Netherlands, Spain and the UK). Whereas data 
on hospital utilisation are available for all countries, the number of contacts with a 
doctor are not available for Denmark, France or Germany, data on long-term care in 
institutions are not available for Spain or the UK and data on long-term care at home by 
professional care-givers are not available for Denmark, the Netherlands, Spain or the 
UK. Table 2.12 shows the results for the projections for the total population and Table 
2.13 shows the results for the elderly (75+ and 80+ respectively). 
Table 2.12 Development of the population, health care utilisation and long-term care 
recipients (1999 = 100) 
According to the baseline scenario, the number of inhabitants will decline in four 
participating countries – Belgium, Finland, Germany and Spain – and will increase in 
the other four participating countries – Denmark, France, the Netherlands and the UK 
by 2050 (Table 2.12). Nevertheless, in all the countries the number of hospital days will 
increase on average by 29% by the year 2050. This increase could be traced back to the 
opposite trends in the younger and older ages. While the hospital days of persons aged 
75+ will increase on average by 118%, in the younger ages declines of 18% (0-14) and 
12% (15-64) are expected. 
Countries Contacts with Contacts with
a doctor
 2) a doctor
 2)
Belgium   103 120       110 150       137       104 125         113 169       150    
Denmark   104 120       - 120       -   106 125       - 132       -
Finland   103 133       105 142       140       104 141         107 156       151    
France   106 116      
1) - 146      
3) 138    
3)   108 119      
1) - 161      
3) 149    
3)
Germany   101 118       - 141       134       103 123       - 158       145    
Netherlands   108 132       112 139       -   110 137         114 158       -
Spain   100 117       105 - -   101 122         107 - -
United Kingdom   105 115      
1) 107 - -   106 121      
1)   109 - -
Belgium   99 135       115 240       195       104 158         128 352       262    
Denmark   104 135       - 175       -   110 159       - 244       -
Finland   95 155       98 201       181       101 190         104 279       237    
France   105 122      
1) - 230      
3) 198    
3)   110 133      
1) - 314      
3) 257    
3)
Germany   92 122       - 212       178       98 140       - 306       240    
Netherlands   110 149       117 233       -   116 177         127 358       -
Spain   88 132       100 - -   94 154      
1)   110 - -
United Kingdom   104 142      
1) 109 - -   109 173         117 - -
1) 2000 = 100.-  2) 2001 = 100.-  3) Only 15+ years.
Source: Calculations by DIW.
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Table 2.13 Development of the population aged 75+, health care utilisation (75+) and  
long-term care recipients (80+) (1999=100) 
 
 
For the most part, the growth rate of persons aged 75+ is comparable with the growth 
rate of hospital days (Table 2.13). Half of the hospital days will be required for persons 
aged 75+ in 2050. The spectrum of diseases of the elderly is different from that of the 
younger inpatients and thus the elderly require another spectrum of hospital treatments. 
Besides acute illnesses, old people generally suffer from functional disability and 
mental illness. This significant structural change in demand requires substantial 
reorganisation and restructuring of hospital departments. As previously mentioned, 
government officials and hospital administrators should take this information into 
account in the strategic planning of hospital services as well as in the training of 
medical and nursing staff. 
With respect to the reduced mortality rates for persons aged 20 to 90, the living-longer 
high scenario leads to a more dynamic development in the number of hospital days.  
An estimation of the number of contacts with a doctor was performed for five 
participating countries. A moderate increase (and for Finland a decline) is expected until 
2050. As in the case of hospital days, the decline in the number of contacts with a 
doctor in the younger age groups counteracts the increase in the older ages.  
The development of people receiving long-term care seems to be more dramatic. For six 
participating countries it was possible to estimate the development of long-term care-
giving in institutions. On average an increase of 120% by the year 2050 is expected. 
And the number of people receiving long-term care by professional care-givers at home 
will double by 2050. These results must be interpreted with caution, because the 
underlying prevalence rates are the result of the institutional settings and the political 
strategies/decisions in the base year. In most EU countries long-term care-giving seems 
Contacts with LTC 
2) LTC 




 2) institutions at home a doctor
 2) institutions at home
People 75+ 75+ 80+ 80+ People 75+ 75+ 80+ 80+
Belgium   136 136       129 164 159   148 148         141   189   180
Denmark   130 131       - 116 -   143 144       -   134 -
Finland   149 151       142 155 151   163 165         155   177   171
France   137 134      
1) - 163 160   148 145      
1) -   184   180
Germany   158 159       - 158 163   173 174       -   182   186
Netherlands   144 150       142 137 -   158 165         157   160 -
Spain   139 145       131 - -   152 159         143 - -
United Kingdom   122 122      
1) 121 - -   134 137      
1)   132 - -
Belgium   205 205       195 282 264   268 268         255   431   385
Denmark   192 193       - 217 -   258 260       -   335 -
Finland   207 209       197 270 255   273 275         259   404   366
France   225 219      
1) - 286 280   282 274      
1) -   409   396
Germany   217 218       - 271 269   287 288       -   414   399
Netherlands   216 230       214 261 -   296 320         293   420 -
Spain   231 238       217 - -   297 314         279 - -
United Kingdom   200 214      
1) 198 - -   266 300      
1)   262 - -
1) 2000 = 100.-  2) 2001 = 100.
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to be the task of the family and waiting lists for nursing homes exist. The supply of 
community care by district nurses or day care or night care centres depends on political 
decisions. Therefore, the estimated development can be deemed to be on the lower side 
of the ‘need’ for long-term care. The pressure on professional long-term care-giving 
will be exacerbated by changes in the family structure and the increasing labour force 
participation of women. 
In the case of long-term care the results are comparable with results from previous 
studies (Jacobzone et al., 1998 and 2000; Jacobzone, 1999; Bebbington, 2000; 
Wittenberg et al., 1998; Dietz, 2002). Jacobzone analysed the disability trends and the 
implications for long-term care-giving in nine countries (Australia, Japan, France, the 
UK, Germany, Sweden, Canada, the Netherlands and the US). He pointed out that no 
general trend in disability could be observed in these countries. He groups the countries 
into those with no gains in disability, moderate or mixed results and significant gains. In 
the static approach, constant institutionalisation or disability rates were assumed and the 
numbers of institutionalised persons and disabled persons in households were estimated. 
For four countries the results can be compared with the results presented here. The 
results for a single country are a bit different from the results presented here, but the 
trend is the same: a high increase in the ‘need’ for long-term care-giving (Table 2.14). 
Table 2.14 Development of long-term care-giving 
 
Bebbington (2000) analysed the trends in life expectancy, healthy life expectancy and 
age-specific disability rates in the past and the implication for long-term care-giving in 
the UK (England). He arrived at the conclusion that the observed gains in life 
expectancy are mostly years spent in illness and that no improvements in age-specific 
disability rates could be observed. The study from Bebbington confirms the results of 
the study for England carried out by Wittenberg et al. (1998). They estimated the 
number of elderly persons living in residential care homes, nursing homes and in 
hospitals by 2031. The data stem from the General Household Survey 1994-95 and 
includes persons aged 65+. Assuming constant prevalence rates they calculated an 
increase in the number of people living in residential and nursing homes to be 22.8% 
between 2000 and 2020. 
Dietz (2002) analysed the development of life expectancy and morbidity in Germany. 
He focused on age-specific diseases. He came to the result that the life span with 
chronic diseases and functional disability has increased in the past and that this trend 
will continue. 
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Chapter 3. 
Effect of Improving Health and Ageing 
on Health Care Utilisation 
n chapter 2 the national sources for utilisation data were combined with the two 
demographic scenarios. Chapter 2 shows the further development in the main fields 
of acute care and long-term care in institutions and by professional care-givers at 
home for the total population. Since the national data includes no information on 
utilisation by health status, only the effects of demographic change and living longer 
could be taken into account. In chapter 3 utilisation data from the European Community 
Household Panel (ECHP) were used, which covers on the one hand (only) persons in 
private households aged 16+, but on the other hand allows differentiation of the 
utilisation by health status. These data were combined with the four demographic and 
health scenarios: the baseline scenario, the baseline scenario with improving health, the 
living-longer high scenario and the living longer in better health scenario. In this 
chapter the development of the number of hospital admissions, the number of bed days 
and the number of contacts with a general practitioner can be estimated for the four 
scenarios. Thus, the main fields of acute care are also covered by these projections, but 
no information exists about long-term care recipients. The ECHP only covers persons in 
private households, not those in institutions. But it includes information about 
longstanding illness/disability. To get an idea about the scope of people with the 
potential need of care, the numbers of people who were severely hampered in their daily 
activities caused by disability/longstanding illness and who have had to cut down things 
they usually do were used.  
3.1 Hospital  utilisation 
The ECHP includes information about hospital admissions and the length of hospital 
stay. It asked if a person was admitted to a hospital at least once in the last year as an 
inpatient and how many nights he/she spent in a hospital in the past 12 months. The 
utilisation data from the ECHP are therefore not fully compatible with the national data, 
because the latter refer to hospital cases. That means if a person was in a hospital more 
than once in the last year, the number of stays were counted. And also the number of 
hospital days from the national sources refers to the single hospital stay, whereas in the 
ECHP the hospital days of all hospital stays in the last year were totalled.  
Another point is that the sample size of the ECHP is not large enough to calculate 
representative utilisation data differentiated by country, age group and health status for 
a single year. Therefore, utilisation data were calculated as a three-year average for the 
years 1999-2001. These utilisation data in a single health status, age group and country 
were held constant over the forecast period and combined with the demographic and 
health scenarios. The demographic scenarios lead to changes in the number and age 
structure of persons for a given health status, while the health scenarios lead to changes 
in the proportion of people in good, fair and bad health status for a given age group. 
Therefore, the effect of demographic development, improvements in life expectancy and 
changes in the health status can be shown. 
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3.1.1 Hospital  admissions 
Table 3.1 shows the proportion of people admitted into a hospital at least once in the 
last year by health status in the participating countries and the EU (without Luxembourg 
or Sweden). The proportion of admitted people increases with age and at a given age if 
the health status deteriorates. This trend can be observed in all countries. In the EU on 
average around 5% of people in good health, 12% of people in fair health and 28% of 
people in bad health were admitted into a hospital in 2001. In the participating countries 
altogether the proportion of admitted people was a little bit higher: 6%, 14% and 29% 
respectively. 
Table 3.1 Proportion of people admitted into a hospital by health status in participating 
countries and the EU
1) 1999-2001 (%) 
Age- Nether-
groups lands
15-29 7,5      6,7      6,9      4,4      8,0      3,8      2,8      7,0      4,9      
30-44 5,9      5,8      7,1      3,9      7,4      5,3      4,2      6,2      4,6      
45-59 7,3      5,2      7,4      4,4      6,2      2,9      4,1      3,3      4,0      
60-69 9,0      6,3      10,0      6,5      6,8      5,3      5,0      6,1      6,1      
70-79 10,3      11,1      14,0      8,9      10,4      6,8      8,0      7,7      9,0      
80+ 15,9      12,3      23,7      12,2      12,9      7,5      9,8      10,4      10,0      
Total 7,4      6,3      7,5      4,7      7,4      4,5      4,0      5,9      4,8      
15-29 16,2      21,2      17,3      11,7      13,4      10,1      12,6      11,0      12,0      
30-44 14,6      14,9      15,9      11,3      11,6      11,7      10,8      11,3      11,1      
45-59 19,9      13,3      16,4      13,4      9,8      9,7      10,3      8,7      10,7      
60-69 17,0      19,3      16,5      14,8      13,9      14,0      11,0      12,0      12,0      
70-79 28,0      21,2      20,2      17,8      16,5      18,8      15,0      15,7      16,3      
80+ 28,8      24,9      26,8      18,9      20,3      15,6      16,4      21,5      17,9      
Total 20,2      17,5      17,2      14,0      12,5      12,8      12,3      11,7      12,4      
15-29 25,0      39,5      36,7      40,8      27,0      27,9      32,5      26,1      33,1      
30-44 39,0      36,8      41,3      31,2      23,4      21,5      25,9      26,7      27,1      
45-59 39,1      33,3      26,5      38,2      23,8      21,1      20,3      22,6      25,5      
60-69 38,5      34,5      35,2      34,6      26,6      33,5      26,5      26,5      26,1      
70-79 41,5      34,3      40,7      40,1      31,1      38,7      30,4      36,1      30,3      
80+ 87,2      44,2      33,7      35,2      36,1      28,3      27,5      35,1      28,0      
Total 42,2      36,3      33,8      36,8      26,5      27,4      26,9      27,6      27,5      
1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001.
Source: ECHP wave 6-8. 
Spain UK
People in good/very good health
EU
 1)
People in fair health
People in bad/very bad health
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In 2001 around 29 million people (15+) were admitted into a hospital in the EU, of 
which 10 million were in good health, 10 million were in fair health and 9 million were 
in bad health (Table A28). The figures for the participating countries altogether are: 
24.2 million admitted people, of whom 8.1 million were in good health, 8.6 million 
were in fair health and 7.5 million were in bad health. By 2050 the number of people 
(15+) admitted at least once a year increases in the baseline scenario by 4.1 million in 
the EU and by 3.7 million in the participating countries altogether (Table A29). This is 
an increase of around 15% (Table A30). The highest increase can be observed for 
people in bad health – around 30% in the participating countries and 32% in the EU. 
Table 3.2 People admitted into a hospital by health status in 2050 in participating 
countries and the EU
1) (2001 = 100) 
 
The higher life expectancy in the living-longer scenario strengthens this development. 
The number of people admitted into a hospital increases by around 28% by 2050 and 
among people in bad health by around 50%. Improvements in health status lead to a 
contrary effect. The number of people admitted into a hospital account for 2.3 million 
people less in the baseline improving-health scenario compared with the baseline 
scenario in 2050. The increase in the percentage of admitted people in the baseline 
improving-health scenario is half as much as in the baseline scenario (EU).  
Health Nether-
status lands
good 101      107      94      106      83      109      87      107      97      94        
fair 126      126      119      128      107      134      123      124      119      119        
bad 147      136      144      135      126      134      141      125      130      132        
total 119      120      113      124      108      123      117      117      115      114        
good 106      112      99      115      93      113      93      114      104      99        
fair 129      125      121      134      116      137      128      129      126      125        
bad 75      93      97      58      88      55      101      66      80      98        
total 108      112      108      108      99      112      107      105      104      108        
good 108      115      99      111      86      115      93      115      102      100        
fair 144      145      134      141      120      154      140      141      134      134        
bad 181      163      173      150      147      153      163      142      150      152        
total 134      135      126      136      121      137      131      130      128      128        
good 114      120      104      122      97      120      100      123      111      105        
fair 148      144      137      148      130      158      146      147      141      141        
bad 95      115      121      67      106      65      120      76      95      115        
total 122      126      121      119      112      125      121      117      117      120        
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
Living-longer better health scenario
Living-longer-high scenario
All EU
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Great differences can be observed in the development of hospital admissions of people 
in bad health between the scenarios with and without improvements in health. Under the 
assumption that additional years are years in good health, the number of admitted 
people in bad health decreases in the baseline improving-health scenario. Improving 
health has therefore an appreciable influence on the development of hospital 
admissions. But the development in the living longer in better health scenario shows 
that the effect of improving health is not great enough to completely compensate for the 
effect of an increasing life expectancy in the underlying scenarios. The changes in 
hospital admissions between 2001 and 2050 in percentages are a little bit higher in the 
living longer in better health scenario than in the baseline scenario.  
The different developments in the four scenarios are shown in Table 3.2 and Figure 3.1. 
If the number of admissions in 2001 is set to 100, the number of admissions in 2050 in 
the EU is 114 in the baseline scenario, 108 in the baseline improving-health scenario, 
128 in the living-longer scenario and 120 in the living longer in better health scenario. 











Baseline scenario Baseline scenario with improving
health
Living-longer-high scenario Living-longer better health scenario
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3.1.2  Hospital bed days 
To show the development in hospital utilisation the number of people admitted into a 
hospital has to be multiplied by the length of hospital stay. The result is the number of 
bed days of inpatients within one year. Table 3.3 shows the mean value of days spent in 
a hospital during the past year. As in the case of hospital admissions, the length of 
hospital stay increases with age and at a given age if the health status deteriorates. 
People in good health spent on average around 7 days a year in a hospital, people in fair 
health spent 11 days and people in bad health spent 19 days in the EU (average 1999-
2001). The figures for the participating countries altogether are nearly the same as for 
the EU. 
Table 3.3 Mean value of hospital days of inpatients within one year by health status  





15-29 4,0      4,6      3,5      4,5      8,2      6,7      6,6      3,3      5,8       
30-44 5,1      6,3      3,9      4,9      7,7      3,5      4,9      4,0      5,7       
45-59 6,3      6,7      3,9      4,7      9,2      6,4      5,2      4,2      6,9       
60-69 6,6      8,7      4,8      5,9      9,1      7,8      8,6      6,5      7,9       
70-79 12,0      12,6      6,4      9,2      13,5      7,8      12,8      7,9      10,5       
80+ 18,9      16,8      8,9      8,8      14,8      11,0      13,6      13,1      13,6       
Total 6,6      7,2      4,0      5,4      8,4      5,6      6,9      4,8      6,8       
15-29 13,8      10,6      10,9      6,4      9,9      9,1      9,2      5,8      9,3       
30-44 10,0      6,9      8,7      7,9      10,8      8,3      8,0      5,6      9,2       
45-59 11,1      12,3      6,4      8,2      13,0      8,8      10,5      6,1      9,8       
60-69 13,8      8,7      9,8      9,6      16,9      11,1      10,3      9,4      12,0       
70-79 15,8      12,7      9,8      11,8      15,1      12,5      12,1      10,8      12,8       
80+ 18,3      15,3      13,9      14,5      17,2      13,7      11,6      15,7      15,1       
Total 13,6      10,9      8,7      9,5      13,3      10,4      10,6      8,0      11,1       
15-29 43,3      15,1      13,1      18,9      17,8      17,7      20,9      8,3      17,6       
30-44 28,5      15,9      22,7      14,0      16,3      12,6      20,9      9,3      17,2       
45-59 22,2      30,1      17,2      19,4      22,6      18,1      13,3      11,9      19,3       
60-69 16,2      23,6      20,6      18,9      22,5      19,3      17,9      11,9      19,4       
70-79 26,3      26,5      20,5      23,8      24,1      24,3      21,7      17,1      20,6       
80+ 14,2      19,2      22,5      22,7      25,7      18,4      20,5      23,3      21,0       
Total 23,0      23,3      19,8      20,1      21,8      19,0      19,3      13,1      19,2       
1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001.
Source: ECHP wave 6-8. 
UK EU
 1)
People in good/very good health
People in fair health
People in bad/very bad health
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In 2001 around 350 million days were spent in a hospital in the EU, of which 67 million 
were used by people in good health, 111 million by people in fair health and 172 million 
by people in bad health. In the participating countries altogether around 300 million 
days were spent in a hospital, of which 53 million were used by people in good health, 
96 million by people in fair and 150 million by people in bad health. In the baseline 
scenario the number of bed days will increase by 27% in the EU and 28% in the 
participating countries combined by 2050 (Tables A31–A33). Thus, the development of 
bed days shows higher potential increases than the increase of hospital admissions. The 
number of bed days used by people in bad health will increase by 35% in the EU and 
36% in the participating countries altogether.  
A higher life expectancy leads to a higher growth rate of bed days than in the baseline 
scenario. The number of bed days increases by 45% by 2050 in the EU and 48% in the 
participating countries combined; and for people in bad health is the increase 56% and 
60% respectively in the baseline and living-longer high scenarios. Improvements in 
health status lead to a lower growth rate of hospital bed days. In the living longer in 
better health scenario the number of bed days increases by 31% in the EU and by 25% 
in the participating countries altogether by 2050. Thus, in the EU on average the 
increase is only a little bit higher than in the baseline scenario and for the participating 
countries altogether a little bit lower. But these differences are not great and have to be 
interpreted with caution. As a result it could be held that in the baseline scenario an 
increase of total bed days of around one-quarter can be expected by 2050 and that 
further improvements in health are able to nearly compensate for the effect of additional 
life expectancies (Table 3.4 and Figure 3.2). 
Table 3.4 Hospital bed days by health status in 2050 in participating countries and the 
EU
1) (2001 = 100)
Health Nether-
status lands
good 121      119      102      114      88      119      103      126      105      104      
fair 135      134      130      141      113      142      129      144      128      128      
bad 131      135      149      140      132      138      144      142      136      135      
total 130      130      132      137      120      135      132      138      128      127      
good 128      126      108      126      99      125      112      136      115      110      
fair 139      133      132      149      124      146      135      151      136      134      
bad 62      93      101      64      95      58      105      78      87      101      
total 110      114      116      105      104      111      114      114      107      113      
good 138      133      111      123      92      130      114      145      115      114      
fair 158      159      151      160      129      167      148      173      147      147      
bad 155      159      180      157      157      157      168      169      160      156      
total 152      152      155      154      139      154      152      164      148      145      
good 147      142      117      137      105      137      124      157      127      121      
fair 163      156      155      169      141      172      155      181      156      154      
bad 76      113      128      74      115      68      124      94      104      120      
total 130      134      138      119      121      128      133      136      125      131      
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
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Figure 3.2 Hospital bed days by health status in the EU
1) (2050)
 
 1) EU (15) without Luxembourg or Sweden; people aged 15+. 
 
The development of hospital bed days is different in the single age groups. As an 
example, the development in the EU is shown in Figure 3.3. In the age groups 15-29, 
30-44 and 45-59 the number of bed days decreases between 2001 and 2050 in all four 
scenarios. The age group 60-69 will experience an increase in the scenarios without 
improvements in health status, but if improvements in health status are taken into 
account there will be no changes (living longer in better health scenario ) and a small 
decrease (baseline scenario with improving health) can be observed. And the older age 
groups show an increase in all scenarios. The highest increase in hospital utilisation can 
be expected for people aged 80+. Therefore, the age structure of hospitalised people will 
change between 2001 and 2050. In 2001 around 14% of hospital bed days are required 
for people aged 80+; in 2050 between 29% (baseline scenario) and 37% (living longer 
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Figure 3.3 Hospital bed days by age groups in the EU
1) (2050) 
1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001. 
Figure 3.4 Age structure of hospital days in the EU
1) 
1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001. 
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3.2  Contacts with a general practitioner 
Along with variables concerning hospital utilisation, the ECHP includes variables 
regarding outpatient utilisation. One question was “During the last 12 months, about 
how many times have you consulted a general practitioner?”. The ECHP also asked 
about medical specialist consultations and dentist consultations. To show the effect of 
the different demographic and health care scenarios, the consultations with a general 
practitioner were used as an example. No data exist for France or Germany. To include 
these two countries in the forecast, however, the average mean value of the contacts in 
the EU is used. 
Table 3.5 Mean value of contacts with a general practitioner within one year by health 







15-29 2,8      2,4      1,9      1,7      1,7      1,8      1,7      2,3      1,7       
30-44 2,5      1,8      1,7      1,8      1,8      1,8      1,7      1,9      1,8       
45-59 3,1      1,6      1,4      2,1      2,1      1,6      2,2      1,9      2,1       
60-69 4,4      2,2      1,4      3,0      3,0      2,2      3,4      2,6      3,0       
70-79 6,2      2,6      1,3      3,7      3,7      2,6      4,1      2,9      3,7       
80+ 7,8      3,0      1,0      4,3      4,3      2,9      4,7      3,0      4,3       
Total 3,2      2,0      1,6      - - 1,8      2,1      2,2      2,1       
15-29 5,5      5,9      3,9      3,9      3,9      5,1      4,8      3,5      3,9       
30-44 5,8      4,3      3,0      4,0      4,0      4,8      4,3      3,5      4,0       
45-59 7,1      4,1      2,7      4,3      4,3      4,2      5,3      3,8      4,3       
60-69 9,6      4,4      2,3      5,4      5,4      4,9      6,5      4,5      5,4       
70-79 10,3      5,1      2,3      6,1      6,1      5,3      6,8      4,5      6,1       
80+ 10,8      5,7      2,8      6,3      6,3      5,2      6,9      4,4      6,3       
Total 8,1      4,6      2,7      - - 4,8      5,8      3,8      4,8       
15-29 5,3      10,3      5,2      7,3      7,3      7,7      8,1      5,8      7,3       
30-44 12,0      9,9      6,5      7,8      7,8      8,2      9,6      6,1      7,8       
45-59 14,6      9,0      4,9      8,6      8,6      8,1      10,2      6,3      8,6       
60-69 18,5      8,3      4,0      9,6      9,6      8,5      10,7      6,4      9,6       
70-79 19,2      7,3      4,3      9,9      9,9      10,4      10,8      6,3      9,9       
80+ 14,1      8,2      14,2      9,2      9,2      8,7      9,7      5,5      9,2       
Total 15,6      8,6      5,7      - - 8,6      10,3      6,1      8,7       
1) EU (15) without Luxembourg, Sweden, France and Germany; three-year-averages 1999-2001.-  2) EU-average.
Source: ECHP wave 6-8. 
People in good/very good health
People in fair health
Belgium Denmark Finland France 
2) Germany 
2) Spain UK EU 
1)
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On average people consulted a doctor 3.4 times a year in the EU (average 1999-2001). 
People in good health visit a general practitioner 2.1 times, people in fair health 4.8 
times and people in bad health 8.7 times a year (Table 3.5). At a given health status the 
number of contacts increases with age. People in bad health age 60+ have contact with a 
general practitioner on average 10 times a year (EU). The differences among the 
countries depend on the health care system besides other factors. In several countries 
general practitioners act as gatekeepers for specialists and hospital admissions. 
Therefore, in this part the focus lies on the development in the countries and the 
differences among the four demographic and health scenarios and not on the analysis of 
differences among countries. 
To obtain the total number of contacts with a general practitioner in the EU, the mean 
value of contacts with a general practitioner in the EU without Luxembourg, Sweden, 
France or Germany was multiplied by the population aged 15+ in the EU without 
Luxembourg or Sweden. Thus, the average mean value of contacts in the EU is also 
applied to France and Germany.  
Table 3.6 Contacts with general practitioner by health status in 2050 in participating  
countries and the EU




good  104      106      87      104      86      109      88      107      98      96      
fair  126      123      110      128      106      129      123      118      117      119      
bad  128      130      176      138      119      130      138      119      126      133      
total  115      115      111      122      107      120      113      113      113      114      
good  109      110      90      114      97      114      94      114      106      100      
fair  129      122      110      134      114      131      128      123      124      124      
bad  58      86      137      59      82      55      99      63      78      100      
total  109      109      106      112      98      112      107      107      105      109      
good  112      111      88      109      90      116      94      114      104      101      
fair  143      139      122      141      117      146      138      130      130      133      
bad  148      152      229      154      137      148      159      131      144      154      
total  128      127      126      133      119      132      126      122      125      126      
good  118      116      92      120      102      121      101      122      113      106      
fair  148      138      122      148      127      149      144      135      138      139      
bad  70      104      183      69      97      64      116      70      92      117      
total  121      120      119      123      110      123      119      116      116      121      
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
Living-longer better health scenario
Living-longer-high scenario
All EU 
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Under this assumption general practitioners received around 1.074 million contacts in 
the EU in 2001, among which 410 million were from people in good health, 378 million 
were from people in fair health and 286 million were from people in bad health. In the 
baseline scenario the number of contacts will increase 14% by 2050. Whereas the 
number of contacts of people in good health will be less than in 2001, the number of 
contacts of people in bad health will increase by 33% (Tables A34-A36). If the life 
expectancy increases by around five additional years, the number of contacts increases 
26% and for people in bad health 54% by 2050. Improvements in health status 
counteract these developments, but the rise in the living longer in better health scenario 
is higher than in the baseline scenario (Table 3.6 and Figure 3.5). Thus, improvements 
in health status can not compensate for the effect of a higher life expectancy (given the 
underlying assumptions). 
Figure 3.5 Contacts with a general practitioner by health status in the EU
1) (2050)
 
1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001. 
Great differences in the development of contacts with a general practitioner between the 
age groups can be observed. The number of contacts of people under age 60 decreases 
in all scenarios, whereas the number of contacts of people aged 60+ increases. As in the 
case of hospital bed days, the highest increase could be expected for people aged 80+ 
(Figure 3.6). In 2001, 9% of contacts with a general practitioner were required by 
people aged 80+. In 2050, between 21% (baseline scenario) and 26% (living longer in 
better health scenario) of contacts with a general practitioner will be required for people 
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1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001. 
Figure 3.7 Age structure of contacts with a general practitioner in the EU
1) 












Baseline scenario Baseline scenario Baseline scenario with
improving health
Living-longer scenario Living-longer better health
scenario
Contacts 2001 Contacts 2050
15-29 30-44 45-59 60-69 70-79 80+AGEING, HEALTH AND RETIREMENT IN EUROPE – AGIR WP4, PART A | 71 
 
 
3.3 Severely  hampered  persons 
To obtain an idea about the extent for the need of long-term care at home, data 
concerning disability from the ECHP were used. Three questions are directly relevant: 
“Do you have any chronic physical or mental health problem, illness or disability?” 
(yes/no/missing); “Are you hampered in your daily activities by this physical or mental 
health problem, illness or disability?” (yes, severely/yes, to some extent/no/missing/not 
applicable); “During the past two weeks, have you had to cut down things you usually 
do about house, at work or in free time because of illness or injury?” (yes/no/missing). 
Jacobzone (1998) pointed out that severe disability is a good proxy for the need for 
long-term care. Therefore, the number of persons who are severely hampered in daily 
activities were used as a soft proxy for the number of persons with a potential need for 
long-term care at home. In total, 8% of all persons reported that they were severely 
hampered in daily activities in 2001 (EU countries without Luxembourg). The share of 
the severely hampered persons increases with age. Around 13% of persons aged 60-69, 
20% of persons aged 70-79 and 30% of persons aged 80+ were reported to be severely 
hampered. 
Among the participating countries the share and the development between 1994 and 
2001 of the number of severely hampered persons was different (Table 3.7). The share 
of severely hampered persons was lowest in Belgium (around 5%) and highest in France 
(10%) in 2001. The data for the UK are not fully compatible, because in waves 1 to 5 
(years 1994 to 1998) and in waves 7 and 8 (years 2000 and 2001) the response item “to 
some extent hampered” was combined with the item “severely hampered”. Only for 
1999 are the UK data fully comparable, and show that around 6% were severely 
hampered.  
Table 3.8 shows the proportion of severely hampered persons in the single participating 
countries by health status as a three-year average of 1999-2001. As expected, the share 
of severely hampered persons increases sharply if the health status deteriorates. The 
highest share of hampered persons can be observed in the Netherlands, where three out 
of four people in bad health were reported to be severely hampered in their daily 
activities. 
The share of persons severely hampered by chronic illness is noticeably higher than the 
share of people who receive long-term care at home (data from national sources – see 
chapter 2). In France, for example, 10% were reported as severely hampered by chronic 
illness or disability, but only 0.6% received professional care at home. In Germany, 
around 8% were reported as severely hampered by chronic illness, but only 1.8% 
receive long-term care at home by informal or professional care-givers. 
To select those who need help from others among the severely hampered persons an 
additional question from the ECHP was used. The ECHP asked if the severely 
hampered person has had to cut down things they usually do as a consequence of a 
chronic illness or disability. Table 3.9 shows the results of the ECHP for the three-year 
average 1999-2001. A large share of severely hampered persons has had to cut down 
things they usually do, with the exception of France. In France only one out of three 
hampered persons have had to cut down things. Utilising both pieces of information 
leads to a new approach with the data for analysing long-term care-giving at home. If 72 | ERIKA SCHULZ 
 
10% were reported as severely hampered and around one-third of them have had to cut 
down things, it could be expected that around 3% of the French population will need 
help with housework or personal help. But the ECHP provides no information on the 
degree to which help is needed. Therefore, the 3% can only be the upper limit of people 
in need of help. In the younger and middle age groups in particular the degree to which 
help is needed will be low, and in these age groups help from other members of the 
family or the partner is common. Thus, the results of the ECHP have to be interpreted 
with caution and they seem to show the upper limit of the need for help. 
Table 3.7 Severely hampered persons by age group in participating countries 
(1994-2001) 
Age-
groups 1994 1995 1996 1997 1998 1999 2000 2001 1994 1995 1996 1997 1998 1999 2000 2001
  0 - 29 1,4 1,0 1,3 0,8 1,3 0,7 0,6 0,5 1,8 2,0 1,7 1,5 1,6 1,7 1,4
30 - 44 3,0 2,5 2,4 2,0 2,5 2,2 2,2 2,7 3,4 3,5 2,9 3,5 2,8 2,7 3,0
45 - 59 6,6 6,7 6,1 5,5 6,2 5,0 4,6 4,6 9,9 10,2 10,7 10,2 10,9 9,7 10,6
60 - 69 11,8 10,4 10,7 7,3 8,1 6,9 7,0 6,9 15,0 15,7 14,5 14,9 15,0 14,9 14,2
70 - 79 15,7 15,5 15,9 14,4 20,1 15,8 14,3 14,9 25,6 24,0 23,5 25,1 23,8 21,2 23,3
80 + 30,4 27,3 27,6 21,1 23,1 18,9 17,6 21,6 38,4 41,0 33,2 41,3 44,2 37,9 41,0
Total 6,6 6,1 6,1 4,9 6,1 5,1 4,8 5,3 7,9 8,2 7,8 8,2 8,3 7,8 8,5
  0 - 29 1,5 1,3 1,2 1,4 1,1 2,0 1,6 1,8 1,7 2,2 2,1 2,1 2,0 2,8 3,0 3,3
30 - 44 1,6 2,7 2,1 1,9 2,6 2,5 2,8 2,6 3,8 4,7 4,1 4,6 4,4 4,4 4,5 4,7
45 - 59 5,4 5,8 6,0 5,9 5,6 5,0 5,6 5,6 6,8 8,2 8,2 8,0 7,9 8,3 9,2 9,4
60 - 69 8,9 12,7 10,9 10,0 10,4 8,9 9,4 10,8 12,1 10,4 12,1 11,4 12,7 10,3 11,6 11,7
70 - 79 15,3 14,1 18,2 18,0 18,2 17,9 20,5 13,8 17,6 15,8 15,9 18,5 17,7 16,7 17,2 16,1
80 + 20,8 21,6 24,9 22,9 24,5 23,3 27,8 29,6 25,5 21,9 26,7 21,1 25,1 20,3 26,2 27,4
Total 5,4 5,9 6,0 5,8 5,9 5,6 6,3 6,1 6,6 6,9 7,0 7,2 7,3 7,3 8,0 8,2
  0 - 29 1,6 1,5 1,9 1,4 1,5 0,9 1,0 0,8 0,8 0,9 1,1 1,0 0,9 1,1
30 - 44 2,3 2,3 2,2 2,8 3,1 2,6 2,4 2,2 2,2 2,1 2,2 2,1 2,4 2,2
45 - 59 8,9 8,3 7,7 7,4 7,8 7,4 6,9 6,7 5,2 6,4 5,3 4,9 5,2 4,9
60 - 69 18,4 15,6 15,2 14,8 14,4 14,8 12,2 12,7 10,5 11,8 10,3 9,6 10,1 11,0
70 - 79 31,1 27,2 23,8 22,7 20,8 21,8 15,4 16,0 13,5 12,9 15,1 13,2 12,8 14,4
80 + 54,4 48,7 40,8 43,9 46,1 45,0 30,1 27,8 24,5 24,5 27,8 23,8 24,7 24,8
Total 8,4 7,6 7,1 7,2 7,2 7,0 6,6 6,5 5,6 5,9 6,0 5,5 5,7 6,1
  0 - 29 3,2 2,2 2,1 2,3 2,3 2,4 3,0 2,7 4,8 3,6 3,8 4,1 3,5 0,7 4,0 4,6
30 - 44 4,9 4,4 4,7 4,6 4,7 4,7 4,1 4,2 8,5 6,8 7,1 7,6 7,4 2,0 8,4 9,2
45 - 59 10,4 9,2 9,2 10,2 10,5 9,6 9,8 10,1 15,9 14,5 15,3 16,5 15,3 5,2 15,2 16,0
60 - 69 19,4 17,2 17,7 17,3 18,4 16,5 15,8 15,7 24,5 20,4 19,5 22,4 21,1 8,7 23,1 22,8
70 - 79 23,5 25,4 23,1 25,7 27,5 27,1 28,6 27,9 29,6 24,6 25,9 27,6 27,4 16,9 29,2 30,9
80 + 36,2 40,7 38,8 42,7 41,2 40,3 33,4 34,5 44,0 41,2 40,8 44,0 44,1 35,7 42,9 43,9
Total 10,2 9,5 9,3 9,9 10,6 10,2 10,1 10,2 14,1 12,1 12,4 13,5 12,9 5,8 13,8 14,6
*) Response catagory severely together with to some extent in wave 1-5 and wave 7-8.
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Table 3.8 Proportion of persons severely hampered by chronic illness or disability  
by health status in participating countries and the EU
1) 
 
Table 3.9 Proportion of severely hampered persons who have had to cut down things 





15-29 0,2     0,5     0,2     0,7     0,4     0,7     0,3     1,2     0,5      
30-44 0,5     0,5     0,4     0,9     0,1     0,7     0,3     1,6     0,6      
45-59 0,8     0,4     0,4     1,1     0,3     1,3     0,7     3,0     1,1      
60-69 0,8     1,3     1,1     1,3     0,6     1,6     0,8     5,4     1,9      
70-79 2,2     2,2     4,3     3,5     1,0     3,1     0,8     7,9     3,4      
80+ 6,4     6,4     5,3     5,4     9,4     4,8     2,2     19,2     9,5      
Total 0,7     0,8     0,5     1,1     0,3     1,1     0,5     3,1     1,0      
15-29 4,3     7,3     2,3     5,5     2,2     12,6     4,2     4,0     5,1      
30-44 6,0     7,2     6,3     5,8     1,3     11,9     5,5     9,2     6,1      
45-59 6,9     9,3     8,8     10,9     3,1     16,8     4,4     16,1     9,2      
60-69 10,4     11,4     13,7     14,6     4,3     14,3     6,4     24,2     9,9      
70-79 13,1     14,7     13,2     23,3     7,1     17,4     5,0     29,7     12,4      
80+ 21,4     22,1     23,6     28,5     12,2     23,3     10,3     46,1     19,9      
Total 9,5     10,9     10,0     12,8     3,4     15,4     5,7     15,9     9,5      
15-29 15,8     50,0     48,3     48,3     18,1     60,5     36,6     18,7     39,2      
30-44 42,7     50,5     58,8     50,6     25,5     73,6     41,0     33,7     46,2      
45-59 50,0     54,3     60,9     65,6     41,6     74,3     36,2     43,6     51,3      
60-69 52,7     63,7     59,2     74,4     44,7     77,0     35,3     47,0     48,4      
70-79 65,4     68,6     72,8     78,4     55,5     78,1     38,7     56,5     52,2      
80+ 49,4     75,0     82,7     80,5     71,5     84,9     56,0     69,5     61,0      
Total 52,3     61,2     64,5     68,7     41,9     75,2     40,4     42,7     51,0      
1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001.-  2) Severely and to some extend
in 2000 and 2001.







Belgium Denmark Finland France Germany Spain
Age- Nether-
groups lands
15-29 31,3     68,2     66,0     23,2     -       56,3     38,5     34,8     42,2      
30-44 53,3     71,0     78,0     26,8     -       72,1     42,9     50,5     54,4      
45-59 55,1     70,7     78,5     33,6     -       60,7     49,9     63,3     59,0      
60-69 49,1     59,7     78,9     36,3     -       62,0     51,9     69,4     55,6      
70-79 46,9     63,3     75,7     36,8     -       56,8     56,4     77,6     58,3      
80+ 47,7     63,6     79,6     35,4     -       47,7     54,4     82,4     58,3      
Total 49,8     65,8     77,7     33,8     -       60,8     51,7     78,9     56,7      
1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001.-  2) Severely and to some extend
in 2000 and 2001.
Source: ECHP wave 6-8.
People in good/very good/fair/bad/very bad health together
Belgium Denmark Finland France Germany Spain UK 
2) EU 
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In the EU around 25 million people were reported to be severely hampered in 2001, of 
which 2 million were in good health, 7 million were in fair health and 16 million were 
in bad health. For the participating countries altogether the figures are 20 million in 
total, of which 1.8 million were in good, 6 million were in fair and 12.5 million were in 
bad health. In the EU among the severely hampered persons around 14.5 million have 
had to cut down things they usually do. This figure cannot be subdivided by health 
status, because the sample size is not large enough to calculate representative 
proportions of people who have had to cut down things by health status. Also a 
calculation as a three-year average does not lead to a representative result. Another 
problem is that this question has not been asked for Germany. In any case, to obtain an 
idea of the development of people who have had to cut down things in Germany the EU 
average is used.  
Owing to this restriction the following tables include the development of severely 
hampered persons for the four scenarios differentiated by health status and the 
development of severely hampered persons who have had to cut down things in total. In 
the baseline scenario the number of severely hampered persons will increase up to 34 
million in the EU and up to 28 million in the participating countries altogether in 2050 
(Tables A37-A39). This is an increase of 33% in the EU and 37% in the participating 
countries altogether. The growth is highest for France and lowest for the Netherlands 
(Table 3.10).  
The increase in the number of severely hampered persons is higher than the increase of 
hospital bed days or the increase of contacts with a general practitioner, but the margin 
of differences in the changes in percentages by health status is not as broad as in the 
case of hospital utilisation or contacts with a general practitioner. The number of 
severely hampered persons in bad health increases by 36% by 2050 in the EU (baseline 
scenario). The figure for people in fair health is 30% and for people in good health 23%.  
In the participating countries altogether the increase of people in bad and in fair health 
is nearly the same (37% and 39% respectively) and is higher than the increase of 
severely hampered persons in good health (30%). A higher life expectancy leads to a 
more dynamic development (living-longer high scenario). The number of severely 
hampered persons increases by 55% in the EU and 60% in the participating countries 
altogether and the differences by the health status are nearly the same as in the baseline 
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Table 3.10 Persons severely hampered by chronic illness or disability by health status 
in 2050 in participating countries and the EU
1) (2001 = 100)
 
 
Improvements in health change the development in a single health status markedly. In 
the baseline scenario, with improvements in health the overall development by 2050 in 
the EU is 15%, but the increase of severely hampered persons in bad health is only 3%, 
in fair health 36% and in good health 32%. Improvements in health lead to a higher 
proportion of people in fair and good health and therefore to a moderate increase of 
severely hampered people in bad health. The same effect can be observed for the living 
longer in better health scenario. Whereas the increase of severely hampered persons in 
Health Nether-
status lands
good 131     129     116     115     131     123     98     137     130     123      
fair 140     134     131     146     130     134     127     141     139     130      
bad 129     139     150     142     134     130     146     132     137     136      
total 133     137     141     142     134     131     139     137     137     133      
cut down 
3) 132     135     141     145     135     127     144     145     140     135      
good 140     139     124     127     155     129     106     149     142     132      
fair 145     133     135     155     143     137     133     147     147     136      
bad 59     96     106     63     98     55     107     72     86     103      
total 103     112     120     106     106     99     113     118     109     115      
cut down 
3) 101     110     120     109     107     95     117     126     113     116      
good 155     152     129     125     158     138     108     161     150     141      
fair 166     159     152     167     153     156     147     165     162     150      
bad 149     167     185     160     160     149     174     153     160     159      
total 156     163     168     160     159     151     164     159     160     155      
cut down 
3) 154     161     169     165     161     143     170     173     165     157      
good 166     164     139     139     190     145     117     176     165     152      
fair 172     157     157     177     169     160     154     173     171     157      
bad 71     119     135     73     120     65     130     84     103     123      
total 122     135     145     121     128     116     134     138     129     135      
cut down 
3) 120     133     146     126     130     108     140     151     135     137      
1) EU (15) without Luxembourg and Sweden; people aged 15+.-  2) Severely and to some extend hampered.-  3) Severely
hampered persons who have to cut down things they usually do due to chronic illness or disability (all health status together).
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
2)
Living-longer better health scenario
Living-longer-high scenario
All EU 
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bad health in the living-longer scenario is around 60% (by 2050 in the EU and also in 
the participating countries altogether), improvements in health status notably reduces 
the increase down to 23% in the EU and 3% in the participating countries. 
Simultaneously, the increase of people in fair and good health is much higher: 57% 
(71%) for people in fair health and 52% (65%) for people in good health in the EU (and 
the participating countries). In total the improvements in health status compensate for 
the effect of increasing life expectancy, but in a single health status improving health 
has a greater effect. 
The development of severely hampered persons who will have to cut down things they 
usually do is similar to the overall development of severely hampered persons in the 
four scenarios, but the dynamic shows a decline for the younger age groups (Figure 
3.8). 
Figure 3.8  Severely hampered persons who will have to cut down things they usually 
do by age group in the EU
1) (2050)
 
1) EU (15) without Luxembourg and Sweden; three-year-averages 1999-2001. 
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As in the case of formal long-term care-giving (chapter 2), the development shows a 
high increase in the oldest age group (Figure 3.9). While the number of hampered 
persons who will have to cut down things they usually do in the younger age groups 
(15-59) will decline, the number of severely hampered persons who will have to cut 
down things aged 80+ will increase by two and a half times in the baseline and baseline 
improving-health scenarios and will increase by around three and a half times in both of 
the living-longer scenarios.  
Therefore, the age structure of severely hampered persons who will have to cut down 
things is expected to change. The proportion of people aged 80+ in this group was 18% 
in 2001 in the EU (Figure 3.8). By 2050, this share will increase up to 35% in the 
baseline scenarios and up to 45% in the living longer in better health scenario, but with 
great differences among the countries. In the Netherlands only 19% of severely 
hampered people will be aged 80+ in 2050, whereas in Finland the proportion among 
the oldest old will be 41% (baseline scenario – Figure 3.10). 
Figure 3.9 Age structure of severely hampered persons who have to cut down things 
 they usually do in the EU
1) 
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Figure 3.10 Age structure of severely hampered persons who will have to cut down 
things they usually do (baseline scenario 2006) 
 
3.4 Summary 
In chapter 3 data from the ECHP were used to show the effects of living longer in better 
health on hospital utilisation, contacts with a general practitioner and the number of 
severely hampered persons as a soft proxy for the need for long-term care at home. The 
four demographic and health scenarios, namely the baseline scenario, the baseline 
scenario with improving health, the living-longer high scenario and the living longer in 
better health scenario, were combined with the three-year averages of utilisation data. 
The forecast of hospital admissions, hospital bed days, contacts with a general 
practitioner and severely hampered persons could be carried out for persons aged 15+. 
The results for the different data sources of utilisation are thus not completely 
comparable with the results in chapter 2, but they allow a picture of the development by 
health status, which is a new approach to forecasting health care utilisation and may 
also be a step forward in the discussion of the development of health care expenditures. 
The population aged 15+ decreases in the baseline scenario in three countries (Finland, 
Germany and Spain) and in the living-longer scenario in one country (Spain), but the 
number of hospital admissions, hospital bed days, contacts with a general practitioner 
and severely hampered persons increases in all countries by 2050. The countries with 
declining populations show no general lower development in utilisation than the others 
(Table 3.11). The highest change is expected for the number of hospital bed days and 
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the number of severely hampered persons – 21% and 33% respectively on average in 
the EU between 2001 and 2050 (baseline scenario) – whereas for the number of 
admissions and contacts with a doctor a more moderate increase is estimated (14% in 
the baseline scenario). 
Table 3.11 Development of the population aged 15+, health care utilisation and  
severely hampered persons in 2050 (2001 = 100) 
 
The five-year higher life expectancy in the living-longer high scenario by 2050 leads to 
an increase in the population of 1 percentage point by 2050, but to a still higher rise in 
the utilisation of health care services (Table A40). The increase of hospital bed days is 
18 percentage points higher and the increase of severely hampered persons is 22 
percentage points higher by 2050, and the development of admissions and contacts with 
a general practitioner is around 12-13 percentage points higher (difference by constant 
health status). 
Improvements in health lead to a contrary effect. Compared with the baseline scenario 
the baseline improving-health scenario leads to a 13 percentage point reduction in the 
increase in hospital bed days and to an 18 percentage point reduction in the increase in 
the number of severely hampered persons, but the number of contacts with a general 
practitioner is only 5 percentage points lower (EU) (see Table A41). Thus, 
improvements in health have a higher effect on hospital utilisation and the need for 
long-term care than on outpatient utilisation. This result could be attributed to behaviour 
Countries Hospital Contacts Hampered Contacts Hampered
days with a GP 
1) persons 
2) with a GP 
1) persons 
2)
Belgium   101 119         130        115        132          107   134 152        128        154       
Denmark   107 120         130        115        135          114   135 152        127        161       
Finland   99 113         132        111        141          105   126 155        126        169       
France   108 124         137        122        145          114   136 154        133        165       
Germany   94 108         120        107        135          101   121 139        119        161       
Netherlands   111 123         135        120        127          119   137 154        132        143       
Spain   91 117         132        113        144          98   131 152        126        170       
United Kingdom   107 117         138        113        145          115   130 164        122        173       
All   101 115         128        113        140          108   128 148        125        165       
EU (15) 
3)   99 114         127        114        135          106   128 145        126        157       
Belgium   101 108         110        109        101          107   122 130        121        120       
Denmark   107 112         114        109        110          114   126 134        120        133       
Finland   99 108         116        106        120          105   121 138        119        146       
France   108 108         105        112        109          114   119 119        123        126       
Germany   94 99         104        98        107          101   112 121        110        130       
Netherlands   111 112         111        112        95          119   125 128        123        108       
Spain   91 107         114        107        117          98   121 133        119        140       
United Kingdom   107 105         114        107        126          115   117 136        116        151       
All   101 104         107        105        113          108   117 125        116        135       
EU (15) 
3)   99 108         113        109        116          106   120 131        121        137       
1) GP= General Practitioner.-  2) Severely hampered persons who have to cut down things they usually do due to chronic illness or disability (all health
status together).-  3) Without Luxembourg and Sweden.
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concerning a visit to a doctor: people in generally good health also visit a doctor for 
acute short-term health problems or for precautionary/prevention reasons. 
Both effects together – longer life and improving health – taken with the underlying 
assumptions (a five-year higher life expectancy, a reduction of the proportion of people 
in bad health by 4 percentage points or nearly 30%) lead to only a marginal additional 
increase in utilisation compared with the baseline scenario in the EU and in some 
countries to a more or less decrease (Table A42). Since the scenarios of life expectancy 
in good health (LEGH) from WP1 were used to create the health scenarios, the expected 
higher growth rates of LEGH for France and Germany lead to a marked reduction in the 
number of hospital bed days and severely hampered persons in these countries. It may 
be that these growth rates are too optimistic, yet they show that improvements in health 





he European Community Household Panel (ECHP) provides information about 
utilisation of health care services as well as information about people who are 
looking after old and disabled persons and the characteristics of these people. 
The relevant question of the ECHP is: “Do your present daily activities include, without 
pay, looking after children or other persons who need special help because of old age, 
illness or disability?” (yes, looking after children/yes, looking after a person other than a 
child/yes, looking after a child and a person other than a child/not looking after any 
person). The categories of “yes, looking after a person other than a child” and “Yes, 
looking after a child and a person other than a child” were combined to derive the total 
number of people who are looking after old or disabled persons. 
In the EU countries around 5.5% of people living in private households looked after old 
or disabled persons in 2001 (Table 4.1). But great differences exist among the 
participating countries in the share of people looking after old persons. The lowest share 
of care-givers is observed for Germany, 2%. The greatest share of care-givers at home 
can be observed in the UK, at around 16%. In the EU countries the proportion of 
persons who looked after old or disabled persons are greatest in the age groups 45-59 
(9%) and 60-69 (8.6%). In Belgium, France, the Netherlands and the UK the share of 
care-givers is highest among persons aged 60-69, and in Denmark, Finland and Spain 
among people aged 45-59. An exception is Germany, where the share of care-giving 
persons increases sharply with age. In Germany 6.5% of persons aged 70-79 were care-
givers as were around 16% of people aged 80+. But in the EU the proportion of care-
givers among persons aged 70-79 (6.6%) and among those aged 80+ (5.1%) is also 
notable. Whereas middle-aged care-givers are mostly members of the family, in 
particular daughters and daughters-in-law, care-givers at older ages are mainly spouses 
or partners. Therefore, the care-giving potential in the oldest age group is also important 
for the provision of care at home. 
Table 4.1 Proportion of people looking after old persons by age group in participating 
countries and the EU*) (2001) 
Nether-
lands
15 - 29 (1,6) (1,7) (1,4) (1,1) (-) (1,9) 1,1 6,5 1,7
30 - 44 4,2 3,3 3,5 2,4 0,8 4,2 4,1 11,8 4,1
45 - 59 9,6 7,2 11,0 4,2 1,7 9,6 10,3 24,9 9,0
60 - 69 13,2 (5,7) 10,3 8,1 3,2 10,6 8,6 27,3 8,6
70 - 79 (4,7) (7,7) (8,4) 4,9 6,5 8,9 6,7 20,6 6,6
80 + (-) (-) (13,3) (4,0) 15,8 (8,7) (2,1) 12,2 5,1
Total 6,1 4,6 6,4 3,6 2,0 6,6 5,3 16,1 5,5




Share of persons looking after old persons in % 
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The analysis in WP2 shows that care-giving at home not only depends on age, but also 
on gender, health status, marital status, employment status and education. Regression 
analysis shows a highly significant influence of these factors on the possibility of 
becoming a care-giver at home. Table 4.2 shows the proportion of care-givers by 
gender, health status, marital status and employment status for the EU as an example. 
The share of care-givers among women in 2001 was twice as high (7.2%) as the share 
of care-givers among men (3.8%). The greatest proportion of care-givers can be 
observed among women aged 45-59, at around 12%. Health status is also relevant to the 
share of care-givers. People in fair health show the greatest proportion of care-givers, 
with the exception of the oldest age groups: those aged 70+ in good health have a higher 
possibility of being care-givers than those in fair or bad health.  
Table 4.2 Proportion of people looking after old persons by gender, health status,  




Marital status influences the possibility of being a care-giver in the various age groups 
in a different way. In the middle-aged group (45-59) the proportion of care-givers is 
highest among never-married women, around 17%, followed by never-married women 
aged 60-69 at around 15%; but in the oldest age group (80+) married persons show the 
highest proportion of care-givers. It can be assumed that daughters who were never 
married or are divorced tend to be care-givers to a greater extent than married 
daughters, whereas in the oldest age groups the possibility of receiving care at home is 
higher if a spouse can provide care. 
The analyses made in WP2 also show that people who are normally working have a 
lower probability of becoming care-givers than people who are unemployed or inactive. 
The share of care-givers among normally working people at middle age (45-59 years 
old) amounts to 7.1%, among unemployed people it is 9.4% and among inactive people 
it is 13.5% (in EU countries in 2001). At all employment statuses women have a higher 
possibility of being care-givers than men and the greatest share of care-givers can be 
observed among inactive women aged 45-59 (14.6%). To summarise: care-givers at 
home are mostly women, who do not work. 
Further developments in the number of care-givers are influenced by changes in age 
structure, health status at a given age, marital status or household composition and 
employment status, in particular changes in the labour force participation rates of 
women. With the data from the ECHP it is possible to show the effect of changes in the 
Normally
working
15 - 29 1,2      2,2      1,5      2,7      2,9      1,8      3,3      4,7      0,0      1,6      1,5      2,5      1,8      1,7     
30 - 44 2,3      5,7      3,7      5,2      6,4      4,0      3,9      5,9      6,0      3,6      3,1      5,5      8,4      4,1     
45 - 59 5,6      12,1      8,9      9,3      8,7      8,6      10,1      9,0      9,3      12,8      7,1      9,4      13,5      9,0     
60 - 69 6,9      10,1      8,9      9,2      6,6      8,5      4,8      9,2      6,9      11,0      5,8      - 9,0      8,6     
70 - 79 5,3      7,7      7,3      6,7      5,6      7,4      10,6      6,0      4,8      7,7      - - 6,6      6,6     
80 + 5,5      4,8      6,1      4,6      5,0      9,0      0,0      5,1      2,7      4,2      - - 5,0      5,1     
Total 3,8      7,2      4,8      7,0      6,4      6,5      6,3      7,6      5,1      3,1      - - - 5,5     
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age structure of the population and changes in the health status at a given age on the 
development of care-givers. As in the case of health care utilisation, the share of care-
givers in a single age group and health status will be held constant and combined with 
the four demographic and health scenarios. These calculations are made for the EU as 
an example. 
In 2001 around 17 million people reported that they looked after old or disabled persons 
(in the EU without Luxembourg or Sweden). Around 37% were aged 45-59 and around 
16% were 70+. In the baseline scenario the number of care-givers is expected to 
increase up to 17.6 million by 2050 (Table 4.3). Owing to the ageing of the population, 
the age structure of care-givers will also change: the share of the oldest age groups (70-
79 and 80+) together rises from 16% in 2001 to 26% in 2050. Improvements in health 
status do not lead to other notable developments, as the baseline improving-health 
scenario shows: the number of care-givers is only marginally higher and also the age 
structure is nearly the same as in the baseline scenario. A higher life expectancy leads to 
a higher number of care-givers, around 18.9 million, and to a higher proportion of the 
oldest care-givers. In 2050 around 30% of all care-givers will be aged 70+, thus the 
share of this age group will nearly double. Improvements in health in the living longer 
in better health scenario do not lead to other marked developments. This means that in 
the case of care-givers, the demographic development is the main influence and that 
changes in health status have only a little impact on the development of the total number 
of care-givers. 
Table 4.3 Development of care-givers using constant care-giving rates in the EU
*) 
2001
Baseline im- Living-longer- Living-longer
proving health high scenario better health
15-29 1 203         954         932         954         933       
30-44 3 500        2 501        2 453        2 510        2 462       
45-59 6 311        5 854        5 858        5 924        5 928       
60-69 3 274        3 761        3 828        3 897        3 966       
70-79 1 902        2 702        2 734        2 967        3 002       
80+  731        1 878        1 883        2 613        2 621       
15+ 16 920        17 649        17 688        18 865        18 912       
15-29 7,1         5,4         5,3         5,1         4,9        
30-44 20,7         14,2         13,9         13,3         13,0        
45-59 37,3         33,2         33,1         31,4         31,3        
60-69 19,3         21,3         21,6         20,7         21,0        
70-79 11,2         15,3         15,5         15,7         15,9        
80+ 4,3         10,6         10,6         13,9         13,9        
15+ 100,0         100,0         100,0         100,0         100,0        
*) EU (15) without Luxembourg and Sweden.
Source: Projections by DIW.
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The analyses in WP2 showed that around half of the care-givers provide care to persons 
in the same household and that the others provide care to persons who live elsewhere. In 
chapter 3 the number of severely hampered persons who have to cut down things they 
usually do due to illness or disability in private households was used as a soft proxy for 
people in need of care at home. With this variable it is possible to establish the relation 
of the number of hampered persons to care-givers. This is only a rough indicator to 
show the development of people in need of long-term care at home in relation to the 
development of informal care-givers and is not to be over-interpreted. It is only used to 
show the different development in the four scenarios and to get an idea of the increasing 
pressure on informal care-giving at home.  
In 2001 the relative number of hampered persons to care-givers was at total 0.86 (which 
means there were 86 severely hampered persons per 100 care-givers on average in the 
EU). By 2050 this will increase up to 1.11 in the baseline scenario, to 0.94 in the 
baseline improving-health scenario, to 1.21 in the living-longer high scenario and to 
1.04 in the living longer in better health scenario (Table 4.4). That means that a higher 
life expectancy leads to a higher relative number of hampered persons to care-givers, 
but that improvements in health can compensate for this effect: the relation between the 
two in the living longer in better health scenario is lower than in the baseline scenario in 
2050.  
Table 4.4 Relation of hampered persons to care-givers in the EU
*) 
2001
Baseline im- Living-longer- Living-longer
proving health high scenario better health
15-29 0,532       0,532       0,320       0,532       0,320      
30-44 0,508       0,508       0,333       0,508       0,333      
45-59 0,536       0,536       0,451       0,536       0,451      
60-69 0,849       0,849       0,652       0,849       0,652      
70-79 1,749       1,749       1,513       1,749       1,513      
80+ 3,599       3,599       3,341       3,599       3,341      
15+ 0,859       1,110       0,943       1,212       1,040      
*) EU (15) without Luxembourg and Sweden.





In all four scenarios the pressure on care-giving at home will increase. These increases 
are not marginal. These relative numbers show the developments under the assumption 
of constant care-giving rates and a constant proportion of severely hampered persons 
per single age group and health status. Therefore, the relation in a single age group in 
2001 is the same as in the baseline scenario, but the demographic change displaces the 
weight of the single age groups and thus the relation in total increases. If the aim is the 
relation in total in constant 2001 figures, then the relation in the single age groups AGEING, HEALTH AND RETIREMENT IN EUROPE – AGIR WP4, PART A | 85 
 
has to change, which implies that the care-giving rates have to rise, and as previously 
mentioned not by a marginal degree. The number of care-givers has to rise up to 22.8 
million, which is 5.2 million more than calculated for the baseline scenario with 
constant care-giving rates. 
Along with changes in age structure and health status, changes in marital status and in 
household composition have an important impact on the possibility of providing and 
receiving care at home. In the older population single households are common. Most of 
these households consist of widowed women. In WP2 changes in the family status of 
the population in the past were analysed. In all the participating countries, the share of 
single households in the younger ages (mostly below 45) has increased. If this trend 
continues, the potential for informal care-givers could decline. As mentioned before, in 
2001 never-married women aged 45-69 had a higher possibility of being care-givers 
than married women, but this is not true for the younger ages. The increasing share of 
never-married persons in the younger ages can reduce the potential of care-givers. On 
the other hand, with respect to the increasing life expectancy for men and women, more 
people will be growing old together. In the past the proportion of married old men 
increased. The potential of care-givers within the oldest age groups could therefore rise. 
Alders & Manting (2003) prepared internationally consistent household scenarios for all 
15 EU countries. Based on information from the labour force statistics (LFS) of a single 
country, they analysed the past trends and created three household scenarios: an 
individualisation scenario that assumed that long-term trends of individualisation, 
emancipation and secularisation will lead to higher proportions of people living alone 
and fewer people living as a couple; a family scenario with an inverse trend; and a 
baseline scenario as an average of the two other trends. The latter was combined with 
the baseline scenario of the Eurostat population forecast and is therefore compatible 
with the analyses carried out in this report. 
In the EU member states, 14 million men and 11.5 million women aged 65-79, and 2.4 
million men and 1.3 million women aged 80+ lived with a partner in 1995 (Table 4.5). 
In their baseline scenario the authors expected a high increase in the number of elderly 
persons living with a partner. The number of men aged 65-79 (women) living with a 
partner will increase up to 21.3 (19.6) million in 2025 and the number of 80+ aged men 
living with a partner will increase up to 4.5 (3.4) million. In these age groups, the share 
of women living with a partner will increase, while for men a little decrease is expected.  
With respect to these results it can be expected that the care-giving potential of women 
aged 65+ for a partner in need for long-term care will increase, but otherwise the care-
giving potential of men aged 65+ for a partner in need of long-term care will decline. 
The share of men aged 80+ living alone will increase from 29% up to 33% in 2025. 
Thus, for this group of oldest men the pressure for professional care-giving could 
increase if the need for long-term care appears. 86 | ERIKA SCHULZ 
 
Table 4.5 EU population by gender, age group and household composition 
 
Male Female Total Male Female Total Male Female Total Male Female Total
0 - 19 0,2    0,2    0,4    0,2    0,4    0,6    0,4    0,5    0,5    0,5    1,1    0,8   
20 - 64 12,6    10,7    23,3    18,5    15,0    33,5    11,3    9,6    10,4    16,4    13,7    15,0   
65 - 79 2,5    9,3    11,8    5,2    10,1    15,3    14,1    38,6    28,2    18,5    31,0    25,2   
80 + 1,2    5,3    6,5    2,6    7,5    10,1    28,6    60,2    50,0    32,5    58,6    48,6   
Total 16,5    25,5    42,0    26,5    33,0    59,5    9,2    13,6    11,5    14,1    17,1    15,6   
0 - 19 0,1    0,3    0,4    0,2    0,5    0,7    0,2    0,7    0,5    0,5    1,3    0,9   
20 - 64 73,2    76,6    149,8    74,8    77,0    151,8    65,4    68,7    67,0    66,3    70,1    68,2   
65 - 79 14,0    11,5    25,5    21,3    19,6    40,9    79,1    47,7    61,0    75,8    60,1    67,4   
80 + 2,4    1,3    3,7    4,5    3,4    7,9    57,1    14,8    28,5    56,3    26,6    38,0   
Total 89,7    89,7    179,4    100,8    100,5    201,3    50,1    47,9    49,0    53,4    52,1    52,8   
0 - 19 43,7    41,3    85,0    38,2    36,0    74,2    96,9    96,3    96,6    96,5    95,2    95,9   
20 - 64 20,1    13,3    33,4    14,1    8,6    22,7    17,9    11,9    14,9    12,5    7,8    10,2   
65 - 79 0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0   
80 + 0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0    0,0   
Total 63,8    54,6    118,4    52,3    44,6    96,9    35,6    29,2    32,3    27,7    23,1    25,4   
0 - 19 1,1    1,1    2,2    1,0    0,9    1,9    2,4    2,6    2,5    2,5    2,4    2,5   
20 - 64 6,1    10,9    17,0    5,5    9,2    14,7    5,4    9,8    7,6    4,9    8,4    6,6   
65 - 79 1,2    3,3    4,5    1,6    2,9    4,5    6,8    13,7    10,8    5,7    8,9    7,4   
80 + 0,6    2,2    2,8    0,9    1,9    2,8    14,3    25,0    21,5    11,3    14,8    13,5   
Total 9,0    17,5    26,5    9,0    14,9    23,9    5,0    9,3    7,2    4,8    7,7    6,3   
0 - 19 45,1    42,9    88,0    39,6    37,8    77,4    100     100     100     100     100     100    
20 - 64 112,0    111,5    223,5    112,9    109,8    222,7    100     100     100     100     100     100    
65 - 79 17,7    24,1    41,8    28,1    32,6    60,7    100     100     100     100     100     100    
80 + 4,2    8,8    13,0    8,0    12,8    20,8    100     100     100     100     100     100    
Total 179,0    187,3    366,3    188,6    193,0    381,6    100     100     100     100     100     100    
Sources: Alders/Manting (2003); projections by DIW.
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Alongside informal care-giving by partners, care-giving by daughters and daughters-in-
law plays an important role, as previously mentioned. Around 58% of informal care-
givers were aged 45-69 in 2001 and around 70% of these care-givers were female. To 
get an idea about the development of this potential care-giver group, the relation of 
people aged 70+ to women aged 45-69 was calculated for the baseline scenario as an 
example. Table 4.6 shows the results. In all participating countries a high increase in the 
relation is expected. In Spain, for example, there were 80 people aged 70+ per 100 
women aged 45-69 in 1999. By 2050 this proportion will increase up to 171. This 
development can also be an indicator of the increasing pressure for potential informal 
care-givers – as the case of the changing relation of hampered persons to care-givers has 
shown. 
Table 4.6 People aged 70+ per 100 women aged 45-69 
 
As shown in WP2, family-oriented women are more often care-givers than career-
oriented women. But in the past the share of family-oriented women decreased in all EU 
countries and it can be assumed that this trend will continue in the future. One indicator 
of changing behaviour is the employment rate of women. In the middle-aged group in 
particular employment has increased in the past. It can be expected that this trend will 
continue. Therefore, the potential supply of informal care-givers could decrease. 
Countries 1999 2001 2010 2020 2030 2040 2050
Belgium 79,4     81,1     79,9     87,3     113,8     137,5     137,0    
Denmark 71,9     69,9     66,7     86,7     104,3     121,6     121,1    
Finland 66,4     67,1     68,1     97,2     123,2     129,6     124,9    
France 79,5     80,8     79,3     89,7     114,4     135,1     138,7    
Germany 72,9     73,6     86,1     88,5     109,1     149,0     141,5    
Netherlands 66,8     66,3     63,6     80,3     102,6     121,7     110,3    
Spain 81,5     84,9     83,7     80,6     92,1     129,1     170,7    
United Kingdom 79,9     79,0     71,5     83,4     101,2     128,9     126,6    
All 76,6     77,4     78,9     86,1     105,9     135,7     138,4    
EU (15) 
*) 76,9     78,1     80,7     86,8     105,2     136,7     143,9    
*) Without Luxembourg and Sweden.





n this report, developments in health care and long-term care services utilisation up 
to 2050 have been projected on two levels: in chapter 2 utilisation data from 
national sources provided by the participants of the AGIR project about hospital 
admissions, length of hospital stay, contacts with a doctor, long-term care-giving in 
institutions and long-term care-giving at home by professional care-givers were used 
and combined with two demographic scenarios. The data from national sources have 
two advantages: 1) they cover the whole population and therefore forecasts of health 
care utilisation can made for the total population; 2) they include information about 
long-term care-giving in institutions (for six participating countries) and information 
about long-term care-giving at home (for four participating countries). But they have the 
disadvantage of not differentiating between the health statuses of the population. 
Therefore, in this chapter only the impact of demographic change and increasing life 
expectancy on the utilisation of health care services can be assessed. 
In chapter 3 data from the European Community Household Panel (ECHP) were used, 
which includes only persons in private households aged 16+, but allows differentiation 
of the health care utilisation data not only by age groups but also by health status in a 
single age group. Information is available about hospital admissions, hospital days and 
contacts with a general practitioner. Thus, the main fields of acute health care are also 
covered by the ECHP. No information exists about people receiving long-term care, but 
the number of severely hampered persons who have to cut down things they usually do 
owing to disability or longstanding illness are used as a soft proxy for the need for long-
term care at home. These care utilisation data were combined with four demographic 
and health scenarios: the baseline scenario, the baseline improving-health scenario, the 
living-longer high scenario and the living longer in better health scenario. The baseline 
scenario stems from Eurostat and includes increases in life expectancy, but in the living-
longer high scenario, which was created from the AGIR partner CPB (Pellikaan & 
Westerhout, 2004), a five-year higher life expectancy was assumed. In the health 
scenarios that have been created in this report it has been assumed that the share of 
people in bad health decreases by 30% on average in the EU by 2050. This assumption 
was derived from the estimation of life expectancy in good health carried out in AGIR 
WP1 (Ahn et al., 2003). 
The results of the forecasts in chapters 2 and 3 are not fully comparable, because they 
use different sources and different definitions of the variables, but in general they show 
similar developments: 
•  developments in the number of hospital days and the need for long-term care-giving 
for severely hampered persons show greater changes than the developments in 
hospital admissions and contacts with a doctor/general practitioner; 
•  the living-longer high scenario leads to an increased population by 2050, but 
developments in the utilisation of health care services are even greater; and 
•  countries with a decreasing population until 2050 do not generally show lower 
increases in health care utilisation than countries with an increasing population. 
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Notable distinctions are the expected increase of long-term care recipients from national 
sources and the increase of severely hampered persons from the ECHP. The 
development of long-term care recipients at home shows a much more significant 
increase than the development of hampered persons. It can be assumed that the soft 
proxy of ‘severely hampered persons who have to cut down things they usually do due 
to longstanding illness or disability’ underestimates the development of the need for 
long-term care at home. This could be linked back to the fact that the oldest old, 
especially persons with a longstanding illness or disability, are generally under-
represented in private household surveys such as the ECHP.  
The estimations in chapter 3 show that improvements in health status lead to a more 
moderate increase in health care utilisation compared with the scenarios without 
improvements in health. But in general, given the underlying assumptions the 
improvements in health cannot completely compensate for the effect of increasing life 
expectancy. In the EU the health care utilisation figures are a little bit higher in the 
living longer in better health scenario than in the baseline scenario in 2050.  
In chapter 4 the development of the number of care-givers at home is calculated using 
constant care-giving rates in a single age group and health status. In contrast to the 
estimations of health care utilisation, a better health status does not lead to a markedly 
higher number of care-givers. The main effect is the demographic development and the 
additional increase in life expectancy in the living-longer scenario. The number of care-
givers increases until 2050, especially in the living-longer scenario, and the share of 
care-givers aged 70+ rises sharply. The development of the relation of severely 
hampered persons to the number of care-givers shows that the pressure on informal 
care-giving will also increase. If the higher rises in the number of long-term care 
recipients at home as estimated by national sources are taken into account, this relative 
number may have a much higher potential. The expected changes in household 
composition and increases in the labour force participation rates of women will also 
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Table A.1 Population development (1990 = 100) 
Countries 2010 2020 2030 2040 2050
Belgium   101      103      103      101      99   
Denmark   103      104      106      105      104   
Finland   102      103      102      99      95   
France   104      106      108      107      105   
Germany   102      101      100      97      92   
Netherlands   105      108      110      111      110   
Spain   101      100      98      94      88   
United Kingdom   103      105      106      106      104   
Total   102      103      103      102      98   
EU (15)   102      103      102      100      96   
Belgium   102      103      104      103      100   
Denmark   103      105      107      107      106   
Finland   102      103      103      100      97   
France   104      107      108      108      106   
Germany   102      102      100      98      94   
Netherlands   105      109      111      112      112   
Spain   101      100      98      95      90   
United Kingdom   103      105      107      107      105   
Total   103      104      104      103      100   
EU (15)   102      103      103      101      98   
Belgium   102      104      105      104      102   
Denmark   103      105      108      108      108   
Finland   102      104      104      102      99   
France   104      107      109      110      108   
Germany   102      102      101      99      96   
Netherlands   105      109      112      114      114   
Spain   101      101      99      97      92   
United Kingdom   103      106      108      108      108   
Total   103      104      105      104      102   
EU (15)   102      104      104      103      100   
Belgium   102      104      105      105      104   
Denmark   103      106      109      110      110   
Finland   102      104      105      103      101   
France   104      108      110      111      110   
Germany   102      103      102      101      98   
Netherlands   105      110      113      115      116   
Spain   102      101      100      98      94   
United Kingdom   103      106      109      110      109   
Total   103      105      106      106      104   
EU (15)   102      104      105      104      102   
Sources: EU-EPC 2000 (Baseline scenario); Pellikaan/Westerhout 2004
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Table A.2 Age structure of the population (%) 
Countries
0 - 14 15 - 59 60 - 74 75 - 89 90+ 0 - 14 15 - 59 60 - 74 75 - 89 90+
Belgium -2,1       -4,2       4,0       1,9       0,4       -2,3       -4,8       4,1       2,5       0,5      
Denmark -2,6       -3,8       4,7       1,7       0,1       -2,8       -4,4       4,8       2,3       0,2      
Finland -2,6       -6,7       6,5       2,5       0,4       -2,8       -7,4       6,6       3,1       0,5      
France -2,2       -4,4       4,5       1,7       0,4       -2,4       -4,9       4,6       2,1       0,6      
Germany -2,2       -4,0       2,3       3,6       0,3       -2,4       -4,7       2,3       4,3       0,5      
Netherlands -2,2       -5,2       5,5       1,8       0,2       -2,5       -5,9       5,6       2,4       0,3      
Spain -1,7       -3,9       2,8       2,2       0,5       -1,9       -4,6       2,9       2,8       0,7      
United Kingdom -2,9       -2,2       3,9       1,0       0,2       -3,1       -2,8       4,0       1,6       0,3      
Total -2,3       -3,8       3,6       2,2       0,3       -2,5       -4,5       3,6       2,8       0,5      
EU (15) -2,2       -3,9       3,4       2,3       0,4       -2,4       -4,5       3,4       2,9       0,5      
Belgium -0,1       -4,2       -1,1       4,6       0,8       -0,7       -6,1       -1,4       6,4       1,8      
Denmark 0,0       -2,6       -1,6       3,6       0,6       -0,7       -4,6       -1,7       5,6       1,4      
Finland -0,9       -2,3       -1,4       3,7       1,0       -1,4       -4,2       -1,7       5,3       1,9      
France -1,2       -4,4       -0,6       5,2       1,0       -1,7       -6,0       -0,7       6,6       1,8      
Germany -0,6       -5,7       0,7       4,5       1,1       -1,2       -7,9       0,3       6,6       2,2      
Netherlands 0,1       -2,1       -1,9       3,3       0,6       -0,6       -4,1       -2,0       5,3       1,4      
Spain -1,1       -10,6       3,0       7,8       0,8       -1,7       -12,7       2,7       9,8       1,8      
United Kingdom -0,8       -5,1       0,3       4,7       0,8       -1,4       -7,1       0,0       6,7       1,8      
Total -0,7       -5,5       0,3       5,0       0,9       -1,3       -7,5       0,0       6,9       1,9      
EU (15) -0,6       -6,0       0,4       5,3       0,9       -1,2       -7,9       0,1       7,2       1,9      
Belgium -2,2       -8,4       2,9       6,5       1,2       -3,0       -10,9       2,7       8,9       2,3      
Denmark -2,7       -6,4       3,1       5,3       0,7       -3,5       -9,1       3,1       7,9       1,6      
Finland -3,5       -9,1       5,0       6,2       1,3       -4,3       -11,6       4,9       8,4       2,5      
France -3,4       -8,8       4,0       6,8       1,4       -4,1       -11,0       3,9       8,7       2,4      
Germany -2,8       -9,7       3,0       8,2       1,4       -3,6       -12,6       2,7       10,9       2,6      
Netherlands -2,1       -7,3       3,6       5,1       0,8       -3,0       -10,0       3,6       7,6       1,8      
Spain -2,8       -14,5       5,9       10,0       1,4       -3,5       -17,2       5,6       12,6       2,6      
United Kingdom -3,6       -7,3       4,2       5,8       1,0       -4,5       -9,9       4,0       8,3       2,1      
Total -2,9       -9,3       3,9       7,2       1,2       -3,8       -11,9       3,7       9,6       2,4      
EU (15) -2,8       -9,9       3,8       7,6       1,3       -3,6       -12,5       3,6       10,1       2,4      
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Table A.3 Changes in the age structure of the population (percentage points) 
 
Countries
0 - 14 15 - 59 60 - 74 75 - 89 90+ 0 - 14 15 - 59 60 - 74 75 - 89 90+
Belgium -2,1       -4,2       4,0       1,9       0,4       -2,3       -4,8       4,1       2,5       0,5      
Denmark -2,6       -3,8       4,7       1,7       0,1       -2,8       -4,4       4,8       2,3       0,2      
Finland -2,6       -6,7       6,5       2,5       0,4       -2,8       -7,4       6,6       3,1       0,5      
France -2,2       -4,4       4,5       1,7       0,4       -2,4       -4,9       4,6       2,1       0,6      
Germany -2,2       -4,0       2,3       3,6       0,3       -2,4       -4,7       2,3       4,3       0,5      
Netherlands -2,2       -5,2       5,5       1,8       0,2       -2,5       -5,9       5,6       2,4       0,3      
Spain -1,7       -3,9       2,8       2,2       0,5       -1,9       -4,6       2,9       2,8       0,7      
United Kingdom -2,9       -2,2       3,9       1,0       0,2       -3,1       -2,8       4,0       1,6       0,3      
Total -2,3       -3,8       3,6       2,2       0,3       -2,5       -4,5       3,6       2,8       0,5      
EU (15) -2,2       -3,9       3,4       2,3       0,4       -2,4       -4,5       3,4       2,9       0,5      
Belgium -0,1       -4,2       -1,1       4,6       0,8       -0,7       -6,1       -1,4       6,4       1,8      
Denmark 0,0       -2,6       -1,6       3,6       0,6       -0,7       -4,6       -1,7       5,6       1,4      
Finland -0,9       -2,3       -1,4       3,7       1,0       -1,4       -4,2       -1,7       5,3       1,9      
France -1,2       -4,4       -0,6       5,2       1,0       -1,7       -6,0       -0,7       6,6       1,8      
Germany -0,6       -5,7       0,7       4,5       1,1       -1,2       -7,9       0,3       6,6       2,2      
Netherlands 0,1       -2,1       -1,9       3,3       0,6       -0,6       -4,1       -2,0       5,3       1,4      
Spain -1,1       -10,6       3,0       7,8       0,8       -1,7       -12,7       2,7       9,8       1,8      
United Kingdom -0,8       -5,1       0,3       4,7       0,8       -1,4       -7,1       0,0       6,7       1,8      
Total -0,7       -5,5       0,3       5,0       0,9       -1,3       -7,5       0,0       6,9       1,9      
EU (15) -0,6       -6,0       0,4       5,3       0,9       -1,2       -7,9       0,1       7,2       1,9      
Belgium -2,2       -8,4       2,9       6,5       1,2       -3,0       -10,9       2,7       8,9       2,3      
Denmark -2,7       -6,4       3,1       5,3       0,7       -3,5       -9,1       3,1       7,9       1,6      
Finland -3,5       -9,1       5,0       6,2       1,3       -4,3       -11,6       4,9       8,4       2,5      
France -3,4       -8,8       4,0       6,8       1,4       -4,1       -11,0       3,9       8,7       2,4      
Germany -2,8       -9,7       3,0       8,2       1,4       -3,6       -12,6       2,7       10,9       2,6      
Netherlands -2,1       -7,3       3,6       5,1       0,8       -3,0       -10,0       3,6       7,6       1,8      
Spain -2,8       -14,5       5,9       10,0       1,4       -3,5       -17,2       5,6       12,6       2,6      
United Kingdom -3,6       -7,3       4,2       5,8       1,0       -4,5       -9,9       4,0       8,3       2,1      
Total -2,9       -9,3       3,9       7,2       1,2       -3,8       -11,9       3,7       9,6       2,4      
EU (15) -2,8       -9,9       3,8       7,6       1,3       -3,6       -12,5       3,6       10,1       2,4      
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Table A.4 Changes in the population aged 15+ by health status between 2001 and 2050  
(%) 
good fair bad total good fair bad total good fair bad total good fair bad total
15-29 -12,3   -12,3   -12,3   -12,3    -9,5   -35,4   -76,9   -12,3   -12,3   -12,3   -12,3   -12,3    -9,5   -35,3   -76,9   -12,3   
30-44 -24,4   -24,4   -24,4   -24,4   -22,0   -23,1   -96,2   -24,4   -24,1   -24,1   -24,1   -24,1   -21,7   -22,9   -96,2   -24,1   
45-59 -8,7   -8,7   -8,7   -8,7   -5,8   -7,2   -56,9   -8,7   -7,7   -7,7   -7,7   -7,7   -4,7   -6,2   -56,4   -7,7  
60-69 21,0   21,0   21,0   21,0   24,7   26,8   -89,6   21,0   25,0   25,0   25,0   25,0   28,8   30,9   -89,3   25,0  
70-79 28,1   28,1   28,1   28,1   40,3   34,2   -35,8   28,1   40,1   40,1   40,1   40,1   53,4   46,8   -29,8   40,1  
80+ 152,6   152,6   152,6   152,6   176,5   164,5   63,4   152,6   254,2   254,2   254,2   254,2   287,7   270,9   129,1   254,2  
15+ -5,5   17,3   26,3   0,7   -1,7   19,4   -43,4   0,7   -1,6   30,9   46,2   7,3   2,6   33,6   -31,3   7,3  
15-29 2,6   2,6   2,6   2,6   4,8    -4,0    -95,1   2,6   2,7   2,7   2,7   2,7   4,8    -3,9    -95,1   2,7   
30-44 -18,2   -18,2   -18,2   -18,2   -16,5   -17,3   -68,6   -18,2   -17,9   -17,9   -17,9   -17,9   -16,2   -17,0   -68,5   -17,9   
45-59 -2,3   -2,3   -2,3   -2,3   -0,2   -1,2   -35,3   -2,3   -0,9   -0,9   -0,9   -0,9   1,2   0,2   -34,4   -0,9  
60-69 18,7   18,7   18,7   18,7   25,9   22,3   -35,9   18,7   24,0   24,0   24,0   24,0   31,6   27,8   -33,0   24,0  
70-79 57,8   57,8   57,8   57,8   67,4   62,7   16,1   57,8   77,8   77,8   77,8   77,8   88,7   83,3   30,8   77,8   
80+ 107,7   107,7   107,7   107,7   140,3   94,5   79,5   107,7   202,5   202,5   202,5   202,5   250,0   183,2   161,4   202,5  
15+ 2,1   19,1   33,1   7,1   5,7   18,8   -10,7   7,1   6,5   33,5   56,7   14,4   10,5   32,7   8,7   14,4  
15-29 -16,9   -16,9   -16,9   -16,9   -14,3   -37,3   -46,1   -16,9   -16,8   -16,8   -16,8   -16,8   -14,3   -37,3   -46,0   -16,8   
30-44 -19,8   -19,8   -19,8   -19,8   -17,3   -27,8   -83,3   -19,8   -19,5   -19,5   -19,5   -19,5   -17,0   -27,5   -83,2   -19,5   
45-59 -19,2   -19,2   -19,2   -19,2   -16,7   -17,9   -51,8   -19,2   -18,1   -18,1   -18,1   -18,1   -15,6   -16,8   -51,2   -18,1   
60-69 25,4   25,4   25,4   25,4   37,0   31,2   -56,9   25,4   30,0   30,0   30,0   30,0   42,0   36,0   -55,4   30,0  
70-79 38,0   38,0   38,0   38,0   50,7   44,4   -10,2   38,0   51,2   51,2   51,2   51,2   65,3   58,3   -1,6   51,2  
80+ 147,6   147,6   147,6   147,6   170,6   159,1   120,0   147,6   249,2   249,2   249,2   249,2   281,6   265,4   210,3   249,2  
15+ -11,9   12,4   41,8   -1,5   -8,2   13,4   -3,8   -1,5   -9,8   23,6   70,6   5,0   -5,9   25,2   20,5   5,0  
15-29 -13,9   -13,9   -13,9   -13,9    -9,4   -25,8   -80,0   -13,9   -13,8   -13,8   -13,8   -13,8    -9,3   -25,7   -79,9   -13,8   
30-44 -16,3   -16,3   -16,3   -16,3   -11,8   -14,6    -101,8   -16,3   -15,9   -15,9   -15,9   -15,9   -11,4   -14,2    -101,8   -15,9   
45-59 -4,4   -4,4   -4,4   -4,4   0,7   -1,7   -52,1   -4,4   -3,1   -3,1   -3,1   -3,1   2,1   -0,4   -51,4   -3,1  
60-69 40,5   40,5   40,5   40,5   63,0   51,6   -72,1   40,5   45,4   45,4   45,4   45,4   68,8   57,0   -71,1   45,4  
70-79 44,6   44,6   44,6   44,6   67,8   56,1   -23,1   44,6   56,7   56,7   56,7   56,7   81,9   69,2   -16,6   56,7  
80+ 163,7   163,7   163,7   163,7   206,1   184,7   63,7   163,7   250,4   250,4   250,4   250,4   306,6   278,3   117,5   250,4  
15+ -2,8   19,9   35,0   7,7   4,7   24,5   -42,7   7,7   0,1   30,3   50,7   14,1   7,9   35,7   -33,7   14,1  
15-29 -18,3   -18,3   -18,3   -18,3   -11,7   -20,7   -98,0   -18,3   -18,3   -18,3   -18,3   -18,3   -11,6   -20,7   -98,0   -18,3   
30-44 -34,6   -34,6   -34,6   -34,6   -29,3   -31,9   -78,5   -34,6   -34,4   -34,4   -34,4   -34,4   -29,1   -31,6   -78,4   -34,4   
45-59 -8,8   -8,8   -8,8   -8,8   -1,4   -5,0   -28,8   -8,8   -7,7   -7,7   -7,7   -7,7   -0,2   -3,8   -27,9   -7,7  
60-69 -2,1   -2,1   -2,1   -2,1   22,0   9,7   -43,9   -2,1   1,4   1,4   1,4   1,4   26,4   13,6   -41,9   1,4  
70-79 29,1   29,1   29,1   29,1   61,0   44,8   -6,9   29,1   42,1   42,1   42,1   42,1   77,1   59,2   2,4   42,1  
80+ 172,5   172,5   172,5   172,5   239,8   205,5   132,4   172,5   283,6   283,6   283,6   283,6   378,4   330,0   227,2   283,6  
15+ -18,2   -0,4   17,3   -5,6   -9,2   7,1   -20,2   -5,6   -16,2   8,2   34,4   1,4   -6,7   16,7   -6,1   1,4  
15-29 8,0   8,0   8,0   8,0   10,8   -1,1   -82,5   8,0   8,1   8,1   8,1   8,1   10,9   -1,0   -82,4   8,1  
30-44 -15,8   -15,8   -15,8   -15,8   -13,6   -14,6   -86,2   -15,8   -15,5   -15,5   -15,5   -15,5   -13,3   -14,4   -86,1   -15,5   
45-59 0,0   0,0   0,0   0,0   2,6   1,4    -39,4   0,0   1,4   1,4   1,4   1,4   4,0   2,8    -38,6   1,4   
60-69 36,4   36,4   36,4   36,4   46,9   41,7   -74,6   36,4   42,1   42,1   42,1   42,1   53,0   47,6   -73,6   42,1  
70-79 54,7   54,7   54,7   54,7   66,6   60,7   -26,0   54,4   73,6   73,6   73,6   73,6   86,9   80,3   -16,9   73,3  
80+ 145,7   145,7   145,7   145,7   164,6   155,2   40,8   145,7   264,8   264,8   264,8   264,8   292,8   278,9   109,0   264,8  
15+ 5,8   26,5   28,1   11,4   9,8   28,9   -46,7   11,3   10,1   42,5   44,9   18,8   14,4   45,4   -37,8   18,8  
15-29 -43,7   -43,7   -43,7   -43,7   -41,9   -58,1   -83,1   -43,7   -43,6   -43,6   -43,6   -43,6   -41,9   -58,0   -83,1   -43,6   
30-44 -36,9   -36,9   -36,9   -36,9   -34,9   -35,9   -88,5   -36,9   -36,6   -36,6   -36,6   -36,6   -34,6   -35,6   -88,5   -36,6   
45-59 -11,3   -11,3   -11,3   -11,3    -8,6    -9,9   -35,9   -11,3   -10,1   -10,1   -10,1   -10,1    -7,3    -8,6   -35,0   -10,1   
60-69 15,3   15,3   15,3   15,3   30,0   22,6   -27,8   15,3   19,7   19,7   19,7   19,7   35,0   27,3   -25,0   19,7  
70-79 61,2   61,2   61,2   61,2   81,7   71,4   23,3   61,2   77,0   77,0   77,0   77,0   99,6   88,2   35,4   77,0   
80+ 152,3   152,3   152,3   152,3   184,4   168,2   111,2   152,3   250,2   250,2   250,2   250,2   294,8   272,3   193,1   250,2  
15+ -23,2   15,1   37,4   -9,2   -19,0   19,3   -1,2   -9,2   -20,3   28,2   58,9   -2,2   -15,7   33,2   16,3   -2,2  
15-29 -6,8   -6,8   -6,8   -6,8   -3,4   -5,0   -64,9   -6,8   -6,8   -6,8   -6,8   -6,8   -3,3   -5,0   -64,9   -6,8  
30-44 -21,7   -21,7   -21,7   -21,7   -18,8   -20,2   -52,8   -21,7   -21,5   -21,5   -21,5   -21,5   -18,6   -20,0   -52,7   -21,5   
45-59 1,5   1,5   1,5   1,5   5,2   3,5   -28,8   1,5   2,5   2,5   2,5   2,5   6,3   4,5   -28,1   2,5  
60-69 37,5   37,5   37,5   37,5   52,5   45,0   -65,0   37,5   42,3   42,3   42,3   42,3   57,8   50,1   -63,8   42,3  
70-79 44,2   44,2   44,2   44,2   60,0   52,1   -30,8   44,2   59,8   59,8   59,8   59,8   77,2   68,5   -23,4   59,8  
80+ 132,4   132,4   132,4   132,4   157,8   145,1   47,0   132,4   230,4   230,4   230,4   230,4   266,4   248,4   109,0   230,4  
15+ 3,5   14,6   19,5   7,4   9,6   18,8   -36,3   7,4   8,9   25,0   33,0   14,5   15,5   29,7   -28,4   14,5  
15-29 -17,4   -14,8   -15,2   -16,9   -13,4   -20,7   -83,4   -16,9   -17,4   -14,8   -15,1   -16,9   -13,3   -20,7   -83,4   -16,9   
30-44 -26,3   -26,7   -28,0   -26,5   -22,7   -24,8   -76,1   -26,5   -26,0   -26,5   -27,8   -26,2   -22,4   -24,6   -76,0   -26,2   
45-59 -4,9   -6,3   -6,4   -5,5   -0,5   -3,6   -33,8   -5,5   -3,7   -5,1   -5,3   -4,3   0,7   -2,4   -33,0   -4,3  
60-69 24,8   17,4   12,2   19,5   41,9   27,3   -48,6   19,5   29,3   21,7   16,3   23,8   47,1   31,9   -46,7   23,8  
70-79 44,5   41,7   40,4   42,3   64,2   53,2   -8,0   42,3   59,1   55,6   54,2   56,4   80,8   68,2   1,0   56,4  
80+ 146,3   156,5   159,9   154,9   179,8   176,8   102,5   154,9   245,5   256,1   262,8   255,4   292,2   284,2   183,1   255,4  
15+ -7,9   11,0   23,6   0,9   -1,5   16,3   -24,5   0,9   -4,4   21,5   40,7   7,8   2,4   27,6   -11,8   7,8  
15-29 -20,7   -20,7   -20,7   -20,7   -20,0   -15,2   -79,3   -20,7   -20,7   -20,7   -20,7   -20,7   -19,9   -15,1   -79,3   -20,7   
30-44 -28,5   -28,5   -28,5   -28,5   -26,6   -27,4   -69,7   -28,5   -28,3   -28,3   -28,3   -28,3   -26,3   -27,1   -69,6   -28,3   
45-59 -7,2   -7,2   -7,2   -7,2   -4,0   -5,6   -33,5   -7,2   -6,1   -6,1   -6,1   -6,1   -2,9   -4,4   -32,7   -6,1  
60-69 14,9   14,9   14,9   14,9   26,8   20,8   -27,8   14,9   19,0   19,0   19,0   19,0   31,3   25,1   -25,3   19,0  
70-79 42,0   42,0   42,0   42,0   56,7   49,4   11,9   42,0   55,8   55,8   55,8   55,8   72,0   63,9   22,8   55,8   
80+ 157,1   157,1   157,1   157,1   183,7   170,4   122,2   157,1   256,8   256,8   256,8   256,8   293,7   275,3   208,4   256,8  
15+ -11,4   11,4   30,8   -1,3   -7,9   16,4   -2,9   -1,3   -8,4   22,3   50,7   5,5   -4,5   28,0   14,3   5,5  
Sources: EU-EPC 2000 (Baseline scenario); Pellikaan/Westerhout 2004 (Living-longer-high scenario); calculations by DIW.
All
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Table A.5 Development of hospital admissions/discharges (1999 = 100) 
Countries 2010 2020 2030 2040 2050
Belgium 106       112       117       119       116      
Denmark 104       112       120       120       120      
Finland 108       119       129       128       123      
France 106       112       118       120       117      
Germany 108       113       116       118       113      
Netherlands 112       123       132       134       131      
Spain 106       109       114       117       113      
United Kingdom 103       111       117       120       119      
Total 106       112       117       119       116      
Belgium 107       115       123       128       129      
Denmark 105       115       127       132       136      
Finland 110       123       138       142       140      
France 107       114       122       127       127      
Germany 109       117       123       128       127      
Netherlands 113       127       139       146       148      
Spain 107       112       119       127       129      
United Kingdom 104       114       122       129       134      
Total 107       115       123       129       130      
*) For France and United Kingdom: 2000 = 100.
Source: Calculations by DIW.
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Table A.6 Hospital cases by age group – Changes within the age groups (per 1000 
 persons) 
Countries
0 - 14 15 - 64 65 - 74 75+ Total 0 - 14 15 - 64 65 - 74 75+ Total
Belgium - 9    27    73   112   203   - 9   31   80    151    253  
Denmark - 18    12    73   63   129   - 18   14   80    92    168  
Finland - 14   - 34    141   170   262   - 14   - 32   150    217    320  
France - 68    196    519   462   1 109   - 68   217   554    610   1 312  
Germany - 163   - 35    623   1 749   2 173   - 163   2   696   2 194   2 730  
Netherlands - 6    79    149   130   352   - 6   83   159    169    405  
Spain - 61    31    79   356   405   - 61   41   97    472    549  
United Kingdom - 129    358    540   432   1 201   - 129   379   593    692   1 535  
Total - 469    634   2 197   3 473   5 835   - 469    736   2 408   4 598   7 273  
Belgium - 12   - 113   - 24   217   67   - 12   - 109   - 13    374    239  
Denmark - 3   - 30   - 23   145   89   - 3   - 26   - 14    273    230  
Finland - 13   - 75   - 56   195   52   - 13   - 72   - 46    369    239  
France - 101   - 499   - 72   1 169   498   - 101   - 468   - 15   1 780   1 196  
Germany - 166   -1 704   - 27   1 767   - 130   - 166   -1 664   95   3 417   1 681  
Netherlands  3   - 40   - 34   196   126   3   - 34   - 18    375    325  
Spain - 66   - 673    167   771   199   - 66   - 662   212   1 254    738  
United Kingdom - 106   - 571    18   1 649   991   - 106   - 544   96   2 851   2 297  
Total - 463   -3 704   - 52   6 110   1 891   - 463   -3 579   295   10 693   6 946  
Belgium - 21   - 86    49   328   270   - 21   - 78   67    525    492  
Denmark - 22   - 18    50   208   218   - 22   - 12   65    366    398  
Finland - 27   - 108    85   365   315   - 27   - 103   103    586    559  
France - 169   - 303    447   1 631   1 607   - 169   - 252   538   2 391   2 508  
Germany - 329   -1 740    596   3 516   2 043   - 329   -1 662   791   5 611   4 411  
Netherlands - 3    39    115   327   477   - 3   49   141    544    730  
Spain - 127   - 642    247   1 127   605   - 127   - 620   309   1 726   1 288  
United Kingdom - 235   - 213    558   2 081   2 192   - 235   - 165   689   3 542   3 832  
Total - 932   -3 070   2 145   9 583   7 727   - 932   -2 843   2 703   15 290   14 218  
*) France and United Kingdom = 2000.
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Table A.7 Hospital cases by age group – Changes within the age groups (%) 
 
Countries
0 - 14 15 - 64 65 - 74 75+ Total 0 - 14 15 - 64 65 - 74 75+ Total
Belgium -3,6   3,1   25,9   35,7   11,8   -3,6   3,5   28,4   48,3   14,7  
Denmark -10,7   2,1   48,7   29,2   11,8   -10,7   2,6   53,2   42,9   15,3  
Finland -12,4   -4,8   61,4   50,8   19,0   -12,4   -4,5   65,2   64,8   23,2  
France -5,5   3,7   41,0   33,7   12,1   -5,5   4,1   43,7   44,5   14,3  
Germany -11,7   -0,4   23,0   58,7   13,4   -11,7   0,0   25,8   73,7   16,9  
Netherlands -2,6   10,0   61,3   50,0   23,2   -2,6   10,5   65,5   64,9   26,7   
Spain -13,9   1,3   10,3   42,9   9,0   -13,9   1,7   12,6   56,8   12,2  
United Kingdom -7,7   5,8   35,3   21,6   10,6   -7,7   6,2   38,8   34,7   13,5  
Total -8,5   2,4   30,6   41,9   12,4   -8,5   2,8   33,6   55,4   15,5  
Belgium -5,2   -12,4   -6,8   51,0   3,5   -5,2   -11,9   -3,6   80,5   12,1  
Denmark -2,0   -5,2   -10,5   52,2   7,3   -2,0   -4,5   -6,3   88,8   18,2  
Finland -12,3   -11,2   -15,2   38,8   3,2   -12,3   -10,7   -12,2   67,0   14,0  
France -8,6   -9,0   -4,0   63,8   4,8   -8,6   -8,5   -0,8   89,8   11,4  
Germany -13,4   -18,8   -0,8   37,4   -0,7   -13,4   -18,2   2,8   66,1   8,9  
Netherlands 1,2   -4,6   -8,7   50,3   6,7   1,2   -3,9   -4,5   87,3   16,9  
Spain -17,4   -27,0   19,7   65,0   4,1   -17,4   -26,4   24,4   96,3   14,6  
United Kingdom -6,9   -8,8   0,9   67,9   7,9   -6,9   -8,3   4,5   106,0   17,8  
Total -9,2   -13,9   -0,6   51,9   3,6   -9,2   -13,4   3,1   82,9   12,8  
Belgium -8,5   -9,7   17,3   104,9   15,7   -8,5   -8,9   23,7   167,7   28,6  
Denmark -12,4   -3,2   33,1   96,6   19,9   -12,4   -2,1   43,6   169,7   36,3  
Finland -23,2   -15,5   36,9   109,3   22,8   -23,2   -14,7   45,0   175,3   40,5  
France -13,6   -5,7   35,3   119,0   17,5   -13,6   -4,7   42,5   174,3   27,3  
Germany -23,6   -19,1   22,0   118,1   12,6   -23,6   -18,2   29,3   188,4   27,2  
Netherlands -1,5   5,0   47,3   125,4   31,5   -1,5   6,2   58,0   208,7   48,2  
Spain -28,9   -26,0   32,0   135,7   13,4   -28,9   -25,2   40,2   207,9   28,6  
United Kingdom -14,1   -3,5   36,5   104,2   19,3   -14,1   -2,7   45,0   177,4   33,8  
Total -17,0   -11,8   29,9   115,5   16,5   -17,0   -10,9   37,7   184,2   30,3  
*) France and United Kingdom = 2000.
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Table A.8 Age structure of hospital admissions/discharges (%) 
Countries
0 - 14 15 - 64 65 - 74 75+ 0 - 14 15 - 64 65 - 74 75+
Belgium 14,2    51,3    16,3    18,2    14,2    51,3    16,3    18,2   
Denmark 15,8    50,9    13,7    19,7    15,8    50,9    13,7    19,7   
Finland 8,5    50,7    16,6    24,2    8,5    50,7    16,6    24,2   
France 13,5    57,9    13,8    14,9    13,5    57,9    13,8    14,9   
Germany 8,6    56,3    16,7    18,4    8,6    56,3    16,7    18,4   
Netherlands 14,8    52,0    16,0    17,2    14,8    52,0    16,0    17,2   
Spain 9,7    54,7    17,1    18,4    9,7    54,7    17,1    18,4   
United Kingdom 14,7    54,2    13,5    17,6    14,7    54,2    13,5    17,6   
Total 11,7    55,3    15,3    17,7    11,7    55,3    15,3    17,7   
Belgium 12,2    47,3    18,4    22,1    11,9    46,3    18,3    23,5   
Denmark 12,6    46,5    18,2    22,7    12,2    45,3    18,1    24,3   
Finland 6,2    40,6    22,6    30,7    6,0    39,3    22,3    32,4   
France 11,4    53,5    17,3    17,8    11,1    52,7    17,3    18,9   
Germany 6,7    49,5    18,1    25,7    6,5    48,2    18,0    27,3   
Netherlands 11,7    46,4    21,0    20,9    11,4    45,4    20,9    22,4   
Spain 7,7    50,8    17,3    24,2    7,5    49,6    17,2    25,8   
United Kingdom 12,3    51,9    16,5    19,4    11,9    50,7    16,5    20,9   
Total 9,5    50,4    17,8    22,3    9,3    49,3    17,7    23,8   
Belgium 11,2    40,0    16,5    32,2    10,1    36,3    15,7    37,9   
Denmark 11,5    41,1    15,2    32,2    10,1    36,6    14,4    38,9   
Finland 5,3    34,9    18,5    41,2    4,6    30,8    17,2    47,4   
France 9,9    46,5    15,9    27,8    9,1    43,3    15,4    32,1   
Germany 5,9    40,5    18,1    35,6    5,2    36,2    17,0    41,7   
Netherlands 11,1    41,5    18,0    29,5    9,8    37,3    17,1    35,8   
Spain 6,1    35,7    19,9    38,3    5,4    31,8    18,6    44,1   
United Kingdom 10,6    43,8    15,4    30,1    9,4    39,4    14,6    36,5   
Total 8,3    41,9    17,0    32,7    7,5    37,8    16,1    38,6   
*) France and United Kingdom = 2000.
Source: Calculations by DIW.
2050
Age-groups
Baseline scenario Living-longer-high scenario
1999
*)
2020104 | ERIKA SCHULZ 
 
Table A.9 Changes in the age structure of hospital admissions/discharges (percentage 
points) 
Countries
0 - 14 15 - 64 65 - 74 75+ 0 - 14 15 - 64 65 - 74 75+
Belgium -2,0      -4,0      2,1      3,9      -2,3      -5,0      1,9      5,3     
Denmark -3,2      -4,4      4,5      3,1      -3,6      -5,6      4,5      4,7     
Finland -2,2      -10,2      5,9      6,5      -2,4      -11,4      5,7      8,2     
France -2,1      -4,3      3,6      2,9      -2,3      -5,2      3,5      3,9     
Germany -1,9      -6,9      1,4      7,3      -2,1      -8,1      1,3      8,9     
Netherlands -3,1      -5,6      4,9      3,7      -3,4      -6,7      4,9      5,2     
Spain -2,0      -3,9      0,2      5,7      -2,3      -5,1      0,1      7,3     
United Kingdom -2,4      -2,3      3,0      1,8      -2,8      -3,5      3,0      3,3     
Total -2,2      -4,9      2,5      4,6      -2,4      -6,1      2,4      6,1     
Belgium -1,0      -7,3      -1,8      10,1      -1,8      -9,9      -2,6      14,3     
Denmark -1,1      -5,4      -3,0      9,5      -2,1      -8,7      -3,8      14,5     
Finland -0,9      -5,6      -4,0      10,6      -1,4      -8,5      -5,1      15,1     
France -1,5      -7,1      -1,5      10,0      -2,0      -9,4      -1,9      13,3     
Germany -0,9      -9,0      0,0      9,9      -1,3      -12,0      -1,0      14,3     
Netherlands -0,6      -4,9      -3,0      8,5      -1,5      -8,1      -3,8      13,4     
Spain -1,6      -15,2      2,6      14,1      -2,1      -17,7      1,5      18,4     
United Kingdom -1,7      -8,0      -1,1      10,8      -2,5      -11,3      -1,9      15,6     
Total -1,2      -8,5      -0,7      10,4      -1,8      -11,4      -1,5      14,8     
Belgium -3,0      -11,3      0,2      14,0      -4,1      -15,0      -0,6      19,7     
Denmark -4,3      -9,8      1,5      12,6      -5,6      -14,3      0,7      19,2     
Finland -3,2      -15,8      1,9      17,1      -3,8      -19,9      0,5      23,2     
France -3,6      -11,4      2,1      12,9      -4,3      -14,5      1,6      17,2     
Germany -2,8      -15,8      1,4      17,2      -3,4      -20,1      0,3      23,3     
Netherlands -3,7      -10,5      1,9      12,3      -5,0      -14,7      1,1      18,6     
Spain -3,6      -19,0      2,8      19,9      -4,4      -22,9      1,5      25,7     
United Kingdom -4,1      -10,4      1,9      12,5      -5,3      -14,8      1,1      18,9     
Total -3,4      -13,4      1,8      15,0      -4,2      -17,5      0,9      20,9     
*) France and United Kingdom = 2000.
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Table A.10 Hospital days by age group (million persons) 
Countries
0 - 14 15 - 64 65 - 74 75+ Total 0 - 14 15 - 64 65 - 74 75+ Total
Belgium 1,1    5,2    2,9    4,6    13,9    1,1    5,2    2,9    4,6    13,9   
Denmark 0,6    2,4    1,1    1,9    5,9    0,6    2,4    1,1    1,9    5,9   
Finland 0,4    4,6    2,2    7,3    14,6    0,4    4,6    2,2    7,3    14,6   
France 7,1    34,9    12,8    10,3    65,1    7,1    34,9    12,8    10,3    65,1   
Germany 9,4    87,1    33,0    40,4    169,8    9,4    87,1    33,0    40,4    169,8   
Netherlands 1,3    5,6    2,6    3,7    13,2    1,3    5,6    2,6    3,7    13,2   
Spain 2,3    17,7    8,4    10,2    38,6    2,3    17,7    8,4    10,2    38,6   
United Kingdom 4,9    25,3    8,9    20,3    59,4    4,9    25,3    8,9    20,3    59,4   
Total 27,1    182,8    71,9    98,7    380,5    27,1    182,8    71,9    98,7    380,5   
Belgium 1,1    5,6    3,6    6,2    16,6    1,1    5,7    3,7    6,8    17,3   
Denmark 0,5    2,5    1,6    2,5    7,1    0,5    2,5    1,6    2,7    7,4   
Finland 0,4    4,4    3,6    11,0    19,4    0,4    4,4    3,7    12,0    20,5   
France 6,7    37,0    18,0    13,7    75,5    6,7    37,1    18,4    14,9    77,1   
Germany 8,3    88,1    40,6    64,1    201,1    8,3    88,5    41,5    70,1    208,4   
Netherlands 1,2    6,4    4,3    5,5    17,5    1,2    6,5    4,4    6,1    18,2   
Spain 2,0    19,2    9,2    14,8    45,2    2,0    19,3    9,4    16,3    47,0   
United Kingdom 4,6    26,8    12,1    24,9    68,4    4,6    26,9    12,4    27,8    71,7   
Total 24,8    190,2    93,0    142,7    450,7    24,8    191,0    95,1    156,8    467,7   
Belgium 1,1    4,9    3,4    9,4    18,7    1,1    5,0    3,6    12,3    21,9   
Denmark 0,5    2,4    1,4    3,7    8,0    0,5    2,4    1,5    5,0    9,4   
Finland 0,3    3,9    3,1    15,3    22,6    0,3    3,9    3,2    20,1    27,6   
France 6,2    33,6    17,3    22,5    79,6    6,2    34,0    18,2    28,2    86,6   
Germany 7,2    71,2    40,3    88,0    206,7    7,2    72,0    42,6    116,4    238,3   
Netherlands 1,3    6,1    3,9    8,5    19,7    1,3    6,2    4,2    11,8    23,4   
Spain 1,6    13,9    11,0    24,4    51,0    1,6    14,1    11,7    32,1    59,6   
United Kingdom 4,2    24,5    12,2    43,5    84,4    4,2    24,7    12,9    60,9    102,8   
Total 22,3    160,5    92,5    215,2    490,6    22,3    162,3    98,0    286,8    569,5   
*) France and United Kingdom = 2000.
Source: Calculations by DIW.
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Table A.11 Hospital days by age group – Changes within the age group  
(per 1000 persons) 
Countries
0 - 14 15 - 64 65 - 74 75+ Total 0 - 14 15 - 64 65 - 74 75+ Total
Belgium -  26      398      742     1 643     2 758    -  26      421      815     2 223     3 433   
Denmark -  60      139      508      588     1 175    -  60      153      554      835     1 482   
Finland -  52    -  222     1 373     3 714     4 812    -  52    -  207     1 458     4 739     5 937   
France -  393     2 117     5 242     3 466     10 433    -  393     2 269     5 591     4 577     12 043   
Germany - 1 076     1 071     7 602     23 697     31 294    - 1 076     1 468     8 495     29 740     38 627   
Netherlands -  34      803     1 629     1 841     4 239    -  34      836     1 743     2 419     4 964   
Spain -  343     1 526      862    4 565    6 609    -  343    1 616    1 056     6 058     8 387   
United Kingdom -  361     1 524     3 198     4 561     8 922    -  361     1 614     3 515     7 527     12 295   
Total - 2 345     7 356     21 157     44 074     70 243    - 2 345     8 170     23 227     58 116     87 169   
Belgium -  59    -  751    -  246     3 186     2 130    -  59    -  720    -  134     5 496     4 583   
Denmark -  11    -  140    -  168     1 193      874    -  11    -  121    -  107     2 215     1 977   
Finland -  46    -  490    -  547     4 277     3 195    -  46    -  471    -  451     8 078     7 111   
France -  579    - 3 389    -  728     8 769     4 074    -  579    - 3 164    -  154     13 346     9 450   
Germany - 1 118    - 16 921    -  333     23 947     5 575    - 1 118    - 16 501     1 159     46 305     29 844   
Netherlands   15    -  347    -  370     2 961     2 259      15    -  297    -  195     5 696     5 217   
Spain -  337    - 5 308     1 819     9 565     5 738    -  337    - 5 209     2 303     15 813     12 569   
United Kingdom -  318    - 2 327      42     18 603     15 999    -  318    - 2 210      504     33 087     31 062   
Total - 2 454    - 29 673    -  532     72 501     39 843    - 2 454    - 28 693     2 924     130 036     101 813   
Belgium -  85    -  352      496     4 829     4 888    -  85    -  299      681     7 719     8 016   
Denmark -  71    -  1      340     1 780     2 048    -  71      32      447     3 050     3 459   
Finland -  98    -  712      826     7 991     8 007    -  98    -  678     1 006     12 817     13 048   
France -  972    - 1 271     4 515    12 236    14 507    -  972    -  895    5 437     17 923     21 493   
Germany - 2 194    - 15 850     7 269     47 644     36 869    - 2 194    - 15 033     9 653     76 045     68 471   
Netherlands -  19      456     1 259     4 802     6 498    -  19      539     1 548     8 114     10 182   
Spain -  680    - 3 783     2 681     14 129     12 347    -  680    - 3 594     3 359     21 871     20 956   
United Kingdom -  680    -  803     3 239     23 164     24 921    -  680    -  596     4 019     40 614     43 357   
Total - 4 798    - 22 317     20 625     116 575     110 085    - 4 798    - 20 523     26 151     188 152     188 982   
*) France and United Kingdom = 2000.
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Table A.12 Development of hospital days in the age groups – Changes within the 
age groups (%) 
Countries
0 - 14 15 - 64 65 - 74 75+ Total 0 - 14 15 - 64 65 - 74 75+ Total
Belgium -2,3    7,6    25,9    35,7    19,9    -2,3    8,0    28,4    48,3    24,8   
Denmark -10,5    5,9    48,4    30,8    19,9    -10,5    6,4    52,7    43,7    25,1   
Finland -12,4    -4,8    61,4    50,8    33,0    -12,4    -4,5    65,2    64,8    40,7   
France -5,5    6,1    41,0    33,7    16,0    -5,5    6,5    43,7    44,5    18,5   
Germany -11,5    1,2    23,0    58,7    18,4    -11,5    1,7    25,8    73,7    22,8   
Netherlands -2,6    14,3    61,5    49,8    32,0    -2,6    14,9    65,8    65,4    37,5   
Spain -14,9    8,6    10,3    44,6    17,1    -14,9    9,1    12,6    59,2    21,7   
United Kingdom -7,4    6,0    35,9    22,5    15,0    -7,4    6,4    39,4    37,1    20,7   
Total -8,6    4,0    29,4    44,7    18,5    -8,6    4,5    32,3    58,9    22,9   
Belgium -5,3    -13,3    -6,8    51,0    12,8    -5,3    -12,7    -3,6    80,5    26,5   
Denmark -2,2    -5,6    -10,8    47,8    12,3    -2,2    -4,8    -6,6    80,8    26,8   
Finland -12,3    -11,2    -15,2    38,8    16,5    -12,3    -10,7    -12,2    67,0    34,7   
France -8,6    -9,2    -4,0    63,8    5,4    -8,6    -8,5    -0,8    89,8    12,3   
Germany -13,5    -19,2    -0,8    37,4    2,8    -13,5    -18,6    2,8    66,1    14,3   
Netherlands 1,2    -5,4    -8,7    53,5    12,9    1,2    -4,6    -4,5    93,2    28,7   
Spain -17,1    -27,6    19,7    64,6    12,7    -17,1    -27,0    24,4    97,1    26,7   
United Kingdom -7,0    -8,7    0,3    74,9    23,4    -7,0    -8,2    4,1    118,9    43,3   
Total -9,9    -15,6    -0,6    50,8    8,8    -9,9    -15,0    3,1    82,9    21,8   
Belgium -7,5    -6,7    17,3    104,9    35,3    -7,5    -5,7    23,7    167,7    57,8   
Denmark -12,5    0,0    32,4    93,3    34,7    -12,5    1,4    42,6    159,9    58,5   
Finland -23,2    -15,5    36,9    109,3    55,0    -23,2    -14,7    45,0    175,3    89,5   
France -13,6    -3,6    35,3    119,0    22,3    -13,6    -2,6    42,5    174,3    33,0   
Germany -23,4    -18,2    22,0    118,1    21,7    -23,4    -17,3    29,3    188,4    40,3   
Netherlands -1,5    8,1    47,6    129,9    49,1    -1,5    9,6    58,4    219,6    76,9   
Spain -29,4    -21,4    32,0    138,1    32,0    -29,4    -20,3    40,2    213,8    54,3   
United Kingdom -13,8    -3,2    36,3    114,2    41,9    -13,8    -2,4    45,1    200,2    72,9   
Total -17,7    -12,2    28,7    118,1    28,9    -17,7    -11,2    36,4    190,7    49,7   
*) France and United Kingdom = 2000.




Baseline scenario Living-longer-high scenario
2020/1999
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Table A.13 Age structure of hospital days (%) 
 
Countries
0 - 14 15 - 64 65 - 74 75+ 0 - 14 15 - 64 65 - 74 75+
Belgium 8,2     37,9     20,7     33,2     8,2     37,9     20,7     33,2    
Denmark 9,6     40,3     17,8     32,3     9,6     40,3     17,8     32,3    
Finland 2,9     31,6     15,3     50,2     2,9     31,6     15,3     50,2    
France 11,0     53,6     19,7     15,8     10,9     53,6     19,7     15,8    
Germany 5,5     51,3     19,4     23,8     5,5     51,3     19,4     23,8    
Netherlands 9,7     42,4     20,0     27,9     9,7     42,4     20,0     27,9    
Spain 6,0     45,9     21,7     26,5     6,0     45,9     21,7     26,5    
United Kingdom 8,3     42,6     15,0     34,1     8,3     42,6     15,0     34,1    
Total 7,1     48,0     18,9     25,9     7,1     48,0     18,9     25,9    
Belgium 6,7     34,0     21,7     37,6     6,4     32,8     21,3     39,5    
Denmark 7,2     35,6     22,0     35,2     6,9     34,3     21,7     37,1    
Finland 1,9     22,6     18,6     56,9     1,8     21,4     18,0     58,8    
France 8,9     49,0     23,9     18,2     8,7     48,2     23,8     19,3    
Germany 4,1     43,8     20,2     31,9     4,0     42,5     19,9     33,6    
Netherlands 7,1     36,7     24,5     31,7     6,8     35,5     24,1     33,6    
Spain 4,3     42,5     20,4     32,7     4,2     41,1     20,0     34,7    
United Kingdom 6,7     39,3     17,7     36,4     6,3     37,6     17,3     38,8    
Total 5,5     42,2     20,6     31,7     5,3     40,8     20,3     33,5    
Belgium 5,6     26,1     18,0     50,3     4,8     22,6     16,2     56,3    
Denmark 6,3     29,9     17,5     46,4     5,3     25,7     16,0     52,9    
Finland 1,4     17,2     13,6     67,8     1,2     14,2     11,7     72,9    
France 7,7     42,2     21,8     28,3     7,1     39,2     21,1     32,6    
Germany 3,5     34,5     19,5     42,6     3,0     30,2     17,9     48,9    
Netherlands 6,4     30,8     19,8     43,0     5,4     26,3     17,9     50,4    
Spain 3,2     27,3     21,7     47,8     2,7     23,7     19,7     53,9    
United Kingdom 5,0     29,1     14,4     51,5     4,1     24,1     12,6     59,2    
Total 4,6     32,7     18,9     43,9     3,9     28,5     17,2     50,4    
*) France and United Kingdom = 2000.
Source: Calculations by DIW.
2050
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Table A.14 Changes in the age structure of hospital days (percentage points) 
 
Countries
0 - 14 15 - 64 65 - 74 75+ 0 - 14 15 - 64 65 - 74 75+
Belgium -1,5     -3,9     1,0     4,4     -1,8     -5,1     0,6     6,3    
Denmark -2,4     -4,7     4,2     2,9     -2,7     -6,0     3,9     4,8    
Finland -1,0     -9,0     3,3     6,7     -1,1     -10,2     2,7     8,6    
France -2,0     -4,6     4,2     2,4     -2,2     -5,4     4,2     3,5    
Germany -1,4     -7,4     0,8     8,1     -1,5     -8,8     0,5     9,9    
Netherlands -2,5     -5,7     4,5     3,8     -2,8     -7,0     4,1     5,7    
Spain -1,6     -3,3     -1,3     6,2     -1,8     -4,7     -1,6     8,2    
United Kingdom -1,6     -3,3     2,7     2,2     -1,9     -5,1     2,3     4,6    
Total -1,6     -5,9     1,8     5,7     -1,8     -7,2     1,4     7,6    
Belgium -1,1     -7,9     -3,8     12,7     -1,6     -10,2     -5,1     16,9    
Denmark -0,9     -5,7     -4,5     11,1     -1,6     -8,5     -5,7     15,8    
Finland -0,5     -5,4     -5,1     10,9     -0,6     -7,2     -6,3     14,1    
France -1,2     -6,8     -2,1     10,1     -1,6     -8,9     -2,8     13,3    
Germany -0,7     -9,4     -0,7     10,7     -1,0     -12,2     -2,0     15,2    
Netherlands -0,7     -6,0     -4,7     11,4     -1,5     -9,2     -6,2     16,8    
Spain -1,2     -15,2     1,3     15,1     -1,4     -17,4     -0,4     19,2    
United Kingdom -1,6     -10,2     -3,3     15,2     -2,2     -13,5     -4,7     20,5    
Total -0,9     -9,5     -1,8     12,2     -1,4     -12,3     -3,1     16,8    
Belgium -2,6     -11,8     -2,7     17,1     -3,4     -15,2     -4,5     23,1    
Denmark -3,4     -10,4     -0,3     14,1     -4,3     -14,5     -1,8     20,6    
Finland -1,5     -14,4     -1,8     17,6     -1,7     -17,4     -3,6     22,7    
France -3,2     -11,4     2,1     12,5     -3,8     -14,3     1,4     16,8    
Germany -2,0     -16,8     0,1     18,8     -2,5     -21,0     -1,5     25,1    
Netherlands -3,3     -11,7     -0,2     15,1     -4,3     -16,1     -2,1     22,5    
Spain -2,8     -18,5     0,0     21,3     -3,2     -22,2     -2,0     27,4    
United Kingdom -3,2     -13,5     -0,6     17,4     -4,1     -18,5     -2,4     25,1    
Total -2,6     -15,3     0,0     17,9     -3,2     -19,5     -1,7     24,4    
*) France and United Kingdom = 2000.




Baseline scenario Living-longer-high scenario
2020/1999
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Table A.15 Development of contacts with a doctor (2001 = 100) 
Countries 2010 2020 2030 2040 2050
Belgium 
1)  (GP) 105     110     117     119     115    
Finland 
2)  (GP+SP) 103     105     105     102     98    
Netherlands  (GP) 107     112     117     118     117    
Spain 
1)  (GP+SP) 104     105     106     105     100    
United Kingdom 
3)  (GP) 103     107     110     111     109    
Total 104     107     109     109     106    
Belgium 
1)  (GP) 106     113     122     129     128    
Finland 
2)  (GP+SP) 103     107     108     107     104    
Netherlands  (GP) 107     114     121     126     127    
Spain 
1)  (GP+SP) 104     107     110     111     110    
United Kingdom 
3)  (GP) 104     109     114     117     117    
Total 104     109     113     116     115    
Average population based on: 1) 1997, 2) 1996, 3) 2000.
GP = General practitioner, SP = Specialist.
Source: Calculations by DIW.
Living-longer-high scenario
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Table A.16 Contacts with a doctor by age group per year (millions) 
Countries
0 - 14
4) 15 - 64
5) 65 - 74 75+ Total 0 - 14
4) 15 - 64
5) 65 - 74 75+ Total
Belgium 
1)  (GP) 6,3    28,2    8,5    10,8    53,7    6,3    28,2    8,5    10,8    53,8   
Finland 
2)  (GP+SP) 3,1    13,5    2,4    1,6    20,6    3,1    13,5    2,4    1,6    20,6   
Netherlands (GP) 9,4    41,1    6,4    7,1    64,1    9,4    41,1    6,4    7,1    64,1   
Spain 
1)  (GP+SP) 55,0    205,4    42,7    47,1    350,1    55,0    205,4    42,7    47,1    350,2   
United Kingdom 
3)  (GP) 44,7    196,0    34,9    33,4    308,9    44,7    196,0    34,9    33,5    309,1   
Total 118,5    484,2    94,8    99,9    797,4    118,5    484,2    94,9    100,1    797,7   
Belgium 
1)  (GP) 5,7    28,9    10,8    14,0    59,3    5,7    29,0    11,0    15,3    61,0   
Finland 
2)  (GP+SP) 2,8    12,8    3,8    2,3    21,7    2,8    12,8    3,9    2,5    22,0   
Netherlands (GP) 9,2    42,4    10,2    10,1    71,9    9,2    42,6    10,5    11,1    73,3   
Spain 
1)  (GP+SP) 49,8    210,1    47,0    61,7    368,6    49,8    210,9    48,0    67,4    376,1   
United Kingdom 
3)  (GP) 40,1    203,2    47,1    40,3    330,6    40,1    203,8    48,3    44,3    336,4   
Total 107,6    497,3    118,9    128,3    852,2    107,6    499,0    121,6    140,5    868,8   
Belgium 
1)  (GP) 5,5    25,2    10,1    21,1    61,8    5,5    25,4    10,6    27,6    69,1   
Finland 
2)  (GP+SP) 2,5    11,4    3,2    3,2    20,2    2,5    11,5    3,4    4,1    21,5   
Netherlands (GP) 9,4    41,1    9,3    15,1    74,9    9,4    41,5    10,0    20,8    81,6   
Spain 
1)  (GP+SP) 40,4    152,4    56,3    102,1    351,2    40,4    154,1    59,7    131,4    385,7   
United Kingdom 
3)  (GP) 37,7    184,9    47,7    66,2    336,5    37,7    186,3    50,6    87,8    362,4   
Total 95,4    415,0    126,6    207,6    844,7    95,4    418,8    134,4    271,6    920,2   
Average population based on: 1) 1997, 2) 1996, 3) 2000.-  4) Netherlands = 0-17 years.-  5) Netherlands = 18-64 years.
GP = General practitioner; SP = Specialist.
Source: Calculations by DIW.
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Table A.17 Contacts with a doctor by age group – Changes within the age group 
(per 1000 persons) 
Countries
0 - 14
4) 15 - 64
5) 65 - 74 75+ Total 0 - 14
4) 15 - 64
5) 65 - 74 75+ Total
Belgium 
1)  (GP) -  540   644  2 315  3 173  5 592 -  540   741  2 527  4 448  7 175
Finland 
2)  (GP+SP) -  342 -  702  1 443   672  1 072 -  342 -  653  1 531   880  1 417
Netherlands (GP) -  250  1 341  3 761  3 001  7 854 -  250  1 490  4 021  4 005  9 266
Spain 
1)  (GP+SP) - 5 176  4 694  4 360  14 637  18 515 - 5 176  5 497  5 325  20 232  25 878
United Kingdom 
3)  (GP) - 4 587  7 151  12 215  6 920  21 700 - 4 587  7 736  13 367  10 845  27 360
Total - 10 894  13 129  24 094  28 404  54 733 - 10 894  14 811  26 770  40 410  71 097
Belgium 
1) (GP) -  250 - 3 643 -  736  7 124  2 495 -  250 - 3 511 -  400  12 291  8 130
Finland 
2) (GP+SP) -  345 - 1 403 -  576   881 - 1 442 -  345 - 1 339 -  475  1 664 -  495
Netherlands (GP)   178 - 1 343 -  887  5 060  3 007   178 - 1 120 -  488  9 664  8 235
Spain 
1) (GP+SP) - 9 367 - 57 654  9 265  40 395 - 17 360 - 9 367 - 56 777  11 733  63 983  9 573
United Kingdom 
3) (GP) - 2 358 - 18 280   623  25 841  5 826 - 2 358 - 17 510  2 360  43 467  25 960
Total - 12 141 - 82 323  7 690  79 301 - 7 473 - 12 141 - 80 257  12 730  131 070  51 402
Belgium 
1) (GP) -  790 - 2 999  1 579  10 298  8 087 -  790 - 2 770  2 127  16 738  15 305
Finland 
2) (GP+SP) -  687 - 2 104   868  1 554 -  370 -  687 - 1 992  1 056  2 544   922
Netherlands (GP) -  72 -  2  2 874  8 061  10 861 -  72   371  3 533  13 669  17 501
Spain 
1) (GP+SP) - 14 543 - 52 960  13 625  55 032  1 155 - 14 543 - 51 280  17 058  84 216  35 451
United Kingdom 
3) (GP) - 6 944 - 11 129  12 839  32 761  27 526 - 6 944 - 9 774  15 727  54 312  53 320
Total - 23 035 - 69 194  31 784  107 705  47 260 - 23 035 - 65 446  39 501  171 480  122 500
Average population based on: 1) 1997, 2) 1996, 3) 2000.-  4) Netherlands = 0-17 years.-  5) Netherlands = 18-64 years.
GP = General practitioner; SP = Specialist.
Source: Calculations by DIW.
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Table A.18 Contacts with a doctor by age group – Changes within the age groups (%) 
Countries
0 - 14
4) 15 - 64
5) 65 - 74 75+ Total 0 - 14
4) 15 - 64
5) 65 - 74 75+ Total
Belgium 
1)  (GP) -8,6    2,3    27,3    29,4    10,4    -8,6    2,6    29,7    41,1    13,3   
Finland 
2)  (GP+SP) -10,9    -5,2    61,3    42,0    5,2    -10,9    -4,8    65,0    54,9    6,9   
Netherlands (GP) -2,6    3,3    58,3    42,3    12,3    -2,6    3,6    62,3    56,5    14,5   
Spain 
1)  (GP+SP) -9,4    2,3    10,2    31,1    5,3    -9,4    2,7    12,5    42,9    7,4   
United Kingdom 
3)  (GP) -10,3    3,6    35,0    20,7    7,0    -10,3    3,9    38,3    32,4    8,9   
Total -9,2    2,7    25,4    28,4    6,9    -9,2    3,1    28,2    40,4    8,9   
Belgium 
1)  (GP) -4,4    -12,6    -6,8    51,0    4,2    -4,4    -12,1    -3,6    80,5    13,3   
Finland 
2)  (GP+SP) -12,3    -11,0    -15,2    38,8    -6,7    -12,3    -10,4    -12,2    67,0    -2,2   
Netherlands (GP) 1,9    -3,2    -8,7    50,2    4,2    1,9    -2,6    -4,7    87,1    11,2   
Spain 
1)  (GP+SP) -18,8    -27,4    19,7    65,5    -4,7    -18,8    -26,9    24,4    95,0    2,5   
United Kingdom 
3)  (GP) -5,9    -9,0    1,3    64,1    1,8    -5,9    -8,6    4,9    98,1    7,7   
Total -11,3    -16,6    6,5    61,8    -0,9    -11,3    -16,1    10,5    93,3    5,9   
Belgium 
1)  (GP) -12,6    -10,6    18,6    95,4    15,0    -12,6    -9,8    25,0    154,8    28,5   
Finland 
2)  (GP+SP) -21,8    -15,6    36,9    97,2    -1,8    -21,8    -14,8    44,8    158,8    4,5   
Netherlands (GP) -0,8    0,0    44,6    113,7    17,0    -0,8    0,9    54,8    192,9    27,3   
Spain 
1)  (GP+SP) -26,5    -25,8    31,9    117,0    0,3    -26,5    -25,0    40,0    178,6    10,1   
United Kingdom 
3)  (GP) -15,5    -5,7    36,8    98,1    8,9    -15,5    -5,0    45,1    162,3    17,3   
Total -19,4    -14,3    33,5    107,8    5,9    -19,4    -13,5    41,6    171,3    15,4   
Average population based on: 1) 1997, 2) 1996, 3) 2000.-  4) Netherlands = 0-17 years.-  5) Netherlands = 18-64 years.
GP = General practitioner; SP = Specialist.
Source: Calculations by DIW.
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Table A.19 Changes in the age structure of contacts with a doctor (percentage points) 
Countries
0 - 14
4) 15 - 64
5) 65 - 74 75+ 0 - 14
4) 15 - 64
5) 65 - 74 75+
Belgium 
1)  (GP) -2,0     -3,9     2,4     3,5     -2,3     -5,0     2,3     4,9    
Finland 
2)  (GP+SP) -2,3     -6,5     6,1     2,7     -2,5     -7,2     6,2     3,5    
Netherlands (GP) -2,0     -5,1     4,1     3,0     -2,2     -6,1     4,2     4,1    
Spain 
1)  (GP+SP) -2,2     -1,7     0,6     3,3     -2,5     -2,6     0,6     4,5    
United Kingdom 
3)  (GP) -2,3     -2,0     3,0     1,4     -2,5     -2,9     3,1     2,3    
Total -2,2     -2,4     2,1     2,5     -2,5     -3,3     2,1     3,6    
Belgium 
1)  (GP) -0,8     -7,9     -1,9     10,6     -1,5     -10,7     -2,7     14,8    
Finland 
2)  (GP+SP) -0,8     -2,7     -1,6     5,1     -1,3     -4,9     -1,8     8,0    
Netherlands (GP) -0,3     -4,2     -1,8     6,2     -1,0     -7,2     -2,0     10,3    
Spain 
1)  (GP+SP) -2,0     -13,6     3,3     12,3     -2,8     -16,1     2,7     16,1    
United Kingdom 
3)  (GP) -0,9     -6,5     -0,1     7,5     -1,5     -9,2     -0,4     11,1    
Total -1,3     -9,2     1,0     9,5     -2,0     -11,9     0,6     13,3    
Belgium 
1)  (GP) -2,8     -11,7     0,5     14,0     -3,7     -15,6     -0,4     19,8    
Finland 
2)  (GP+SP) -3,1     -9,2     4,5     7,8     -3,8     -12,1     4,4     11,5    
Netherlands (GP) -2,2     -9,3     2,4     9,2     -3,2     -13,3     2,2     14,4    
Spain 
1)  (GP+SP) -4,2     -15,3     3,8     15,6     -5,2     -18,7     3,3     20,6    
United Kingdom 
3)  (GP) -3,2     -8,5     2,9     8,9     -4,0     -12,0     2,7     13,4    
Total -3,6     -11,6     3,1     12,0     -4,5     -15,2     2,7     17,0    
Average population based on: 1) 1997, 2) 1996, 3) 2000.-  4) Netherlands = 0-17 years.-  5) Netherlands = 18-64 years.
GP = General practitioner; SP = Specialist.
Source: Calculations by DIW.
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Table A.20 Long-term care recipients in institutions by age group – Changes within the 
age groups (per 1000 persons) 
Countries
0 - 59
1)2) 60 - 79
2) 80+ Total 0 - 59
1)2) 60 - 79
2) 80+ Total
Belgium - 0,1      3,7      41,5      45,0     - 0,1      4,4      57,9      62,2    
  Denmark - 0,2      4,3      3,0      7,1     - 0,2      4,9      6,5      11,2    
Finland - 0,6      4,9      11,2      15,5     - 0,6      5,3      15,8      20,6    
  France - 1,0      15,1      121,4      135,5     - 0,9      17,3      163,2      179,5    
Germany  0,8      26,9      224,8      252,6      1,0      33,1      318,7      352,9    
Netherlands  0,0      19,3      48,9      68,2      0,0      21,8      78,6      100,5    
Total - 1,1      74,1      450,8      523,8     - 0,7      86,8      640,7      726,8    
Belgium - 0,2      2,9      77,3      80,0     - 0,2      4,7      159,0      163,5    
  Denmark - 0,3      0,6      19,1      19,3     - 0,3      1,7      38,0      39,4    
Finland - 0,6     - 1,4      23,5      21,5     - 0,6     - 0,8      46,3      44,9    
  France - 3,3      16,6      237,2      250,4     - 3,2      22,4      435,2      454,4    
Germany - 14,4      9,0      441,5      436,1     - 14,2      20,8      902,4      909,0    
Netherlands - 0,1      2,7      161,6      164,1     - 0,1      8,0      341,9      349,9    
Total - 19,0      30,3      960,1      971,4     - 18,6      57,0     1 922,8     1 961,1    
Belgium - 0,4      6,6      118,7      125,0     - 0,4      9,1      216,9      225,7    
  Denmark - 0,5      4,9      22,1      26,4     - 0,5      6,6      44,4      50,6    
Finland - 1,2      3,4      34,7      37,0     - 1,2      4,6      62,1      65,5    
  France - 4,3      31,6      358,6      385,9     - 4,1      39,6      598,3      633,9    
Germany - 13,6      35,9      666,3      688,7     - 13,2      54,0     1 221,1     1 261,9    
Netherlands - 0,1      22,0      210,4      232,3     - 0,1      29,9      420,6      450,4    
Total - 20,1      104,4     1 410,9     1 495,2     - 19,3      143,8     2 563,5     2 688,0    
1) Denmark and France = 15-59 years.-  2) Netherlands = 0-64 years and 65-79 years.
Source: Calculations by DIW.
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Table A.21 Long-term care recipients in institutions by age group – Changes within 
the age groups (%) 
Countries
0 - 59
1)2) 60 - 79
2) 80+ Total 0 - 59
1)2) 60 - 79
2) 80+ Total
Belgium - 6      17      64      50     - 6      20      89      69    
  Denmark - 3      46      16      20     - 3      52      34      32    
Finland - 9      50      55      42     - 9      54      77      56    
  France - 3      23      63      46     - 2      26      84      61    
Germany  1      18      58      41      1      22      82      58    
Netherlands  0      51      37      39      0      57      60      58    
Total - 1      25      55      42     - 1      29      78      58    
Belgium - 10      12      72      59     - 9      18      129      108    
  Denmark - 5      4      87      46     - 4      12      149      85    
Finland - 11     - 10      74      41     - 11     - 5      128      79    
  France - 9      20      75      58     - 9      27      122      95    
Germany - 20      5      72      50     - 20      11      128      94    
Netherlands - 2      5      90      68     - 1      13      163      127    
Total - 15      8      76      55     - 15      15      132      99    
Belgium - 15      30      182      140     - 15      42      331      252    
  Denmark - 8      52      117      75     - 7      71      235      144    
Finland - 19      35      170      101     - 18      47      304      179    
  France - 12      48      186      130     - 11      60      309      214    
Germany - 19      23      171      112     - 19      35      314      206    
Netherlands - 2      58      161      133     - 1      78      320      258    
Total - 16      35      173      120     - 15      48      313      216    
1) Denmark and France = 15-59 years.-  2) Netherlands = 0-64 years and 65-79 years.
Source: Ccalculations by DIW.
2050/2001
Age-groups
Baseline scenario Living-longer-high scenario
2020/2001
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Table A.22 Age structure of long-term care recipients in institutions (%) 
Countries
0 - 59
1)2) 60 - 79
2) 80+ 0 - 59
1)2) 60 - 79
2) 80+
Belgium 3      24      73      3      24      73     
  Denmark 20      27      54      20      27      54     
Finland 17      27      56      17      27      56     
  France 12      22      65      12      22      65     
Germany 11      25      64      11      25      64     
Netherlands 3      22      75      3      22      75     
Total 10      24      66      10      24      66     
Belgium 2      19      79      1      17      81     
  Denmark 16      32      52      15      31      55     
Finland 11      28      61      10      26      64     
  France 8      19      73      8      18      75     
Germany 8      21      71      7      19      73     
Netherlands 2      24      74      2      22      76     
Total 7      21      72      6      20      74     
Belgium 1      13      86      1      10      90     
  Denmark 10      23      67      8      19      74     
Finland 7      18      75      5      14      81     
  France 5      14      81      4      11      85     
Germany 4      15      81      3      11      86     
Netherlands 1      15      84      1      11      88     
Total 4      15      81      3      11      86     
1) Denmark and France = 15-59 years.-  2) Netherlands = 0-64 years and 65-79 years.
Source: Calculations by DIW.
2050
Age-groups
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1)2) 60 - 79
2) 80+ 0 - 59 60 - 79 80+
Belgium -1,0      -5,4      6,4      -1,2      -7,1      8,2     
  Denmark -3,8      5,7      -1,9      -5,1      4,2      1,0     
Finland -6,3      1,4      4,9      -7,2      -0,3      7,5     
  France -4,1      -3,6      7,7      -4,9      -4,8      9,7     
Germany -3,2      -4,2      7,4      -4,1      -5,7      9,8     
Netherlands -0,9      1,8      -1,0      -1,1      0,0      1,1     
Total -3,1      -2,9      6,0      -3,8      -4,4      8,3     
Belgium -0,7      -5,7      6,4      -0,8      -7,4      8,3     
  Denmark -5,5      -9,2      14,8      -7,0      -12,1      19,1     
Finland -4,1      -10,2      14,2      -5,0      -12,4      17,4     
  France -3,5      -4,5      8,0      -4,0      -6,2      10,2     
Germany -3,8      -6,3      10,1      -4,3      -8,3      12,6     
Netherlands -0,9      -8,9      9,8      -1,1      -10,9      12,0     
Total -3,2      -6,4      9,6      -3,7      -8,3      12,0     
Belgium -1,7      -11,1      12,8      -2,0      -14,5      16,5     
  Denmark -9,3      -3,5      12,8      -12,2      -7,9      20,1     
Finland -10,3      -8,8      19,1      -12,2      -12,7      24,9     
  France -7,7      -8,1      15,7      -8,9      -11,0      19,9     
Germany -7,1      -10,5      17,6      -8,4      -14,0      22,4     
Netherlands -1,8      -7,1      8,8      -2,2      -10,9      13,1     
Total -6,3      -9,3      15,6      -7,5      -12,7      20,2     
1) Denmark and France = 15-59 years.-  2) Netherlands = 0-64 years and 65-79 years.
Source: Calculations by DIW.
2050/2001
Age-groups
Baseline scenario Living-longer-high scenario
2020/2001
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Table A.24 Long-term care recipients at home by age group (per 1000 persons) 
Countries
0 - 59
1) 60 - 79 80+ Total 0 - 59
1) 60 - 79 80+ Total
Belgium  11      48      64      123      11      48      64      123    
Finland  13      29      36      78      13      29      36      78    
  France  124      212      306      642      124      212      307      643    
Germany  272      475      591     1 338      272      475      591     1 338    
Total  420      764      998     2 182      420      764      999     2 183    
Belgium  11      57      101      169      11      59      115      184    
Finland  12      43      55      110      12      45      62      119    
  France  121      276      490      887      121      283      553      957    
Germany  270      555      966     1 791      271      573     1 102     1 946    
Total  413      932     1 611     2 956      414      959     1 832     3 205    
Belgium  10      62      168      239      10      67      246      322    
Finland  11      39      92      142      11      42      133      186    
  France  110      306      857     1 272      110      327     1 215     1 653    
Germany  219      577     1 591     2 387      220      629     2 357     3 206    
Total  349      983     2 709     4 041      351     1 065     3 951     5 367    
1) France = 15-59 years.
Source: Calculations by DIW.
2050
Age-groups
Baseline scenario Living-longer-high scenario
2001
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Table A.25 Long-term care recipients at home by age group – Changes within the 
age groups (per 1000 persons) 
Countries
0 - 59
1) 60 - 79 80+ Total 0 - 59
1) 60 - 79 80+ Total
Belgium - 0,7      9,2      37,3      45,8     - 0,6      10,7      51,2      61,2    
Finland - 1,2      14,3      18,4      31,6     - 1,1      15,7      25,7      40,2    
  France - 3,4      64,4      183,7      244,8     - 3,1      70,7      246,1      313,8    
Germany - 1,6      79,8      374,2      452,4     - 1,0      97,9      510,3      607,2    
Total - 6,8      167,8      613,6      774,6     - 5,8      195,0      833,3     1 022,5    
Belgium - 1,0      4,7      67,2      70,9     - 1,0      8,4      130,7      138,1    
Finland - 1,3     - 4,2      37,7      32,2     - 1,2     - 2,4      71,1      67,5    
  France - 11,2      29,3      367,1      385,2     - 10,8      44,3      662,2      695,7    
Germany - 51,3      21,9      625,8      596,4     - 50,8      55,7     1 255,2     1 260,2    
Total - 64,9      51,7     1 097,8     1 084,6     - 63,8      106,1     2 119,3     2 161,6    
Belgium - 1,7      13,9      104,5      116,8     - 1,6      19,1      181,9      199,4    
Finland - 2,4      10,1      56,1      63,7     - 2,3      13,3      96,8      107,7    
  France - 14,6      93,7      550,8      630,0     - 13,9      115,0      908,3     1 009,5    
Germany - 53,0      101,7     1 000,0     1 048,7     - 51,7      153,6     1 765,5     1 867,4    
Total - 71,7      219,4     1 711,5     1 859,2     - 69,6      301,1     2 952,6     3 184,0    
1) France = 15-59 years.
Source: Calculations by DIW.
2050/2001
Age-groups
Baseline scenario Living-longer-high scenario
2020/2001
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Table A.26 Age structure of persons receiving long-term care at home (%) 
Countries
0 - 59
1) 60 - 79 80+ 0 - 59
1) 60 - 79 80+
Belgium 9,1     39,0     51,8     9,1     39,0     51,9    
Finland 16,6     37,1     46,3     16,6     37,0     46,4    
  France 19,3     33,0     47,7     19,3     33,0     47,7    
Germany 20,3     35,5     44,2     20,3     35,5     44,2    
Total 19,3     35,0     45,7     19,2     35,0     45,7    
Belgium 6,3     33,9     59,9     5,7     31,9     62,4    
Finland 10,8     39,5     49,8     10,0     37,7     52,3    
  France 13,6     31,1     55,2     12,7     29,5     57,8    
Germany 15,1     31,0     53,9     13,9     29,5     56,6    
Total 14,0     31,5     54,5     12,9     29,9     57,1    
Belgium 4,0     25,8     70,2     3,0     20,8     76,2    
Finland 7,5     27,5     65,0     5,7     22,7     71,5    
  France 8,6     24,0     67,4     6,7     19,8     73,5    
Germany 9,2     24,2     66,7     6,9     19,6     73,5    
Total 8,6     24,3     67,0     6,5     19,8     73,6    
1) France = 15-59 years.
Source: Calculations by DIW.
2050
Age-groups
Baseline scenario Living-longer-high scenario
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1) 60 - 79 80+ 0 - 59
1) 60 - 79 80+
Belgium -2,9       -5,2       8,0       -3,4       -7,1       10,5      
Finland -5,8       2,4       3,4       -6,6       0,7       5,9      
  France -5,7       -1,8       7,6       -6,7       -3,4       10,1      
Germany -5,2       -4,5       9,7       -6,4       -6,1       12,4      
Total -5,3       -3,5       8,8       -6,3       -5,1       11,4      
Belgium -2,3       -8,1       10,3       -2,8       -11,0       13,8      
Finland -3,3       -11,9       15,3       -4,3       -14,9       19,2      
  France -5,0       -7,1       12,1       -6,0       -9,8       15,7      
Germany -5,9       -6,8       12,7       -7,1       -9,8       16,9      
Total -5,4       -7,2       12,5       -6,4       -10,1       16,5      
Belgium -5,2       -13,2       18,4       -6,1       -18,2       24,3      
Finland -9,2       -9,5       18,7       -10,9       -14,3       25,1      
  France -10,7       -9,0       19,7       -12,6       -13,2       25,8      
Germany -11,1       -11,3       22,5       -13,4       -15,9       29,3      
Total -10,6       -10,7       21,3       -12,7       -15,2       27,9      
1) France = 15-59 years.
Source: Calculations by DIW.
2050/2001
Age-groups
Baseline scenario Living-longer-high scenario
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Table A.28 Persons admitted into a hospital by health status in 2001 and 2050 
in participating countries and the EU
1) (per 1000 persons) 
Health Nether-
status lands
good  472      210      210     1 359     2 473      430      930     2 008     8 093     9 839    
fair  359      141      228     2 286     3 078      371      862     1 258     8 584     9 851    
bad  188      98      86     1 364     3 491      169      890     1 236     7 522     8 821    
total 1 018      450      525     5 008     9 042      970     2 682     4 503     24 198     28 511    
good  478      226      198     1 436     2 063      467      811     2 153     7 832   9 269    
fair  453      179      272     2 924     3 298      498     1 063     1 565     10 251   11 754    
bad  277      133      124     1 840     4 391      227     1 251     1 545     9 788   11 608    
total 1 207      538      593     6 200     9 752     1 192     3 126     5 264     27 872   32 631    
good  500      236      207     1 568     2 300      487      867     2 292     8 457   9 808    
fair  464      177      276     3 059     3 575      509     1 105     1 628     10 794   12 170    
bad  140      91      84      797     3 066      93      903      821     5 994   8 352    
total 1 104      504      566     5 424     8 940     1 089     2 876     4 741     25 244   30 329    
good  511      241      207     1 513     2 136      496      868     2 318     8 290   9 797    
fair  519      206      307     3 232     3 684      571     1 208     1 776     11 502   13 212    
bad  340      160      149     2 051     5 152      258     1 453     1 755     11 318   13 402    
total 1 369      607      663     6 797     10 972     1 326     3 529     5 848     31 110   36 410    
good  536      253      218     1 657     2 389      518      930     2 474     8 975   10 388    
fair  533      203      312     3 392     4 006      586     1 259     1 850     12 141   13 702    
bad  179      113      105      918     3 694      110     1 067      945     7 131   9 857    
total 1 248      569      635     5 967     10 090     1 213     3 256     5 270     28 247   33 947    
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
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Table A.29 Persons admitted into a hospital by health status changes between 2001  
and 2050 in participating countries and the EU
1) (per 1000 persons) 
Health Nether-
status lands
good  6       16      - 13       77      - 410       37      - 119       145      - 261    - 570     
fair  94       37       44       638       220       127       201       307      1 668    1 902     
bad  89       36       38       476       900       58       361       309      2 266    2 788     
total  189       89       69      1 191       710       222       443       761      3 673    4 120     
good  28       25      - 3       209      - 173       57      - 63       284       364    - 123     
fair  105       36       47       774       496       138       243       370      2 210    2 430     
bad - 48      - 7      - 3      - 567      - 425      - 76       13      - 415      -1 528    - 180     
total  85       54       42       416      - 102       119       193       239      1 046    2 128     
good  39       31      - 3       154      - 338       65      - 63       309       195    - 45     
fair  159       64       78       946       604       200       345       516      2 913    3 354     
bad  152       62       63       686      1 659       89       562       518      3 791    4 574     
total  350       157       138      1 786      1 925       355       845      1 343      6 899    7 884     
good  64       42       8       298      - 84       87       0       465       880     455     
fair  174       62       84      1 105       927       215       396       591      3 553    3 957     
bad - 9       15       18      - 447       201      - 60       176      - 292      - 397    1 319     
total  229       119       110       956      1 043       242       572       764      4 036    5 731     
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
Living-longer better health scenario
Living-longer-high scenario
All EU 
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Table A.30 Persons admitted into a hospital by health status changes between 2001 and  
2050 in participating countries and the EU 1) (%) 
Health Nether-
status lands
good 1,3      7,5      -6,1      5,7      -16,6      8,6      -12,8      7,2      -3,2      -5,8      
fair 26,1      26,2      19,2      27,9      7,1      34,1      23,3      24,4      19,4      19,3      
bad 47,3      36,4      43,9      34,9      25,8      34,2      40,6      25,0      30,1      31,6      
total 18,5      19,7      13,1      23,8      7,9      22,8      16,5      16,9      15,2      14,5      
good 6,0      12,1      -1,5      15,4      -7,0      13,2      -6,8      14,1      4,5      -1,2      
fair 29,2      25,4      20,8      33,8      16,1      37,3      28,2      29,4      25,7      25,0      
bad -25,5      -7,2      -3,1      -41,6      -12,2      -45,0      1,5      -33,6      -20,3      -2,1      
total 8,4      12,1      8,0      8,3      -1,1      12,3      7,2      5,3      4,3      7,5      
good 8,2      14,7      -1,4      11,4      -13,7      15,2      -6,7      15,4      2,4      -0,5      
fair 44,4      45,2      34,4      41,3      19,6      53,9      40,0      41,0      33,9      34,0      
bad 80,7      63,3      72,9      50,3      47,5      52,7      63,1      41,9      50,4      51,8      
total 34,3      34,9      26,4      35,6      21,3      36,6      31,5      29,8      28,5      27,6      
good 13,6      20,1      3,6      21,9      -3,4      20,3      0,0      23,2      10,9      4,6      
fair 48,4      43,5      36,7      48,3      30,1      57,9      46,0      46,9      41,4      40,6      
bad -4,5      15,2      21,3      -32,7      5,7      -35,3      19,7      -23,6      -5,3      15,4      
total 22,5      26,4      20,9      19,1      11,5      25,0      21,3      17,0      16,7      20,3      
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
Living-longer better health scenario
Living-longer-high scenario
All EU 
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Table A.31 Hospital bed days by health status 2001 and 2050 in participating countries  
and the EU
1) (per1000 persons) 
Health Nether-
status lands
good 3 090   1 525    871   7 298   21 150   2 461   6 267   10 029   52 692   67 180  
fair 4 968   1 565   2 086   21 836   42 193   3 914   9 014   10 634   96 209   110 715  
bad 4 102   2 243   1 742   27 460   77 778   3 227   17 146   16 490   150 188   172 152  
total 12 159   5 333   4 699   56 594   141 121   9 602   32 427   37 153   299 090   350 047  
good 3 726   1 814    889   8 352   18 568   2 932   6 430   12 627   55 338   69 920  
fair 6 718   2 100   2 717   30 755   47 866   5 569   11 659   15 334   122 717   141 810  
bad 5 382   3 025   2 590   38 420   102 631   4 459   24 737   23 369   204 613   231 772  
total 15 826   6 938   6 195   77 526   169 065   12 961   42 826   51 330   382 668   443 503  
good 3 956   1 922    939   9 231   20 918   3 074   6 990   13 641   60 670   74 615  
fair 6 905   2 074   2 761   32 501   52 273   5 719   12 159   16 042   130 435   147 328  
bad 2 527   2 081   1 764   17 538   73 687   1 874   17 921   12 803   130 195   168 931  
total 13 388   6 076   5 465   59 270   146 879   10 666   37 070   42 486   321 301   390 874  
good 4 270   2 035    965   8 998   19 549   3 211   7 140   14 535   60 703   76 291  
fair 7 880   2 488   3 161   34 935   54 308   6 542   13 341   18 394   141 049   162 834  
bad 6 350   3 570   3 145   43 191   121 955   5 086   28 887   27 896   240 080   269 145  
total 18 501   8 092   7 272   87 124   195 813   14 839   49 367   60 825   441 833   508 270  
good 4 550   2 171   1 022   9 978   22 133   3 373   7 788   15 757   66 771   81 632  
fair 8 122   2 445   3 226   37 010   59 486   6 728   13 946   19 268   150 232   169 431  
bad 3 125   2 528   2 234   20 299   89 682   2 200   21 284   15 541   156 894   200 337  
total 15 796   7 144   6 482   67 287   171 301   12 302   43 018   50 566   373 896   451 401  
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario 2001
2050
Germany Spain UK All EU 
1)
Living-longer better health scenario
Living-longer-high scenario
Baseline scenario
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Table A.32 Hospital bed days by health status – Changes between 2001 and 2050 in  
participating countries and the EU
1) (per 1000 persons) 
Health Nether-
status lands
good  636     288     18    1 053    -2 582     471     163    2 598    2 646    2 740    
fair 1 750     534     631    8 919    5 673    1 655    2 645    4 700    26 508    31 095    
bad 1 280     782     848    10 960    24 853    1 232    7 590    6 879    54 424    59 621    
total 3 667    1 605    1 496    20 932    27 944    3 358    10 399    14 177    83 579    93 456    
good  865     396     69    1 932    - 232     612     722    3 613    7 978    6 907    
fair 1 938     509     675    10 665    10 080    1 805    3 146    5 408    34 226    37 657    
bad -1 574    - 162     22    -9 922    -4 090    -1 353     774    -3 687    -19 993    1 820    
total 1 229     743     766    2 676    5 758    1 064    4 643    5 333    22 211    46 384    
good 1 178     509     94    1 697    -1 605     749     870    4 499    7 990    9 084    
fair 2 908     921    1 073    13 084    12 090    2 625    4 321    7 749    44 771    52 040    
bad 2 245    1 324    1 401    15 713    44 110    1 857    11 726    11 389    89 765    96 854    
total 6 331    2 754    2 569    30 494    54 594    5 230    16 917    23 638    142 527    157 978    
good 1 457     645     151    2 677     978     911    1 518    5 721    14 058    13 898    
fair 3 150     878    1 138    15 159    17 268    2 811    4 926    8 623    53 954    59 681    
bad - 981     283     490    -7 179    11 837    -1 029    4 123    - 966    6 579    33 086    
total 3 627    1 806    1 779    10 657    30 083    2 693    10 567    13 378    74 591    106 666    
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
Living-longer better health scenario
Living-longer-high scenario
All EU 
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Table A.33 Hospital bed days by health status – Changes between 2001 and 2050 in  




good 21      19      2      14      -12      19      3      26      5      4      
fair 35      34      30      41      13      42      29      44      28      28      
bad 31      35      49      40      32      38      44      42      36      35      
total 30      30      32      37      20      35      32      38      28      27      
good 28      26      8      26      -1      25      12      36      15      10      
fair 39      33      32      49      24      46      35      51      36      34      
bad -38      -7      1      -36      -5      -42      5      -22      -13      1      
total 10      14      16      5      4      11      14      14      7      13      
good 38      33      11      23      -8      30      14      45      15      14      
fair 58      59      51      60      29      67      48      73      47      47      
bad 55      59      80      57      57      57      68      69      60      56      
total 52      52      55      54      39      54      52      64      48      45      
good 47      42      17      37      5      37      24      57      27      21      
fair 63      56      55      69      41      72      55      81      56      54      
bad -24      13      28      -26      15      -32      24      -6      4      20      
total 30      34      38      19      21      28      33      36      25      31      
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
Living-longer better health scenario
Living-longer-high scenario
All EU 
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Table A.34 Contacts with a general practitioner by health status 2001 and 2050 in  




good  20,8      6,6      4,5      59,1      66,8      17,8      48,3      74,2      298,0      410,2    
fair  14,4      3,7      3,4      77,7      113,1      13,9      40,8      40,5      307,5      378,1    
bad  6,2      2,3      1,8      33,3      113,8      5,3      34,1      27,2      223,8      286,1    
total  41,3      12,6      9,6      170,1      293,7      37,0      123,1      141,9      829,4     1 074,4    
good  21,6      7,0      3,9      61,7      57,6      19,5      42,4      79,7      293,3      392,1     
fair  18,1      4,6      3,8      99,6      119,3      17,9      50,1      47,9      361,2      449,1     
bad  7,9      3,0      3,1      45,9      135,9      6,9      46,9      32,2      281,7      381,1     
total  47,6      14,5      10,7      207,1      312,8      44,2      139,4      159,8      936,3     1 222,4     
good  22,7      7,3      4,0      67,2      64,9      20,3      45,4      84,7      316,6      415,4     
fair  18,6      4,5      3,8      104,3      129,4      18,2      52,2      49,7      380,7      465,5     
bad  3,6      2,0      2,4      19,8      93,7      2,9      33,8      17,1      175,2      277,5     
total  44,9      13,8      10,2      191,3      288,0      41,4      131,4      151,6      872,5     1 158,4     
good  23,3      7,4      4,0      64,6      60,1      20,6      45,2      84,8      310,0      415,0     
fair  20,6      5,2      4,2      110,0      132,0      20,3      56,4      52,7      401,3      502,0     
bad  9,1      3,5      4,0      51,3      156,3      7,8      54,1      35,7      321,8      440,2     
total  53,0      16,1      12,1      225,9      348,3      48,7      155,7      173,2     1 033,1     1 357,3     
good  24,5      7,7      4,1      70,6      68,0      21,5      48,6      90,5      335,5      440,5     
fair  21,3      5,1      4,2      115,4      143,5      20,7      58,9      54,8      424,0      521,1     
bad  4,3      2,4      3,2      22,9      110,4      3,4      39,6      19,1      205,3      327,1     
total  50,1      15,2      11,5      209,0      321,9      45,6      147,1      164,4      964,8     1 288,7     
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
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Table A.35 Contacts with a general practitioner by health status – Changes between  
2001 and 2050 in participating countries and the EU
1) (per 1000 persons) 
Health Nether-
status lands
good  832    365   - 592   2 572   -9 186   1 664   -5 874   5 482   -4 736   -18 103  
fair 3 741    841    354   21 839   6 235   4 003   9 299   7 415   53 727   71 040  
bad 1 747    686   1 334   12 551   22 092   1 594   12 839   5 048   57 890   95 038  
total 6 320   1 893   1 097   36 961   19 141   7 261   16 264   17 944   106 881   147 975  
good 1 902    642   - 436   8 135   -1 861   2 470   -2 876   10 561   18 536   1 797  
fair 4 242    813    352   26 528   16 290   4 345   11 395   9 249   73 215   90 988  
bad -2 579   - 330    648   -13 503   -20 076   -2 395   - 269   -10 106   -48 610   -1 294  
total 3 566   1 124    564   21 159   -5 647   4 420   8 250   9 704   43 141   91 491  
good 2 492    749   - 519   5 516   -6 713   2 782   -3 066   10 650   11 891   4 676  
fair 6 249   1 468    737   32 189   18 820   6 402   15 597   12 175   93 637   123 742  
bad 2 959   1 195   2 271   17 976   42 407   2 519   19 990   8 465   97 781   153 915  
total 11 699   3 413   2 489   55 681   54 514   11 703   32 521   31 290   203 309   282 333  
good 3 709   1 070   - 358   11 527   1 193   3 670    274   16 280   37 365   26 851  
fair 6 868   1 415    753   37 687   30 377   6 836   18 085   14 266   116 287   146 391  
bad -1 854    89   1 466   -10 397   -3 460   -1 906   5 504   -8 109   -18 666   48 031  
total 8 723   2 574   1 861   38 817   28 110   8 600   23 864   22 437   134 986   221 274  
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
Living-longer better health scenario
Living-longer-high scenario
All EU 
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Table A.36 Contacts with a general practitioner by health status – Changes between  




good 4,0     5,5     -13,2     4,4     -13,8     9,3     -12,2     7,4     -1,6     -4,4     
fair 26,0     22,6     10,3     28,1     5,5     28,9     22,8     18,3     17,5     18,8     
bad 28,4     30,1     75,9     37,7     19,4     30,2     37,7     18,6     25,9     33,2     
total 15,3     15,0     11,4     21,7     6,5     19,6     13,2     12,6     12,9     13,8     
good 9,2     9,7     -9,8     13,8     -2,8     13,8     -6,0     14,2     6,2     0,4     
fair 29,5     21,8     10,3     34,1     14,4     31,3     27,9     22,8     23,8     24,3     
bad -41,9     -14,5     36,9     -40,5     -17,6     -45,3     -0,8     -37,2     -21,7     -0,5     
total 8,6     8,9     5,8     12,4     -1,9     11,9     6,7     6,8     5,2     8,6     
good 12,0     11,3     -11,6     9,3     -10,0     15,6     -6,3     14,4     4,0     1,1     
fair 43,4     39,4     21,5     41,4     16,6     46,1     38,2     30,1     30,4     32,7     
bad 48,0     52,4     129,0     53,9     37,2     47,7     58,6     31,1     43,7     53,8     
total 28,3     27,0     25,8     32,7     18,6     31,6     26,4     22,0     24,5     26,3     
good 17,8     16,1     -8,0     19,5     1,8     20,6     0,6     21,9     12,5     6,5     
fair 47,7     38,0     22,0     48,5     26,8     49,3     44,3     35,2     37,8     39,1     
bad -30,1     3,9     83,3     -31,2     -3,0     -36,1     16,1     -29,8     -8,3     17,2     
total 21,1     20,4     19,3     22,8     9,6     23,2     19,4     15,8     16,3     20,7     
1) EU (15) without Luxembourg and Sweden; people aged 15+.
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
Living-longer better health scenario
Living-longer-high scenario
All EU 
1)132 | ERIKA SCHULZ 
 
Table A.37 Persons severely hampered by chronic illness or disability by health status  
in 2001 and 2050 in participating countries and the EU




good  47      26      16      315      128      108      106     1 103     1 849     2 096    
fair  172      89      138     2 109      902      453      399     1 801     6 064     7 472    
bad  207      166      171     2 557     5 679      461     1 343     1 914     12 500     16 165    
total  426      281      326     4 982     6 709     1 023     1 849     4 819     20 413     25 733    
cut down
3)  211     184      254     1 684     -       615     948     3 227     7 122     14 536    
good  61      33      18      363      167      133      104     1 516     2 397     2 577    
fair  241      119      182     3 077     1 174      609      508     2 537     8 447     9 689    
bad  267      231      258     3 622     7 632      602     1 963     2 530     17 105     22 028    
total  569      384      458     7 063     8 974     1 344     2 576     6 583     27 949     34 294    
cut down
3)  278      248      358     2 447     5 156      779     1 365     4 680     15 311     19 591    
good  65      36      20      401      199      140      112     1 647     2 620     2 779    
fair  249      118      187     3 266     1 292      622      531     2 653     8 918     10 074    
bad  123      160      182     1 611     5 592      254     1 441     1 377     10 740     16 206    
total  437      314      389     5 278     7 082     1 017     2 084     5 677     22 278     29 060    
cut down
3)  213      203      305     1 839     4 092      584     1 112     4 059     12 406     16 680    
good  72      39      20      394      203      149      115     1 783     2 775     2 968    
fair  286      142      211     3 515     1 385      708      589     2 977     9 813     11 182    
bad  309      277      317     4 085     9 112      687     2 333     2 927     20 048     25 760    
total  667      458      548     7 994     10 700     1 544     3 037     7 687     32 637     39 910    
cut down
3)  325     296      429     2 779     6 162     880     1 616     5 575     18 061     22 860    
good  77      43      22      437      243      157      124     1 943     3 045     3 209    
fair  296      140      218     3 738     1 528      726      616     3 117     10 378     11 644    
bad  148      198      232     1 878     6 818      300     1 744     1 615     12 934     19 352    
total  522      380      472     6 053     8 589     1 183     2 484     6 675     26 358     34 205    
cut down
3)  253     245      370     2 116     4 969     666     1 330     4 869     14 818     19 675    
1) EU (15) without Luxembourg and Sweden; people aged 15+.-  2) Severely and to some extend hampered.-  3) Severely
hampered persons who have to cut down things thea usually do due to chronic illness or desability (all health status together).
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK
2)







 AGEING, HEALTH AND RETIREMENT IN EUROPE – AGIR WP4, PART A | 133 
 
Table A.38 Persons severely hampered by chronic illness or disability by health status  
in participating countries and the EU
1) – Changes between 2001 and 2050  
(per 1000 persons) 
Health Nether-
status lands
good  14      8      3      48      39      25     - 2      413      548     481     
fair  69      30      43      968      272      156      109      736     2 383    2 217     
bad  60      65      86     1 065     1 953      140      620      616     4 605    5 863     
total  143      103      132     2 081     2 264      321      727     1 764     7 536    8 561     
cut down 
3)  67      64      105      762     1 335      164      417     1 453     4 367    5 055     
good  19      10      4      86      71      32      6      544      771     672     
fair  77      29      49     1 157      389      169      131      852     2 854    2 649     
bad - 85     - 6      11     - 947     - 87     - 207      98     - 538     -1 760     456     
total  11      33      64      296      373     - 5      236      858     1 865    3 778     
cut down 
3)  2      19      51      155      270     - 31      164      832     1 462    2 362     
good  26      13      5      79      75      41      9      679      925     870     
fair  114      53      72     1 404      482      255      189     1 174     3 743    3 705     
bad  101      111      145     1 526     3 428      226      989     1 011     7 538    9 582     
total  241      177      222     3 010     3 985      521     1 187     2 864     12 207    14 157     
cut down 
3)  114      112      175     1 093     2 337      265      668     2 344     7 108    8 312     
good  31      17      6      122      115      49      18      839     1 196    1 101     
fair  124      51      79     1 627      625      272      217     1 314     4 309    4 213     
bad - 60      32      61     - 681     1 134     - 161      400     - 301      424    3 589     
total  95      99      146     1 068     1 874      160      634     1 852     5 928    8 903     
cut down 
3)  42      61      116      430     1 144      51      382     1 638     3 865    5 346     
1) EU (15) without Luxembourg and Sweden; people aged 15+.-  2) Severely and to some extend hampered.-  3) Severely
hampered persons who have to cut down things they usually do due to chronic illness or disability (all health status together).
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK 
2)
Living-longer better health scenario
Living-longer-high scenario
All EU 
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Table A.39 Persons severely hampered by chronic illness or persons by health status 
in participating countries and the EU
1) – 





good 31,0     29,0     16,1     15,4     30,8     23,2     -1,8     37,4     29,7     22,9      
fair 39,9     34,2     31,3     45,9     30,1     34,4     27,3     40,8     39,3     29,7      
bad 28,7     39,1     50,4     41,6     34,4     30,4     46,1     32,2     36,8     36,3      
total 33,5     36,6     40,6     41,8     33,7     31,4     39,3     36,6     36,9     33,3      
cut down 
3) 31,7     35,0     41,2     45,3     34,9     26,7     44,0     45,0     39,9     34,8      
good 39,9     38,9     24,2     27,4     55,4     29,5     5,7     49,3     41,7     31,9      
fair 44,7     32,9     35,4     54,8     43,1     37,4     32,9     47,3     47,1     35,7      
bad -40,8     -3,7     6,2     -37,0     -1,5     -44,8     7,3     -28,1     -14,1     2,9      
total 2,5     11,8     19,5     5,9     5,6     -0,5     12,7     17,8     9,1     14,9      
cut down 
3) 0,8     10,4     20,1     9,2     7,1     -5,1     17,3     25,8     13,4     16,5      
good 54,7     51,5     29,4     25,1     58,2     37,6     8,0     61,5     50,0     41,5      
fair 66,0     59,2     52,0     66,5     53,4     56,2     47,4     65,1     61,7     49,5      
bad 48,9     66,8     84,6     59,6     60,3     48,9     73,6     52,8     60,3     59,2      
total 56,4     63,0     68,1     60,4     59,3     50,9     64,1     59,4     59,7     55,0      
cut down 
3) 53,8     60,6     69,1     64,9     61,1     43,0     70,4     72,6     64,9     57,1      
good 65,8     64,5     38,7     38,6     89,5     45,0     16,8     76,0     64,6     52,3      
fair 72,0     56,8     57,1     77,1     69,2     60,1     54,2     72,9     71,0     56,7      
bad -28,7     19,2     35,4     -26,6     20,0     -35,0     29,7     -15,7     3,4     22,8      
total 22,3     35,3     44,8     21,4     27,9     15,6     34,3     38,4     29,0     35,2      
cut down 
3) 19,8     33,1     45,8     25,5     29,9     8,3     40,2     50,7     35,3     37,3      
1) EU (15) without Luxembourg and Sweden; people aged 15+.-  2) Severely and to some extend hampered.-  3) Severely
hampered persons who have to cut down things they usually do due to chronic illness or disability (all health status together).
Source: Projections by DIW.
Baseline scenario
Baseline scenario with improving health
Belgium Denmark Finland France Germany Spain UK 
2)
Living-longer better health scenario
Living-longer-high scenario
All EU 
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Table A.40 Development of the population aged 15+, health care utilisation and  
severely hampered persons in 2050 – Difference between the living-longer 
high scenario and the baseline scenario (2001 = 100) 
 
Countries Contacts Hampered
with a GP 
1) persons 
2)
Belgium   7   16   22   13   22
Denmark   7   15   22   12   26
Finland   6   13   23   14   28
France   6   12   17   11   20
Germany   7   13   19   12   26
Netherlands   7   14   19   12   16
Spain   7   15   20   13   26
United Kingdom   7   13   25   9   28
All   7   13   20   12   25
EU (15) 
3)   7   13   18   12   22
Belgium   7   14   20   12   19
Denmark   7   14   20   11   23
Finland   6   13   22   13   26
France   6   11   14   10   17
Germany   7   13   17   11   23
Netherlands   7   13   17   11   13
Spain   7   14   18   13   23
United Kingdom   7   12   22   9   25
All   7   12   17   11   22
EU (15)
**)   7   13   17   12   21
1) GP= General Practitioner.-  2) Severely hampered persons who have to cut down
things they usually do due to chronic illness or disability (all health status together).-
3) Without Luxembourg and Sweden.
Source: Projections by DIW.
constant health







days136 | ERIKA SCHULZ 
 
Table A.41 Development of the population aged 15+, health care utilisation and  
severely hampered persons 2050 – Difference between improving health 
and constant health (2001 = 100) 
Countries Hospital Contacts Hampered Contacts Hampered
days with a GP 
1) persons 
2) with a GP 
1) persons 
2)
Belgium   0   10   20   7   31   0   12   22   7   34
Denmark   0   8   16   6   25   0   8   18   7   28
Finland   0   5   16   6   21   0   5   17   6   23
France   0   15   32   9   36   0   17   35   10   39
Germany   0   9   16   8   28   0   10   17   9   31
Netherlands   0   11   24   8   32   0   12   26   8   35
Spain   0   9   18   7   27   0   10   20   7   30
United Kingdom   0   12   24   6   19   0   13   28   6   22
All   0   11   21   8   27   0   12   23   8   30
EU (15) 
3)   0   7   13   5   19   0   7   14   6   20
1) GP= General Practitioner.-  2) Severely hampered persons who have to cut down things they usually do due to chronic illness or disability (all health
status together).-  3) Without Luxembourg and Sweden.
Source: Projections by DIW.
Baseline scenario
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Table A.42 Development of the population aged 15+, health care utilisation and  
severely hampered persons 2050 – Difference with regard to the baseline 
scenario (2001 = 100) 
Countries Hospital Contacts Hampered Contacts Hampered
days with a GP 
1) persons 
2) with a GP 
1) persons 
2)
Belgium   0   0   0   0   0   7   16   22   13   22
Denmark   0   0   0   0   0   7   15   22   12   26
Finland   0   0   0   0   0   6   13   23   14   28
France   0   0   0   0   0   6   12   17   11   20
Germany   0   0   0   0   0   7   13   19   12   26
Netherlands   0   0   0   0   0   7   14   19   12   16
Spain   0   0   0   0   0   7   15   20   13   26
United Kingdom   0   0   0   0   0   7   13   25   9   28
All   0   0   0   0   0   7   13   20   12   25
EU (15) 
3)   0   0   0   0   0   7   13   18   12   22
Belgium   0 -  10 -  20 -  7 -  31   7   4   0   6 -  12
Denmark   0 -  8 -  16 -  6 -  25   7   7   4   5 -  2
Finland   0 -  5 -  16 -  6 -  21   6   8   6   8   5
France   0 -  15 -  32 -  9 -  36   6 -  5 -  18   1 -  19
Germany   0 -  9 -  16 -  8 -  28   7   4   2   3 -  5
Netherlands   0 -  11 -  24 -  8 -  32   7   2 -  7   4 -  19
Spain   0 -  9 -  18 -  7 -  27   7   5   0   6 -  4
United Kingdom   0 -  12 -  24 -  6 -  19   7   0 -  2   3   6
All   0 -  11 -  21 -  8 -  27   7   1 -  3   3 -  5
EU (15) 
3)   0 -  7 -  13 -  5 -  19   7   6   4   7   2
1) GP= General Practitioner.-  2) Severely hampered persons who have to cut down things they usually do due to chronic illness or disability (all health
status together).-  3) Without Luxembourg and Sweden.















AGIR – Ageing, Health and Retirement in Europe 
 
AGIR is the title of a major study on the process of population ageing in Europe and its 
future economic consequences. This project was motivated by an interest in verifying 
whether people are not only living longer but also in better health. It aims at analysing 
how the economic impact of population ageing could vary when not only demographic 
factors, but also health developments are taken into consideration. The project started in 
January 2002 for a period of three years.  
The principal objectives of the study are to:  
•  document developments in the health of the elderly, ideally since 1950, based on 
a systematic collection of existing national data on the health and morbidity of 
different cohorts of the population; 
•  analyse retirement decisions and the demand for health care as a function of age, 
health and the utility of work and leisure; 
•  combine these results, and on that basis to elaborate scenarios for the future 
evolution of expenditure on health care and pensions; and 
•  analyse the potential macroeconomic consequences of different measures aiming 
at improving the sustainability of the European pension systems.  
The AGIR project is carried out by a consortium of nine European research institutes, 
most of which are members of ENEPRI: 
•  CEPS (Centre for European Policy Studies), Brussels 
•  CEPII (Centre d’Etudes Prospectives et d’Informations Internationales), Paris 
•  CPB (Netherlands Bureau for Economic Policy Analysis), The Hague 
•  DIW (Deutsches Institut für Wirtschaftsforschung), Berlin  
•  ETLA (the Research Institute of the Finnish Economy), Helsinki 
•  FEDEA (Fundación de Estudios de Economía Aplicada), Madrid 
•  FPB (Belgian Federal Planning Bureau), Brussels 
•  NIESR (National Institute for Economic and Social Research), London 
•  LEGOS (Laboratoire d’Economie et de Gestion des Organisations de Santé,  
Université de Paris-Dauphine), Paris 
It has received finance from the European Commission, under the Quality of Life 
Programme of the 5
th EU Research Framework Programme. The project is coordinated 
by Jorgen Mortensen, Associate Senior Research Fellow at CEPS. For further information, 
contact him at: jorgen.mortensen@ceps.be. 
 About ENEPRI 
he European Network of Economic Policy Research Institutes (ENEPRI) is composed of leading 
socio-economic research institutes in practically all EU member states and candidate countries that 
are committed to working together to develop and consolidate a European agenda of research. 
ENEPRI was launched in 2000 by the Brussels-based Centre for European Policy Studies (CEPS), which 
provides overall coordination for the initiative.  
While the European construction has made gigantic steps forward in the recent past, the European 
dimension of research seems to have been overlooked. The provision of economic analysis at the 
European level, however, is a fundamental prerequisite to the successful understanding of the 
achievements and challenges that lie ahead. ENEPRI aims to fill this gap by pooling the research efforts 
of its different member institutes in their respective areas of specialisation and to encourage an explicit 
European-wide approach. 
 
ENEPRI is composed of the following member institutes: 
CASE  Center for Social and Economic Research, Warsaw, Poland 
CEPII  Centre d’Études Prospectives et d’Informations Internationales, Paris, France 
CEPS  Centre for European Policy Studies, Brussels, Belgium 
CERGE-EI  Centre for Economic Research and Graduated Education, Charles University, Prague, 
Czech Republic 
CPB  Netherlands Bureau for Economic Policy Analysis, The Hague, The Netherlands 
DIW  Deutsches Institut für Wirtschaftsforschung, Berlin, Germany 
ESRI  Economic and Social Research Institute, Dublin, Ireland 
ETLA  Research Institute for the Finnish Economy, Helsinki, Finland 
FEDEA  Fundación de Estudios de Economía Aplicada, Madrid, Spain 
FPB  Federal Planning Bureau, Brussels, Belgium 
IE-BAS  Institute of Economics, Bulgarian Academy of Sciences, Sofia, Bulgaria 
IER  Institute for Economic Research, Ljubljana, Slovenia 
IHS  Institute for Advanced Studies, Vienna, Austria 
ISAE  Istituto di Studi e Analisi Economica, Rome, Italy 
ISWE-SAS  Institute for Slovak and World Economy, Bratislava, Slovakia 
NIER  National Institute of Economic Research, Stockholm, Sweden 
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